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Abstract 
This thesis focuses on two main areas: the synthesis of novel anti-metabolites of 1-deoxy-
D-xyulose-5-phosphate (DXP) and the stereoelectronics which influence the conformation 
of fluoromethyl groups in organic compounds. 
DXP, a sugar phosphate, has recently been established as a key biosynthetic intermediate 
to a number of plant and bacterial co-enzymes and vitamins. Chapter 1 describes the role 
of DXP in three biosynthetic pathways; in the formation of the isoprenoid building block 
isopentenyl pyrophosphate, and the vitamins Bi and Be. A new strategy to novel 
antibiotics and / or herbicides is proposed by the inhibition of DXP metabolism. A 
description of phosphonates as hydrolytically stable phosphate mimics is presented, 
including fluorine phosphonates that enable fine tuning of these mimics. Synthetic 
targets are designed as inhibitors of the DXP reductoisomerase catalysed reaction from 
DXP to 2-C-methyl-D-erythritol-4-phosphate (MEP). In Chapter 2 the successful 
synthesis of the CH2 phosphonate analogues of DXP and MEP is described. The DXP 
analogue was initially approached via the diethyl phosphonate ester, however it proved 
necessary in the end to prepare the dibenzyl ester followed by hydrogenation. Synthesis 
towards the CF2, and the a-fluorinated ketone, phosphonate analogues of DXP were 
incomplete due to low yields. Further syntheses is described towards the reduced form of 
the CH2 phosphonate analogue of DXP, and to a compound related to fosmidomycin. 
Chapter 3 describes fluorine's stereoelectronic influence in determining the 
conformations of fluoromethyl containing organic compounds through n/71-0* 
conjugation and gauche effects. Solid state evidence for the influence of these effects is 
presented through the first X-ray crystallographic data of fluoromethylaromatics and P-
fluoroethylamides respectively. Structures of bis-2,6-(fluoromethyl)pyridine and its N-
oxide displayed fluoromethyl conformations with the C-F bond co-planar to the aromatic 
ring whereas benzyl fluoride and 4-bromobenzyl fluoride displayed conformations with 
the C-F bond orthogonal to the aromatic ring. Structures of //-(2-fluoroethyl)-3,5-
dinitrobenzamide and 7\^-(2-fluoroethyl)-4-nitrobenzamide reveal a fluorine / amide 
gauche effect. 
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Chapter 1 
Biosynthesis of DXP 
and its inhibition 
1.1 Introduction 
The discovery of chemicals to combat the growth of microbial and plant organisms 
remains a central pursuit of contemporary science. Study of the biosynthetic pathways to 
the essential metabolites of these organisms often provides insights into designing novel 
antibiotics and herbicides. The role of l-deoxy-D-xylulose-5-phosphate, produced by both 
bacteria and plants, is highlighted in this thesis. This compound has recently been found 
to occupy a pivotal role in the biosynthesis of a number of metabolites including several 
vitamins. An excellent opportunity is therefore presented to synthesise rationally 
designed novel anti-metabolites based on the metabolism of l-deoxy-D-xylulose-5-
phosphate. 
1.2 Biological role of l-deoxy-D-xylulose-5-phosphate 
Recent biosynthetic investigations have revealed that l-deoxy-D-xylulose-5-phosphate 
(DXP) is an intermediate in three biosynthetic pathways (Figure 1) in bacteria and plants. 
Two of these pathways are involved in the biosynthesis of the vitamins Bi and Be. The 
other involves the production of isopentenyl pyrophosphate (IPP), an essential building 
block to compounds such as co-enzyme Q and cholesterol, collectively known as the 
isoprenoids. The involvement of this metabolite in these three pathways is discussed in 
greater detail in sections 1.3-1.5. 
, Vitamin's A, D3, K 
"OPP Co-Enzyme Q 
Isopentenyl pyrophosphate (IPP) 
O OH 
OH 
1-Deoxy-D-xylulose-{5-phosphate) 
N 
NH2 
Vitamin Bg (PLP) 
N "S^ ^ OPP 
Vitamin Bi (TPP) 
O 0 0 
^ II II II 
P = —P-OH PP = —P-O-P-OH 
OH OH OH 
Figure 1 The intermediacy of l-deoxy-D-xylulose-5-phosphate in three biosynthetic 
pathways to vitamins and IPP. 
1.3 The l-deoxy-D-xyIulose-5-phosphate pathway 
Isoprenoids are secondary metabolites of plants and micro-organisms, and representatives 
of them are well are known as flavours and fragrances. Examples of some isoprenoids are 
shown below. This large (greater than twenty thousand) family of ubiquitous natural 
compounds vary hugely in their structure, fiinction and source organism, their unifying 
characteristic being that they are partly, or wholly derived from IPP. The unique 
importance of the isoprenoids in the pharmaceutical, agrochemical, and flavour and 
fragances industries has therefore made studying the biosynthetic pathways to, and from 
IPP, of intrinsic value. 
Cholesterol Limonene 
,0 H 
CO2H 
Gibberellin A3 
'OH 
P-Carotene 
Since the elucidation of IPP biosynthesis in the late 1950's,* by the pioneering studies of 
Bloch, Comforth and coworkers, it was generally assumed that there was only one route 
(known as the mevalonic acid (MVA) pathway due to the intermediacy of MVA) 
operating to produce IPP. When [l-'^C]-glucose was fed to eubacteria (also known as 
true bacteria; this class encompases the enteric (gut) bacteria and the photosynthetic 
organisms formerly known as blue-green algae, but now better known as cyanobacteria), 
the MVA pathway resuhs in an indicative labelling pattern in IPP, as shown in Scheme 1. 
This route was increasingly being called into doubt in bacterial systems by the late 1980's 
when a number of feeding experiments could not readily be rationalised by the 
intermediacy of MVA. In 1988 Flesch and Rohmer reported an unexpected labelling 
pattern in recovered hopanoids after feeding of [l-'^C]-acetate.'^ Although conflicting 
results had been reported before, they had not been so conclusive as to suggest that an 
alternative pathway was operating to form IPP. More conflicting results followed, after 
feeding of isotopically labelled glucose, pyruvate and erythrose to eubacteria revealed that 
the isoprenoid units of hopanoids, and the prenyl side chains of ubiquinones were not 
formed via the MVA pathway.^ 
- O H 
OH 
OH 
GH2OH 
[1-"C]-Glucose 
IPP 
O^ S-CoA 
+ 
O ^ S - C o A 9O2H 
O ^ S - C o A 
O ^ S-CoA 
OPP 
CO2H 
MVA-5PP 
•OH 
O ^ S - C o A 
CO2H 
•OH 
OH 
MVA 
Scheme 1 The MVA pathway, showing the expected '^ C labelling pattern in IPP after 
feeding of [l-'^C]-glucose. C. 
Initial forays to unmask this non-MVA pathway were carried out by Rohmer et al,*'^ who 
established in bacteria that the novel route is initiated by the addition of a C2 acyloin unit 
(derived from pyruvate in a TPP mediated decarboxylation) to a C3 unit (a sugar 
phosphate) affording a C5 phosphate sugar. The C3 unit was later identified as 
glyceraldehyde-3-phosphate (GAP), after a series of experiments using different E. coli 
mutants.* Deuterium incorporation into the isoprenoids of E. coli after feeding 
experiments with deuterium-labelled 1-deoxy-D-xylulose showed^ that condensation of 
GAP and the C2 acyloin unit affords l-deoxy-D-xylulose-5-phosphatc (DXP). The TPP 
dependent enzyme that mediates this reaction, DXP synthase, has been isolated and 
overexpressed in E.coli^'^ The next enzyme on the pathway catalyses the first committed 
step to IPP formation, and was isolated in 1998 in Japan.'**'*' This enzyme was shown to 
produce 2-C-methyl-D-erythritol-4-phosphate (MEP) on incubafion with DXP and 
NADPH and has been named DXP reductoisomerase by Seto and co-workers.*"'" 
Scheme 2 illustrates the progress made so far in elucidating the DXP (non-MVA) 
pathway. 
- O H 
HOH 
h O H 
OH 
CH2OH 
[1-^^C]-Glucose 
= 0 
CO2H 
CHO 
- O H 
-OP 
Pyruvate 
DXP Synthase 
TPP 
GAP 
O OH 
,0P DXP 
OH 
DXP 
O OH 
I -OP 
OH 
OH OH 
,0P 
OH 
MEP 
DXP reductoisomerase 
NADPH, Mn 2+ 
Unl<nown 
Steps 
IPP 
Scheme 2 The DXP pathway and the expected '^C labelling pattern in IPP after feeding 
of[l-'^C]-glucose. = '^C. 
The subsequent steps required to convert MEP to IPP in bacteria are not known at present, 
although a number of recent reports* '^^ '^*'* have placed significant restrictions on the 
possible intermediates. Apart from eubacteria, green algae'^  and higher 
plants '^^ '*-'"''**''''^ "-^ '^" have also been shown to produce isoprenoids via DXP. The DXP 
reductoisomerase enzyme has recently been characterised in the green plant Mentha x 
piperita^'^ In higher plants however, both the DXP and MVA pathways operate to deliver 
different classes of terpene metabolite. The DXP pathway operates in subcellular 
organelles called the plastids, DXP reductoisomerase in Mentha x piperita being found to 
contain an additional preprotein that directs the enzyme to the plastids. The MVA 
pathway operates in the cytoplasm of the cells and in general is responsible for higher 
order terpenes, > C15. Such findings appear to support endosymbiosis theory, where plant 
organelles evolved from bacteria.^ 
1.4 Biosynthesis of vitamin Bi 
The elucidation of vitamin Bi biosynthesis has been and continues to present a 
challenge.^ '* Lack of vitamin Bi (also known as thiamin) is the nutritional factor 
associated with the disease beriberi. Thiamin pyrophosphate (abbreviated to TPP, but 
also known as cocarboxylase), is the active co-enzyme which takes part in 
decarboxylation reactions,'^ ^ an essential process required in channelling pyruvate and 
hydroxypyruvate into carbohydrate metabolism. TPP is also required in C-C bond 
forming reactions catalysed by transketolase enzymes. Thiamin biosynthesis occurs in 
most micro-organisms and higher plants, and different pathways exist for different classes 
of organisms. This is the case both for formation of pyrimidine and thiazole units 
(Figure 2) and also after coupling, in the final stages of co-enzyme biosynthesis.'^ '* 
^ OH 
Thiazole Pyrimidine 
Thiamin 
Figure 2 Thiamin and its subunits pyrimidine and thiazole. 
1,4.1 Biosynthesis of the pyrimidine subunit 
Full details of the biosynthetic pathways to pyrimidine formation have yet to be revealed. 
Formate supplies one carbon atom to the subunit in both entericbacteria^* and yeast,'^ ' but 
in different positions. For prokaryotes, glycine^^ and ribose^ '^''"'''* have been found to 
supply the remaining atoms, as delineated in Scheme 3, whilst in eukaryotes, glycine is 
not utilised at all and the remaining carbon atoms appear to be derived from glucose. 
H 
H02C"- t -NH2 
6' + 1 
Ribose 
HO OH" 'N 
6 
HO2Q 
HCO2H H,N 
Scheme 3 Biosynthesis of the pyrimidine unit in entericbacteria. 
(5-AminoimidazoIyl)ribotide 1 appears to be an advanced precursor to the pyrimidine ring 
system in entericbacteria. Isotopic labelling experiments carried out on bacteria with 
[S-'^'C]-!, [3-'^N]-l and [ '^NHij- l afforded incorporation of '^ C into the carbon skeleton 
and '^N in positions N l and NH2 respectively of the pyrimidine ring system.'^ '"^" A key 
resuh demonstrated incorporation of label from [U-'^C]-1 into pyrimidine in the presence 
of glucose, but no incorporation when unlabelled 1 was fed in the presence of [U-''^C]-
glucose.^ ^ The conversion of the key intermediate 1 into pyrimidine has been rationalised 
through a series of hypothetical intramolecular rearrangements. In eukaryotes, such as 
yeast, 1 has not been found to be an advanced precursor.^ '* Instead histidine^^ and 
pyridoxol^^ are implicated as the precursors to the pyrimidine ring in yeast. Further work 
is needed however, to confirm i f and how histidine and pyridoxol are incorporated into 
pyrimidine. 
1.4.2 Biosynthesis of the thiazole subunit 
From isotopic labelling experiments, yeast and entericbacteria have been found to possess 
different biosynthetic routes to the thiazole subunit (Scheme 4).^ '* Preliminary results 
indicate that green plants utilise the same pathway as entericbacteria, whereas aerobic 
bacteria employ the yeast pathway.^ '* In entericbacteria, tyrosine and DXP (or its 
unphosphorylated species, DX) have been found to provide the nitrogen and carbon atoms 
to the thiazole ring, whereas glycine and an unknown pentulose are the precursors to this 
ring system in yeast. The sulphur atom appears to derive from cystine in both micro-
organisms. 
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Scheme 4 A summary of the biosynthesis of the thiazole ring of thiamin in 
entericbacteria and yeast. 
For entericbacteria tyrosine has been found to supply one carbon atom and the nitrogen 
atom of the thiazole ring. Feeding experiments with [a-'''C]-tyrosine and [U-''*C]-tyrosine 
have resulted in incorporation at C2 of the thiazole ring, '^* and a feeding experiment with 
['^N]-tyrosine to a bacterium resulted in the incorporation of into the thiazole ring I5> 
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system.^ ^ Incorporation of label into an unestablished position of thiamin after feeding of 
[a-'''C]-tyrosine to a green plant has also demonstrated the intermediacy of tyrosine in 
thiazole ring biosynthesis.^* For yeast and aerobic bacteria intact incorporation of the 
C-N fragment, derived from glycine, serves as the precusor for the C2-N bond of the 
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thiazole ring. 
In entericbacteria, the remaining carbon atoms in the thiazole ring have been shown to 
arise from a carbohydrate source by the incorporation of intact C2 (C4',C4) and C3 
(C5-C7) units from [U-''^C]-glucose into the thiazole ring of thiamin."'' Conclusive 
evidence that these two units combine to form the C5 unit that is then incorporated into 
the ring has been obtained from the intact incorporation of [2,3-'^C2]-l-deoxy-D-xylulose 
into C4-C5 of the thiazole ring. Scheme 5 shows the steps required for the conversion 
of tyrosine, DXP and cystine to form the thiazole ring of thiamin. 
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DXP H O ^ ^ ' ^ J ^ O P 
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Thiazole 
Scheme 5 Putative mechanism for the biosynthesis of the thiazole unit in entericbacteria 
from tyrosine and DXP.^'' 
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In yeast the five-carbon chain of the thiazole ring arises from a pentulose that is not 
derived from the combination of a C2 and C3 unit. Instead, the biosynthetic experiments 
indicate that either a xylulose or a ribulose (or their 5-phosphates) is utilised in the 
formation of the thiazole ring in a maimer similar to entericbacteria, except that the 
pentulose combines with glycine (not tyrosine) and an oxidative step is not required, since 
the yeast's carbohydrate source is at a higher oxidation level. 
1.4.3 Coupling of the subunits 
Again both yeast and entericbacteria display different biosynthetic pathways. The 
biosynthetic steps (Scheme 6) that lead to TPP were mostly characterised by 1975. 
Separate enzymatic steps are required in entericbacteria for phosphorylation of the 
thiazole subunit and its coupling to the pyrimidine subunit, whereas a single enzyme 
catalyses this biotransformation in yeast and aerobic bacteria. Thiamin pyrophosphate is 
formed directly from thiamin monophosphate in entericbacteria, but by diphosphorylation 
of thiamin in yeast and aerobic bacteria. 
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Scheme 6 Final biosynthetic steps to thiamin pyrophosphate for entericbacteria and for 
yeast and aerobic bacteria.^ "* 
1.5 Biosynthesis of vitamin Bfi 
Pyridoxol PLP 
Pyridoxal phosphate (PLP) which derives from vitamin Be is a necessary co-factor for the 
many enzymes that enable cellular transformations of amino acids, such as 
decarboxylafion, transaminafion, P-eliminafion and racemisafion. Deficiency of vitamin 
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Be leads to retarded growth, dermatitis, convulsions and other symptoms in humans. 
The terms vitamin Be and pyridoxine are used interchangeably to denote the six 
compounds that all have some vitamin activity. These are pyridoxol, the corresponding 
4'-amine, pyridoxamine, the corresponding 4-aldehyde, pyridoxal, and their 
5'-0-phosphate esters.^' Elucidafion of pyridoxine biosynthesis has predominantly been 
studied with E. coli, although some evidence does suggest that a similar process takes 
place in plant chloroplasts.'*" 
1.5.1 Biosynthesis of the immediate precursors to vitamin Bg 
As with vitamin Bi and terpene biosynthesis it has been found that GAP and pyruvate are 
condensed in a TPP mediated process to yield DXP. This sugar delivers the C5 fragment 
C2', C2-C4 and C4' of pyridoxine (Scheme 7), GAP contributing C3, C4, and C4' of 
pyridoxine and pyruvate C2' and C2.''' A feeding experiment with [2,3-'''C2]-l-deoxy-D-
xylulose showed the intact incorporation of the C2-C3 bond into pyridoxine.''^ 
Experiments with labelled glycolaldehyde'**''*^ and glycine'*^ have also shown that these 
metabolites provide the remaining atoms, N l , C6, C5 and C5' of pyridoxine in certain 
mutants of E. coli. However, the main pathway in E. coli has been found to utilise 
4-phospho-D-erythrose'*'*''*^ (Scheme 7) and interestingly this pathway requires the 
co-factor PLP. Intriguingly therefore PLP is involved in its own biosynthesis.'** An 
experiment with 4-hydroxy-L-threonine (HT), contiguously labelled with '^C at C2-C3, 
was shown to definitively supply these atoms as an intact unit, by bond-labelling C5-C6 
of pyridoxine.'*' Additionally, unlabelled HT has been found to suppress incorporation of 
label from [U-'"^C]-glucose into C6, C5 and C5', but not into the other carbon atoms of 
pyridoxine.'*^ It has also been found that in E. coli one of the enzymes that converts 
4-phospho-D-erythrose to pyridoxine is able to utilise only the phosphorylated form of 
HT, 4-phosphohydroxy-L-threonine (PHT), indicating that PHT, not HT is involved in 
pyridoxine biosynthesis. Scheme 7. 
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Scheme 7 Summary of the putative pathway to pyridoxol 5'-phosphate (PNP) 
biosynthesis in E. coli. 
1.5,2 Final steps of vitamin Be biosynthesis 
Studies have shown that the first 65 vitamer produced is pyridoxol 5'-phosphate (PNP), 
and that it derives its phosphate from PHT, not DXP. 49,50,51 In E. coli two enzymes are 
now known to be required for the formation of PNP from PHT and DXP. The first 
catalyses the oxidation and decarboxylation of PHT (Scheme 8), to generate l-amino-3-
(phosphohydroxy)propan-2-one 2.^ ^ The second enzyme pyridoxol phosphate synthase 
catalyses the condensation of 2 and DXP to generate PNP. The mechanistic details here 
remain to be resolved, however it is noteworthy that loss of DXP's phosphate group 
occurs during the ring closure reaction (Scheme S).^ ""^ ' 
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Scheme 8 Current hypothesis for the final steps to PNP from PHT and DXP 51 
1.6 Summary of biosynthetic reactions utilising DXP 
It emerges from this biosynthetic survey that DXP is a substrate for three enzymes in 
different pathways. Inhibition of DXP metabolism therefore emerges as an attractive 
target for the repression of the biosynthesis of certain vitamins and other essential 
metabolites in bacteria and green plants. 
In the DXP biosynthetic route to IPP, DXP undergoes enzymatic isomerisation then 
reduction to yield 2-C-methyl-D-erythritol-4-phosphate (MEP). DXP reductoisomerase 
has been characterised from E. coli and a green plant, and requires NADPH and Mn^* ions 
(Scheme 9, i). IPP biosynthesis via DXP is known to operate in bacteria, green algae and 
green plants. 
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Vitamin Bi biosynthesis in entericbacteria (and potentially green plants) '^* is thought to 
involve reaction of DXP with tyrosine to form a Schiff base intermediate. This then 
undergoes a sequence of reactions to generate the thiazole subunit of vitamin Bi 
(Scheme 9, i i) . 
In the fmal step to vitamin Be, PNP synthase (characterised from E.coli) catalyses Schiff 
base formation between l-amino-3-(phosphohydroxy)propan-2-one 2 and DXP. Loss of 
DXP's phosphate group is subsequently required in the fmal steps leading to PNP 
(Scheme 9, i i i) . 
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Scheme 9 Reactions of DXP in vitamin biosynthesis. 
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1.7 Precedence for inhibition of DXP metabolism 
Specific inhibition of DXP reductoisomerase has recently been reported.^'' The inhibitor, 
fosmidomycin 3 was found from a database search of compounds that inhibited known 
DXP dependent bacteria, but not mevalonate dependent bacteria. 
Fosmidomycin 3 
Kinetic studies with 3 indicate that it inhibits DXP reductoisomerase in a dose dependent 
manner with an IC50 value of 8.2 nM.^^ Inhibition was found to occur through a mixed 
(competitive and noncompetitive) manner, with a Ki value of 38 nM. Fosmidomycin 3 
also specifically inhibits the conversion of DXP to MEP in chromoplasts of higher plants, 
being found to hinder production of P-carotene from DXP, again in a dose dependent 
manner with an IC50 value of 2.5 i^M.^" DXP reductoisomerase thereby provides an 
example of a novel target for both herbicidal as well as antibacterial action. 
1.7.1 Structural-activity relationship of fosmidomycin 3 
Fosmidomycin and the putative aldehydic intermediate in the DXP reductoisomerase 
reaction have close structural similarities with each other, with the 7V-formyl group 
mimicking the aldehyde and the phosphonate mimicking the phosphate (Figure 3). As 3 
is an effective inhibitor of DXP reductoisomerase, then a good strategy to developing 
novel antibiotics and / or herbicides would appear to be the design of fosmidomycin type 
inhibitors. 
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Figure 3 Structural relationship between the putative aldehydic intermediate in the DXP 
reductoisomerase reaction and fosmidomycin 3. 
1.8 Phosphonates as phosphate analogues 
Phosphates are ubiquitous in biological systems, the monoesters found as alkyl 
phosphates, sugar phosphates and phosphoproteins. The phosphodiester linkage 
comprises the backbone of the nucleic acids RNA and DNA, and is also found in the 
phospholipid component of biological membranes.^ '* Some examples of biologically 
important phosphates are shown below. 
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In biological systems phosphates are hydrolysed to inorganic phosphate and alcohols by 
phosphatases, a widely distributed class of enzymes that have a broad substrate 
specificity. However, the change from a P-O-C to a P-C-C linkage (Figure 4) greatly 
enhances the metabolic stability of the phosphonate, the new linkage being unable to be 
hydrolysed by phosphatase enzymes. 
O 0 
" O - P - O — R y -O- i^-CHa-R 
"O ' O 
Figure 4 Phosphonates as phosphate mimics. 
The use of phosphonates as phosphate analogues thus provides a method of metabolic 
regulation or perturbation. It has been said that, ' i f phosphate esters represent the 
currency of metabolism, then the analogous phosphonates can be viewed as exquisite 
counterfeits: perhaps passible in many transactions but ultimately forgeries nonetheless.^ ^ 
However, phosphonate analogues do have significantly different characteristics to their 
parent phosphates. These include a change in the second pK^ of the acids, the first pA^ a for 
both phosphonic and phosphoric acids indicating complete ionisation at physiological pH. 
Geometric changes also result on replacing O for methylene. These factors are discussed 
below. 
1.8.1 Optimisation of phosphonates as phosphate mimics 
The second pK^ and geometry of the phosphonate can be altered through fluorine 
substitution of the methylene hydrogens. Figure 5 shows the average second pK^ of a 
phosphate and various phosphonates.Both the dihydro and difluoro phosphonates have 
a pKa about one unit higher and lower respectively than the phosphate group, and the CHF 
phosphonate has a pK^ that most closely approximates the phosphate group. Analysis of 
the X-ray structures of the amino phosphate / phosphonates 4, 5, 6 and 7 has revealed the 
C-X-P angles, depicted in Figure 5. The difluoro analogue now approximates the 
geometry of the phosphate most closely in this respect, with increasing disparity shown 
for the monofluoro and dihydro analogues. Another aspect to consider when using 
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phosphonates as phosphate analogues is the electrostatic profile of the bridging unit. For 
example, the replacement of oxygen for a difluoromethylene group in a biological system, 
may have a significant impact on the analogues ability to bind in the close confines of an 
enzymes active site. A combination of ionic, geometric, steric and electrostatic factors 
determines which of the analogues emerge as the most effective at binding to a given 
enzyme system. 
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•o -P-o ' ' ^ • o - ' ' V ^ o - i ' v " ^ " 0 - - ' ' ^ ' ^ 
H O X H O X H O X 
p/<a ca. 6.45 p/<a ca, 7,65 pKa ca. 6.2 pKg ca. 5.64 
0 0 0 0 
II II II II 
• O / - O ^ R H , 'Sdy^^M to'yrf'^, sfyrf'^^ 
H H H F F F 
4 5 6 7 
angle 
Figure 5 pA^ a values of phosphates and phosphonate and C-X-P angles of the compounds 
4 to 7. 
1.9 Examples of phosphonate mimics 
A number of systems have been evaluated that have shown either the CF2 or CH2 
phosphonate to be the most effective analogue in replacing a phosphonate for a phosphate 
group in an enzymatic reaction. For example, in the enzyme catalysed condensation for 
addition of IPP to geranyl pyrophosphate 8, the CH2 and CF2 phosphonate analogues have 
been studied. Figure 6.^ ^ It emerged that the first-order rate constant for the reaction is 
higher for the CF2 than the CH2 substrate, indicating that here, the CF2 phosphonate is the 
better mimic of the phosphate group. 
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X 
0, 8 3.0 X 10"^  
CH2, 9 1.1 X 10"^  
CF2, 10 3.9 X 10"* 
Figure 6 First-order rate constants for condensation of IPP onto substrates 8, 9 and 10. 57 
The CH2, CHF and CF2 phosphonate analogues of phosphotyrosine (pTyr) (Figure 7) 
were assayed for their binding ability when part of a pentapeptide acting as an inhibitor of 
a tyrosine phosphatase signalling protein. The results indicate that the CF2 phosphonate 
mimic is most effective at promoting binding, with an efficacy similar to the phosphate, 
pTyr. The excellent performance of the CF2 analogues in such cases has been rationalised 
mainly in terms of the low p^a imparted by the presence of the fluorine atoms. 
0 = P - 0 
Gly-NH-CH-CO-Val-Pro-Met-Leu 
X ID50 / iiM 
0, pTyr 0.17 
CH2, 11 1.0 
CHF, 12 0.50 
CF2, 13 0.17 
Figure 7 Competitive bindings of peptides incorporating pTyr or the phosphonates 11, 
C O 
12, or 13 with the C-terminal SH-2 domain of phosphatidylinositol 3-kinase. 
23 
A system that has been used to compare all of the phosphonate congeners against the 
parent phosphate group is the NADH linked oxidation by glycerol-3-phosphate 
dehydrogenase (Figure 8).^ ^ Here the affinity of the 5«-glycerol-3-phosphate / 
3-phosphonate substrate for the enzyme was analysed in terms of Km and Frei values for 
the oxidation reaction, these results are summarised in Figure 8. The CF2 analogue now 
emerged as the least effective mimic of the phosphate, with the CHF and CH2 analogues 
performing significantly better than the parent phosphate. This result has been 
rationalised in terms of the enzyme preferring a substrate that can best minimise the 
electrostatic interaction in the active site, an interaction that has apparently not been 
optimised by the evolutionary process (ie. Km for CH2 and CHF < 0, the natural 
phosphate). 
giycerol-3-piiospliate 
dehydrogenase 
NAD^ 
HO. 
NADH + H^ 
O 
o 
X 
0, 14 0.29 1.0 
CH2, 15 0.18 0.8 
CHF, 16 0.17 0.9 
CF2, 17 0.73 0.8 
Figure 8 Kinetic data for the enzyme catalysed oxidation of 14,15,16 and 17. 59 
As is evident from the above experiments different biological systems can respond 
differently to the phosphonate congeners. Therefore each phosphonate analogue in turn 
must be tested in a particular system. 
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1.10 Natural products containing a C-P bond 
o 
II 
18 
The first naturally occurring compound to be isolated containing a C-P bond was 
2-aminoethylphosphonic acid 18, in 1959.^ " Since then over 25 C-P containing 
compounds have been described. Some of these compounds are found to have 
antibacterial, antiviral, antibiotic, pesticidal, herbicidal and anti-cancer properties.This 
wide range of activity has prompted extensive interest in the synthesis of these molecules 
to enable evaluation of their biological activity and examination of their structural-activity 
relationships. Two of these compounds, fosmidomycin 3 and phosphonothrixin 19 are 
particularly notable. 
1.10.1 Fosmidomycin 3 
Fosmidomycin 3 which has already been discussed as a potent inhibitor of DXP 
reductoisomerase in bacteria and higher plants (1.7), was isolated from a culture broth of 
Streptomyces lavendulae in 1980 as a co-metabolite of other 7V-hydroxyamino phosphonic 
acids.Synthesis of the C-P bond in 3 was achieved via the Michaelis-Becker reaction of 
sodium diethyl phosphonate with 3-(7V^-tosyl-A^-benzyloxyamino)propyl bromide 20. 
Hydrolysis of the tosylate then afforded 21, Scheme 10. A^-Formylation of 21 with acetic-
formic anhydride, followed by hydrolysis of the phosphonate ester finally afforded 3.^ ' 
^O^PNa . H O ' P ^ ^ ^ N H 5 . H O ' P ^ ^ N 
- O ii) HGI-AcOH HO HO D 
21 3 
Scheme 10 i . PhH, 5 h, reflux; i i . 50 h, reflux, 63 %; i i i . 30 min, RT, 70 %. 
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1.10.2 Phosphonothrixin 19 
O H O >.-0H 
^ S o ' ^ V 
o 
(5)-(-)-Phosphonothrixin 19 
Phosphonothrixin 19 is a novel herbicidal antibiotic that inhibits germinafion of grass and 
broadleaf weeds as well as inhibiting chlorophyll production upon foliar application on 
weeds.*^ It was first isolated in 1995 from a fermentation broth of Saccharothrix sp. 
ST-888.^° Its structure was elucidated in the same year^ ^ and an enantioselective 
synthesis described in 1997 securing the absolute stereochemistry of 19.^ ^ A sample of 
(5)-19 had been synthesised in 92 % ee (Scheme 11) by exploiting a Sharpless 
asymmetric epoxidation to generate the chiral epoxy alcohol 22 in 92 % ee.^ ^ Attack on 
the epoxide with the chloromagnesium salt of dibenzyl phosphite followed by ozonolysis, 
yielded the phosphonate diester 23, hydrogenation of which afforded {S}-19. The origin 
of the biological activity of 19 is not known, however it must be noted that it is a close 
structural isomer of 24, the CH2 phosphonate analogue of DXP (Figure 9), and this may 
underlie its wide ranging potency. Phosphonothrixin 19 also has close structural 
similarities to a proposed intermediate in the biosynthesis of riboflavin. 
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q-T^ " ' S ? / ' ' ' ' " ^ ? H 0 , - 0 H . OHO - O H 
H O ^ / _ U HO. ^  / . B n O ' P ^ - N < / ^ HO'P-
BnO 
BnO II HO 
0 O 
22 23 19 
Scheme 11 i . D-DET, Ti(0'Pr)4, TBHP, CH2CI2, 1 d, -20 °C, 57 %; i i . Et20, 2.5 h, 
-50 to 0 °C, 40 %; i i i . O3, CH2CI2, 3 min, -78 °C then Me2S, 1 h, RT, 79 %; iv. H2-Pd(C), 
MeOH / H2O, quant. 
0 QH O 9H OHO^,-OH 
HO ^ i fl HO i n HO 
OH O OH O O 
DXP 24 19 
Figure 9 Structural analogies between DXP, 24 and 19. 
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1.10.2.1 Biosynthesis of riboflavin 
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ring 
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Riboflavin 
Riboflavin (Vitamin B2) provides the functional isoalloxazine ring of two co-enzymes, 
flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN). Flavoproteins bind 
to one of the above co-enzymes to provide an essential enzymatic system that mediates 
two-electron oxidation and reduction reactions, including hydride and oxygen transfer. 
These are reactions essential to all cells, but only plants and certain micro-organisms can 
synthesise riboflavin, the deficiency of this vitamin being known to cause skin lesions and 
dermatitis in man.^ '* A variety of pathogenic bacteria however, such as the Escherichia 
and Salmonella species are absolutely dependent on their ability to synthesise riboflavin 
because they lack an uptake system of this vitamin.^^ Inhibition of the pathway to 
riboflavin is therefore a potential target for chemotherapy of bacterial infections. 
65 Biosynthetic studies on riboflavin have mainly been carried out on bacteria and yeast. 
Their pathways have been characterised to a high level and are found to be similar, both 
involving seven distinct enzyme-catalysed reactions.^ ^ The convergent biosynthesis 
requiring one molecule of guanine triphosphate (OTP) and two molecules of ribulose-5-
phosphate 25 as substrates, is shown in Scheme 12. 65,66 
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Scheme 12 Biosynthesis of riboflavin. 
During the biosynthesis of riboflavin, OTP combines with 25 to form the intermediate 26. 
Reaction of 26 with L-3,4-dihydroxy-2-butanone-4-phosphate 27 then affords the 
riboflavin precursor 28, which after dismutation yields riboflavin and the intermediate 26 
the latter then being reutilised in the pathway. The biosynthesis of 27 from 25 is catalysed 
by 3,4-dihydroxy-2-butanone-4-phosphate synthase, a Mg^ "^  requiring enzyme, which has 
been characterised from bacteria and plants. This small enzyme of only about 200 amino 
acids catalyses a highly complex reaction that involves the rearrangment between C3 and 
C5 of 27, followed by the elimination of C4 as formate. Scheme 13.^ '^^ ^ 
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Scheme 13 Putative reaction mechanism for the formation of L-3,4-dihydroxy-2-
butanone-4-phosphate 27.^ ^ 
Of particular interest in the above mechanism is the rearrangement of 29 to 30. Structure 
29 bears a close resemblance to DXP (Figure 10), the only difference is that the C3 
hydroxy of DXP is oxidised to the ketone in 29. 
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Figure 10 Structural analogies between DXP and 29. 
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The rearranged product 30 has a very similar structure to phosphothrixin 19 (Figure 11). 
I f 19 does inhibit this enzyme, as described below, then this could also account for the 
observed herbicidal and antibiotic activity of 19. 
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Figure 11 Structural analogies between 30 and 19. 
1.11 a-Fluorinated ketone inhibitors 
a-Fluorocarbonyls are more readily hydrated than their non-fluorinated counterparts 
(Figure 12) due to stability incurred by the high electronegativity of the fluorine atom. 
This inductive effect of fluorine has been employed in the design of inhibitors of enzymes 
that progress through tetrahedral transition-state complexes.^^''"''' A striking example of 
how effective this can be is the inhibition of acetylcholinesterase, a serine mediated 
hydrolase (Figure 12). In the enzyme active site, the first step of the hydrolysis reaction 
requires the serine's alkoxide nucleophile to attack the substrate's carbonyl to form a 
tetrahedral intermediate. However, the hemiketal adduct of the trifluoroketone analogue 
31 of acetylcholine 32 is so stable that its dissociation equilibrium is remarkably low, with 
a first-order half life of 30 h at 25 °C, this affords 31 a K, value of 6 x 10"" M for 
acetylcholinesterase.^^ Comparison of the dissociation rates (Figure 12) from the 
acetylcholinesterase enzyme for the analogues 33 to 35 exemplifies the inductive effect of 
fluorine.^' 
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Figure 12 Acetylcholinerase inhibition with compounds 31, 33, 34 and 35. 
The 1-fluoro- 36 and 1,1-difluoro-l-deoxy-D-xylulose 37 analogues of DX had been 
synthesised recentiy to assess their potency as antibiotics.'^ However, these fluorinated 
sugars showed no antibacterial activity. This was most probably due to 36 and 37 existing 
predominantly in their cyclic form in solution (as determined by '^ F NMR), and thereby 
preventing in vivo phosphorylation of the terminal hydroxymethyl group to generate the 
corresponding DXP analogues (Figure 13). 
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1.12 Synthetic targets 
In this thesis work is described towards the synthesis of a number of potential DXP anti-
metabolites. A description of these target compounds follows below, with a more 
detailed retrosynthetic analysis described in section 1.4. 
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HO'P-x 
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24 X = CH2 
38 X = CHF 
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OH OH 
40 X = CH2 
41 X = CHF 
42 X = OF 
OH 0 
43 X = CH2 
44 X = CHF 
45 X = CF2 
OH OH 
46 
0 OH 
O o 
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The synthetic targets shown above have been selected as potential inhibitors of the 
reaction catalysed by DXP reductoisomerase. Compounds 24, 38, 39 and 40, 41, 42 are 
the phosphonate analogues of DXP and MEP respectively. Targets 43, 44, 45 are also 
phosphonate analogues of DXP, but they contain a fluorine atom in place of a hydrogen 
alpha to the carbonyl group. Another target, 46, the reduced form of 24, was selected as it 
may act as an inhibitor of DXP metabolism, unable to undergo rearrangement mediated 
by the reductoisomerase enzyme, Scheme 9 (page 18), or imine formation as illustrated in 
the reactions in ii and iii of Scheme 9. The remaining target compound, 47, was selected 
as an analogue of fosmidomycin. 
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1.13 Synthetic methods for C-P bond formation 
The above phosphonate targets require the formation of C-P bonds. Three main strategies 
for forming a C-P bond are applicable to the syntheses of the target compounds in section 
1.12, and are described below. 
1. The Michaelis-Arbuzov reaction of a trialkylphosphite with an alkylhalide: 
(R0)3P + R'X (R0)2(0)PR' + RX 
2. The Michaelis-Becker reaction of an alkali salt of a dialkylphosphite with an 
alkylhalide: 
(R0)2P(0)M + R'X " (R0)2(0)PR' + IVIX 
3. A Michael type reaction of either a trialkylphosphite or alkali salt of dialkylphosphite 
with an a, p-unsaturated C=C double bond: 
(R0)3P or (R0)2(0)PM + R'-CH=CH2 R'CH2CH2P(0)(OR)2 
1.14 Proposed routes to synthetic targets 
1.14.1 DXP analogues 24, 38, 39 and 43 to 45 
The retrosynthetic analysis for the DXP analogues is illustrated in Figure 14. The major 
synthetic problems posed by these targets are the construction of the C-P bond and the 
selective preparation of single diastereoisomers. The chosen retrosynthetic route requires 
hydrolysis of the alkyl (ethyl) esters to afford the phosphonic acid. Such hydrolytic 
reacfions are generally mediated by TMSBr.'"* Direct access to diols with the threo 
relative configuration will be addressed by utilising the Sharpless AD-mix asymmetric 
dihydroxylation reaction.^^ This reaction utilises OSO4 and a chiral auxiliary and has been 
shown to work with high selectivity for mainly unconjugated alkenes, however there is 
precedence for this reaction in enones,^ ^ and 1-alkenylphosphonates.'' 
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Figure 14 Retrosynthetic analysis for the formation of 24, 38, 39 and 43 to 45. 
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Facile installation of the enone functionality is envisaged via Wittig methodology, 
through reaction of the ylids 48 or 49 with the phosphono aldehydes, 50, 51 and 52. 
Aldehydes 50 to 52 are conceived to be accessible through reductive ozonolysis of the 
corresponding alkenes.'^ The synthesis of the phosphono alkenes will be approached 
through allylation of the respective starting phosphonatesJ^ For the CH2 analogue 24, the 
commercially available diethyl methylphosphonate will be utilised, whereas the 
fluorinated phosphonates will be synthesised via a Michaelis-Arbuzov reaction between 
O A 
triethylphosphite and dibromodifluoromethane or tribromofluoromethane. 
1.14.2 MEP analogues 40 to 42 
A retrosynthetic analysis for the synthesis of 40 to 42 wil l also employ the phosphono 
aldehydes 50 to 52, Figure 15. A Grignard reaction using these aldehydes with 
isopropenylmagnesium bromide should provide access to the racemic allylic alcohol. 
Introduction of the vicinal diol group will also be explored by Sharpless AD-mix 
dihydroxylation to generate the protected phosphono triol. Deprotection using a TMSBr 
mediated hydrolysis reaction should yield the target molecules 40 to 42. HQ i^  
0 
II 
OH OH 
50 
OH O H 
H Q ^ 
40 X = CH2 
41 X = CHF 
42 X = GF2 
0 
II 
- 0 
52 
Figure 15 Retrosynthetic analysis for the formation of 40 to 42. 
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1.14.3 3(if),4(5),5(/f^-3,4,5-Trihydroxyhexylphosphonic acid 46 
Triol 46 is the reduced form of 24. A standard NaBH4 reduction of suitably protected 24 
should afford the triol as a mixture of diastereoisomers. Removal of the phosphonate 
esters with TMSBr offers a straightforward route to this compound (Figure 16). 
46 
O H OH 
OH OH 
OH 0 
Figure 16 Retrosynthetic analysis for the formation of 46. 
1.14.4 Fosmidomycin analogue 47 
The synthesis of the fosmidomycin type structure 47 (Figure 17), is again envisaged to 
utilise a TMSBr mediated hydrolysis to afford 47. The diethyl 7^-hydroxyimide precusor 
53 could be accessible through oxidation of the imide 54 following a literature method.^' 
The imide 54 itself may be formed through reaction of the acid chloride with acetamide.^ ^ 
Finally, conversion of the commercially available ester 55 to the acid chloride under 
previously described literature conditions will allow generation of the C-P bond.^ ^ 
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Figure 17 Retrosynthetic analysis for the formation of 47. 
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Chapter 2 
Synthesis of potential DXP 
anti-metabolites 
38 
2.1 Introduction 
Chapter 2 discusses in detail the synthesis of the novel target compounds highlighted in 
section 1.13. The DXP analogues are described first; the CHi analogue 24 in sections 2.2 
and 2.3, and the CF2 analogue 39 in section 2.4. Synthesis of the CH2 analogue 40 of 
MEP, and the triol 46 are outlined next in sections 2.5 and 2.6 respectively. Finally, work 
carried out by Hannah F. Sore towards the fosmidomycin analogue 47 is described in 
section 2.7. 
2.2 Synthesis of DXP analogue 24 via diethyl phosphonate 
HO O 
r/2reo-3(i?),4(5)-3,4-dihydroxy-5-oxohexylphosphonic acid 24 
2.2.1 Syntheses of phosphono aldehydes 50 to 52 
Initially syntheses were devised towards the aldehydic compounds diethyl 
l,l-difluoro-3-oxopropylphosphonate 50, diethyl l-fluoro-3-oxopropylphosphonate 51 
and diethyl 3-oxopropylphosphonate 52. These compounds were identified as key 
intermediates for the preparation of the required l-deoxy-D-xylulose-5-phosphate (DXP) 
analogues. 
O 
^ 0 ' 
50 51 52 
39 
2.2.1.1 Preparation of diethyl 1,1 -difluoro-3-oxopropylphosphonate 50 
Chambers and co-workers first reported'* the preparation of the difluorinated aldehyde 50 
(Scheme 14), via a reductive ozonolysis of diethyl l,l-difluorobut-3-enylphosphonate 56, 
the reaction proceeding in a yield of 75 %. Their synthesis of the olefmic precursor 56 to 
this aldehyde followed that reported'^ by Burton and co-workers by the reaction of the 
cadmium reagent 57 with allyl bromide. Burton found that a change in solvent from 
dioxane'^ to THF^* proved expedient in increasing the yield of this reaction from 
31 to 62 %. The organo-cadium reagent 57 itself had been prepared from cadium metal 
and diethyl bromodifluoromethylphosphonate 58, and was found to be stable in solution. 
The phosphonate 58 had been formed via an apparent Michaelis-Arbuzov reaction 
between triethyl phosphite and dibromodifluoromethane in 95 % yield, as described by 
fin 
Burton and Flynn. 
O O 
(EtO)3P + CF2Br2 (EtO)2PCF2Br — — • (EtO)2 PCF2CdBr 
58 
Q ,„ o 
57 
II IV II 
/ - O A ^ 0 A 
/ F F / ^ F F 
50 56 
Scheme 14 i . EtjO, 12 h, reflux, 95 %; i i . Cd, THF, 3h, 65 °C; i i i . CsHsBr, Nal, THF, 
20 h, 25 °C reflux; 62 %; iv. O3, CH2CI2 / MeOH, -78 °C, then MejS, 75 %. 
Burton and Sprague subsequently described*'* an alternative organozinc reagent that 
facilitates alkylation of 58 to afford l,l-difluoro-3-alkenephosphonates (Scheme 15). 
Allylation had been achieved by addition of allyl bromide to the organozinc reagent 59, in 
the presence of a catalytic amount of CuBr, to afford 56 in a moderate yield of 47 %. 
Synthesis of the organozinc reagent 59 itself is achieved by addition of 58 to acid-washed 
zinc in a monoglyme solution.*'* 
40 
Preparation of 56 was chosen to be carried out via the organozinc reagent 59 
(Scheme 15), utilising the above methods.^ *''^ '*''^  In our hands carrying out the allylation 
of the organozinc reagent as described afforded an improved yield of 77 %, cf 47 % 
reported in the literature. Otherwise reproducible yields and high purity of products were 
obtained as previously described. 
O O 
II II 
(EtO)3P + CFsBrs ^ (EtO)2PCF2Br ^ (EtO)2 PCFzZnBr 
58 , 59 
O O 
-° A r° F F 
50 56 
Scheme 15 i . EtsO, 12 h, reflux, 95 %; i i . Zn, monoglyme, 95 %; i i i . CaHjBr, CuBr, 
monoglyme, 12 h reflux; 77 %; iv. O3, CH2CI2 / MeOH, -78 °C, then Me2S, 75 %. 
2.2.1.2 Preparation of diethyl l-fluoro-3-oxopropylphosphonate 51 
The monofluorinated aldehyde diethyl l-fluoro-3-oxopropylphosphonate 51 had not 
previously been reported, however the synthesis of the olefinic precursor diethyl 
l-fluorobut-3-enylphosphonate 60 (Scheme 16) had been described^^ by Savignac and 
Patois. This involved a reaction between diethyl dibromofluoromethylphosphonate 61 
and allyl iodide, via the double halogen exchanged intermediate a-lithiated-a-
fluorophosphonate 62, obtained by addition of n-BuLi and TMSCl (2:1) to 61. Alkylation 
of 62 with allyl iodide followed by ethanolysis to remove the TMS group afforded the 
desired material 60. The formation of the starting phosphonate 61 had been investigated^" 
by Burton and Flynn, who obtained a 78 % yield of this phosphonate by reaction of 
triethyl phosphite and tribromofluoromethane. A brief overview of this reaction is given 
by Savignac and co-workers,^^ describing optimised conditions that afford 60 in 97 % 
yield. 
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Scheme 16 i . EtzO, 12 h, reflux, 78 %; i i . «-BuLi (2.2 equiv.), TMSCI, THF, -78 °C; i i i . 
C3H5I, -78 °C, then LiOEt / EtOH, 0 ''C, NH4Cl(aq), 91 %. 
It was envisaged that after following the above reactions, the aldehyde could be accessed 
through reductive ozonolysis of the alkene as described above (2.2.1.1). Accordingly 61 
was obtained in 85 % yield and 60 in 80 %. However, initial attempts to obtain the 
aldehyde via ozonolysis of the alkene were unsuccessful. 
Performing the ozonlysis reaction under the same conditions as the difluoro analogue 56 
yielded a mixture of products. From NMR analysis at least two aldehydic products were 
apparent and by comparison of integral values, it was evident that aldehydic products 
comprised the majority of the sample. '^ F NMR revealed that there were two fluorine 
containing species, whereas the '^P NMR spectrum indicated that less than half of the 
total phosphorus containing species showed any heteronuclear coupling. The most 
intense peak in the '^ 'P NMR spectrum, comprising over half of the sample, was a singlet. 
After addition of EtaN to the sample the relative size of this peak increased, and the '^ F 
resonances disappeared. From the above results it is proposed that the predominant 
product from the ozonolysis reaction was the aldehyde 63, derived by HF elimination of 
the desired product 51. Further work on this reaction was postponed due to the lack of 
success with this methodology. 
O 
63 
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2.2.1.3 Preparation of diethyl 3-oxopropylphosphonate 52. 
Diethyl 3-oxopropylphosphonate 52 has been prepared previously by several routes. One 
method utilised a PdCb catalysed oxidation of the alkenic phosphonate 64.^ ' This gave 
an equal mixture of aldehyde and ketone 65 products (Scheme 17). 
O 
o 
II 
64 
0 0 
/ - O 
^ 65 
Scheme 17 PdCb, CuCb, O2, H2O, 6 h, 85 °C, 40 % for 52 and 40 % for 65.^ ^ 
A more general route to phosphorylated aldehydes has been described.^ ^ A Michaelis-
Arbuzov reaction between a triakyl phosphite and a dihaloalkene affords haloalkenic 
phosphonate 66. Halide substitution of these products with alcoholate anions afforded 
enol ethers, which after hydrolysis gave the corresponding aldehydes (Scheme 18) such as 
52. 
(EtO)3P + B r ^ x ^ ^ B r ' ^ ^ ^ Q - ) 
0 
II 
Br 
O 
66 
O ... 0 
II III ^ II 
/ 52 / 
Scheme 18 i . 120-140 °C, 90 %; i i . NaOEt / EtOH, 1 h, reflux, 66 %; i i i . HCl(aq) (no yield 
given). 
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Another strategy to the required aldehyde 52 and other phosphorylated aldehydes has 
utilised acetal protection,*^'^"'^'"'^ via a Michaelis-Arbuzov reaction with a haloalkylacetal 
followed by acid hydrolysis to give the aldehyde. In the event a novel approach to 52 was 
proposed. It was envisaged that coupling of diethyl methylphosphonate with allyl 
bromide, utilising n-BuLi as the base, would give diethyl but-3-enylphosphonate 67. 
Reductive ozonolysis of the alkene 67 should then afford the aldehyde 52. 
Initial attempts at alkene synthesis in this manner afforded 67 in low (~ 25 %) yield. A 
change of electrophile to allyl iodide or allyl mesolate did little to improve this yield 
(27 % and < 20 % respectively). Scheme 19. Using a five-fold excess of allyl bromide 
increased the yield of 67 to 52 %, and a product could be isolated after distillation in 
> 97 % purity (Scheme 19). In order to access the aldehyde, ozonolysis was initially 
performed using the conditions described above (2.2.1.1). These conditions yielded the 
desired product, but only as the minor component of the crude product mixture. The 
unidentifiable component that made up the majority of the sample remained inseparable 
from 52 by either distillation or column chromatography. Ozonolysis using CH2CI2 as the 
only solvent (cf previous CH2CI2 / MeOH mix), curtailed the production of side-products 
affording pure aldehyde 52 after distillation, albeit in low (40 %) yield (Scheme 19). 
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Scheme 19 i . «-BuLi, THF, -78 °C, then CsHjBr (1 equiv.), then NH4Cl(aq), 0 °C, -25 %; 
i i . «-BuLi, THF, -78 °C, then NH4Cl(aq), 0 °C, 27 %; i i i . «-BuLi, THF, -78 °C, then 
NH4Cl(aq), 0 °C, < 20 %; iv. n-BuLi, THF, -78 °C, then CaHsBr (5 equiv.), then NH4Cl(aq), 
0 °C, 52 %; V. O3, CH2CI2 / MeOH, -78 °C, then MejS, 40 %. 
Further material was brought forward utilising dimethyl methylphosphonate 68 as the 
starting phosphonate because of its relatively low cost. Using an excess of allyl bromide 
as before yielded the desired material dimethyl but-3-enylphosphonate 69 in 43 % yield 
after distillation. Reductive ozonolysis of 69 using CH2CI2 as the only solvent afforded 
the aldehyde dimethyl 3-oxopropylphosphonate 70 in 35 % yield (Scheme 20). The poor 
yields prompted another survey of the literature and this resulted in an investigation into 
the allylation reaction above (Scheme 20).^ ^ It had been found that by converting a 
lithiomethylphosphonate to a copper (I) methylphosphonate and using this as the 
nucleophilic species, considerably higher allylation yields were obtained.^^ Dimethyl 
copper (I) methylphosphonate 71 was duly prepared as described^^ and subsequently 
reacted with one equivalent of allyl bromide to generate 69 after distillation, in an 
excellent yield of 95 % and with > 99 % purity (Scheme 20). This product was then 
subjected to ozonolysis and quenched with DMS. Attempted distillation of the crude 
ozonised product after quenching, resulted in a violent explosion. The reaction was 
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carefully repeated, ensuring that DMS was used in excess to quench any ozonide formed. 
After obtaining a negative test for peroxides, the mixture still exploded shortly after 
distillation had begun. It was judged imprudent to pursue this method and a different 
approach to aldehyde 70 was pursued. 
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Scheme 20 i . «-BuLi, THF, -78 °C, then CsHjBr (5 equiv.), then NH4Cl(aq), 0 °C, 43 %; 
i i . O3, CH2CI2, -78 °C, then Me2S, 35 %; i i i . «-BuLi, THF, -78 °C, then Cu(l)I, -35 °C, 
then CsHsBr, -35 °C, 95%. 
An alternative route to the phosphorylated aldehyde was now sought. Formation of the 
aldehyde by deprotection of its acetal protecting group had previously been successful, the 
acetal phosphonate being accessible from a Michaelis-Arbuzov reaction. However, 
because the allylation of 71 had proved a high yielding coupling strategy, reaction of 71 
with a haloalkylacetal was now attempted. Reaction of the protected aldehyde 
2-bromomethyl-l,3-dioxolane 72 with 71 was duly carried out (Scheme 21), however all 
attempts to couple the two reactants were unsuccessful. Dimethyl methylphosphonate 
was first deprotonated with LDA at -78 °C, but neither the resultant 
lithiomethylphosphonate or the organocopper reagent 71 reacted in either a THF or DMF 
solvent, the crude reaction mixture always yielding a moderate recovery of starting 
46 
material. Another route to the aldehyde was again sought, and to this end the Michaelis-
Becker reaction between 2-(2-bromoethyl)-l,3-dioxane 73 and dibenzyl phosphite was 
attempted. Use of NaH as the base to produce the desired acetal phosphonate 
(Scheme 21), again resulted in only recovery of the starting material. 
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Scheme 21 Proposed routes to protected phosphono acetals. 
Martin and co-workers '^* had found that they could not induce efficient coupling between 
68 and a halo or tosyl alkylacetonide. However, by utilising the Michaelis-Arbuzov 
methodology they successfully overcame the problematic coupling reaction. It therefore 
seemed prudent to follow this strategy for the synthesis of the target acetal 
phosphonate.'^ ''^ '^^ '-^^ 
Accordingly, the reaction of triethyl phosphite with 73 did indeed generate the acetal 
phosphonate, 2-(2-diethoxyphosphonylethyl)-l,3-dioxane 74 in good (70 %) yield 
(Scheme 22). However, attempts to obtain the aldehyde 52 by selective removal of the 
acetal protecting group with aqueous HCl or PTSA, resulted in low mass recovery of a 
crude organic mixture (Scheme 22), which still contained acetal. Concurrent hydrolysis 
of the phosphonate ester could perhaps account for the low yield, since '^P NMR did 
reveal phosphorus containing species in the aqueous phase, even after continuous 
extraction. 
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Scheme 22 i . 4 h, 145 °C, 30 min, 165 °C, 68.5 %. 
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It was clear that the present acetal moiety was incompatible with the phosphonate group. 
An aldehydic protecting group that would hydrolyse at a faster rate was required. The 
relative rate of acid-catalysed hydrolysis of cyclic acetals (Figure 18) has been studied 
and the results indicate that hydrolysis of a dioxolane (5 membered ring) acetal proceeds 
at a greater rate than a dioxane (6 membered ring) acetal. 
0-
> 
Figure 18 Relative rate of acid-catalysed hydrolysis of cyclic acetals. 
In the light of these observations it appeared prudent to undertake the synthesis of 
2-(diethoxyphosphonylethyl)-1,3-dioxolane 75. Accordingly the Michaelis-Arbuzov 
reaction again afforded the acetal 75 in high (85 %) yield (Scheme 23), and its hydrolysis 
to 52 was now investigated. Firstly a series of preliminary reactions with HCl, PTSA and 
PPTS were carried out to ascertain the best proton source for the hydrolysis. HCl was 
found to be the most promising and fiirther reactions were assayed for the yield and purity 
of 52, in an effort to establish the optimum hydrolysis conditions. Table 1. The optimised 
48 
conditions (Entry 6, Table 1) afforded 52 in near quantitative (> 98 %) yield with 
> 97.5 % purity, as illustrated in Scheme 23. 
[HCI(,q)] / [75 ( a q ) ] / Duration of Purity by '^P Yield of reaction 
moi dm"^  mol dm''' reflux / h NMR / % / % 
1 0.5 0.42 3 73 82 
2 0.5 0.42 4 68 88 
3 0.25 0.14 3.25 82 96 
4 0.1 0.125 3.5 94 97 
5 0.1 0.085 3 95 97 
6 0.1 0.085 3 98 97 
Table 1 Reaction conditions utilised during optimisation of the hydrolysis reaction of 75. 
(EtO)3P 
Scheme 23 i . 4 h, 145 °C, 1 h, 165 °C, 85 %; i i . 0.1 M HCl(aq), 3 h, reflux, 98 %. 
The synthetic route in Scheme 23 was reproducible and was used to generate 52 in high 
yield and purity. The crude product could be processed ftirther without the need for 
purification. After this work had been completed a comprehensive review on 
phosphorylated aldehydes was published.This review also detailed the preparation of 
52 via the general methodology of a Michaelis-Arbuzov reaction to afford a phosphono 
acetal (in this case, a diethyl acetal), followed by acid hydrolysis to form 52. 
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2.2.2. Synthesis of DXP analogue 24 from aldehyde 52 
Now that the key aldehyde intermediate 52 was available, the synthesis of the CH2 
analogue of DXP could progress. A retrosynthetic analysis to the CH2 analogue 24 of 
DXP from the aldehyde 52 is shown in Figure 19. The next step towards 24 required the 
Wittig reaction to afford the enone 76. Preparation of the fluorinated ylid 49 would afford 
access to the DXP analogue 43. 
H O ' ' 
O H O 
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24 Y = H 
43 Y = F 
76 Y = H 
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49 
Figure 19 Retrosynthetic analysis to 24 and 43. 
2.2.2 Synthesis of enone 76 
Reaction of the commercially available ylid 48, with the previously prepared aldehyde 52 
(2.2.1.3) generated a mixture of diethyl (£)-5-oxohex-3-enylphosphonate 76 and 
triphenylphosphine oxide. The progress of the reaction could be monitored conveniently 
by tic or more straightforwardly by '^ 'P NMR. A variety of purification methods were 
utilised to optimise the yield of 76, with column chromatography resulting in clean 
50 
product (> 99 % purity) and in a 70 % yield, Scheme 24. The success of this reaction 
now prompted the synthesis of the fluoro yhd 49. 
O 
48 
Scheme 24 THF, 16 h, reflux, 70 %. 
2.2.2.2 Synthesis of fluoro ylid 49 
O 
3 -Fluoro-2-oxopropylidenetriphenylphosphorane 49 
DXP analogues (43 to 45) with fluorine substituted alpha to the carbonyl were identified 
as key target compounds as discussed in 1.13. The synthesis of the fluorinated ylid 49 
was undertaken to enable access to the 6-fluorinated enones using the above methodology 
(2.2.2.1). Conversion of the 6-fluorinated enones to DXP analogues could clearly follow 
an analogous route to that for the non-fluorinated analogue, as discussed above. 
HO' , ' 
O H O O H O 
44 
H O ' ' 
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Preparation of the fluorinated ylid 49 has been reported via the ketone chloro-3-
fluoropropan-2-one 77.**"' Ketone 77 itself had been prepared via nucleophilic attack of 
fluoride on epichlorohydrin at the least hindered site,""'"* '^"'^ '"''* followed by 
oxidation'*''''"'^ of the intermediate alcohol 78 to afford 77, Scheme 25. 
51 
O O H O 
78 77 
Scheme 25 i. EtsN.SHF, 4 h, 100 °C, 55 %; ii. Na2Cr207, T B A B , CH2CI2 / H2O, RT, 
then 50 % H2S04(aq), then 1 d, R T , 55 %. 
The availability of 1,3-dichloropropanone 79 however, prompted an investigation into 
preparing 49 via halogen exchange of the ylid 3-chloro-2-
oxopropylidenetriphenylphosphorane 80. In the event dichloroketone 79 was converted in 
a straightforward manner to the chloro ylid 80 in approximately 70 % overall yield, via 
79b, following a literature preparation (Scheme 26).'*^ ^ However, attempts to achieve 
halogen exchange were unsuccessful using the fluorinating agents KF or KHF2, 
Scheme 27. 
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Scheme 26 i . PhjP, THF, 4 h, reflux, 84 %; iv. NaaCOs, MeOH / H2O, 80 %. 
KF or KHF2 
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Scheme 27 Attempted synthesis of 49, via halogen exchange. 
Due to the failure of this approach, the synthesis of 49 (Scheme 28) from epichlorohydrin 
was resumed. Inconsistant yields (30-52 %) were obtained in the epoxide opening 
reaction with Et3N.3HF. In general the yields were lower than that described (55 % ) , " " 
none-the-less after distillation chloro-3-fluoropropan-2-ol 78 was attainable. Oxidation of 
ketone 77 was sluggish and only about a 65 % conversion could be achieved, even with 
52 
extended reaction times. Separation of the alcohol from the ketone by treatment with 
sodium bisulphite worked well, however a poor recovery of the ketone, even after 
continuous extraction, resulted in a low isolated yield (14 %) . However, conversion of 
chloro-3-fluoropropan-2-one 77 to the ylid 49, via 77b, as previously described,""* proved 
straightforward and afforded 49 in an overall yield of 65 % from ketone 77, Scheme 28. 
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Scheme 28 i . EtsN.SHF, 4 h, 100 °C, 52 %; i i . KaCrjOy, TBAB, CH2CI2 / H2O, RT, then 
50 % H2S04(aq), then 5 d, RT, 14 %; i i i . PhsP, THF, 5 h, reflux, 70 %; iv. Na2C03, MeOH 
/ H2O, 92 %. 
The Wittig reaction between aldehyde 52 and the ylid 49 was carried out in refluxing THF 
(Scheme 29) and progressed at a very slow rate. After five days reaction the '^ F NMR 
and '^P NMR of the reaction mixture indicated that the conversion to the desired product, 
diethyl (£)-6-fluoro-5-oxohex-3-enylphosphonate 81, was low (< 10 %) . As a result 
fiirther work on this reaction was postponed and the synthesis of 82 became the focus of 
attention. 
52 
O 
49 81 
Scheme 29 THF, 5 d, reflux, < 10 % conversion. 
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2.2.2.3 Dihydroxylation of enone 76 
DXP has the threo relative configuration between the stereogenic centres carrying the 
3,4-hydroxy groups. As discussed in 1.14.1 during the synthesis of DXP analogues this 
stereochemistry should be accessible from a Sharpless asymmetric dihydroxylafion (AD) 
reaction on the trans olefin. However, standard Sharpless conditions on 76 (Scheme 30) 
using the appropriate AD-mix reagent, did not result in any threo diol 82 product, even 
after an extended reaction time. Repeating the reaction with 1 mol % of Os04, and then a 
stoichiometric amount of OSO4 reagent in the presence of the chiral ligand, was still 
unsuccessful. This lack of reactivity was deduced to be due to the conjugated double 
bond deactivating the system towards electrophilic attack. 
AD-mix-p 
O H 0 
76 82 
Scheme 30 Failed AD-mix reaction to form 82. 
In order to remove the conjugation, methods to protect the carbonyl group of 76 by 
forming a ketal, were investigated. Standard ketone protection conditions with triethyl 
orthoformate in EtOH gave the Michael addition product, diethyl 3-ethoxy-5-
oxohexylphosphonate 83, Scheme 31, in an efficient but frustrating 70 % yield. 
Attempted formation of the dioxolane 84 by reacfion of ethylene glycol with oxalic 
acid'**' afforded a mixture of starting material and products, but no 84. 
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Scheme 31 i . (EtO)3CH, EtOH, PTSA, 30 min, 72 %; i i . (HOCH2)2, (HC02)2, CH3CN, 
90 min. 
Next, a low temperature aprotic method of carbonyl protection, pioneered by 
Noyori,'"^'"'^'"'' was attempted. This methodology utilises the organosilicon 
compounds, trimethylsilyl trifluoromethanesulphonate (TMSOTf) and 1,2-
bis[(trimethylsilyl)oxy]ethane (BTSE) as catalyst and acetalisation agent respectively. It 
has been shown to afford the dioxolanes 85, 86 and 87 of a,P-unsaturated ketones 88, 89 
and 90 (Scheme 32) in high yield and without concomitant double bond migration. The 
formation of hexamethylsiloxane (TMS2O) was proposed as a major factor in shifting the 
equilibrium towards the products. The initial results were encouraging and after 
optimisation this reaction afforded the ketal (£)-2-(4-diethoxyphosphonylbut-l-enyl)-2-
methyl-l,3-dioxoIane 84 in moderate (55 %) yield with > 90 % purity. Scheme 33. 
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Scheme 32 Reported aprotic acetalisations of a, p-unsaturated ketones. (TMSOCH2)2, 
TMSOTf, CH2CI2; i . 20 h, -78 °C, 92 %;'°^ i i . 30 min, -78 °C, 48 h, 20 °C, 57 %;"° 
i i i . 44 
Scheme 33 i . (TMSOCH2)2, TMSOTf, CH2CI2, 28 h, -60 °C, 55 %. 
Now an AD-mix dihydroxylation reaction of the protected enone 84 did afford the 
threo-diol 91, albeit inconsistantly and in low (20 %) yield (Scheme 34). This material 
showed a positive optical rotation of [ajo^'' +10.5 ° (c. 1.0, CHCI3). However, assessment 
of the diol's enantiomeric excess through 'H NMR and by using the Eu(hfc)3 chiral shift 
reagent proved inconclusive. Further analysis such as preparing a suitable derivative 
(eg with Mosher's acid), was not pursued due to lack of sufficient material. 
Scheme 34 AD-mix-p, (CH3)3COH / H2O, 22 h, 20 %. 
56 
In an effort towards finding improved methods for syn dihydroxylation of 76, alternative 
strategies were investigated. Use of KMn04 under alkaline conditions rarely affords diols 
in high yield,"^ primarily due to oxidative cleavage. However, Woodward's"'' method of 
syn dihydroxylation, using iodine and silver acetate in wet acetic acid, followed by 
alkaline hydrolysis, has been shown to yield syn diols in good yield. The reaction 
proceeds through an iodo acetate intermediate and has been modified by use of KIO3, 
instead of silver acetate, to provide a less expensive means of dihydroxylation."'* 
Utilisation of the modified Woodward's method afforded a mixture of products alongside 
the starting material, but failed to yield appreciable amounts of the desired diol. 
Apart from OSO4, another group VIII metal oxide, RUO4, has been shown to mediate syn 
dihydroxylation in moderate to excellent yield (Scheme 35)."^ The use of catalytic RUO4 
with the co-oxidant NaI04, enables a very rapid reaction (~ 3 min) which has been termed 
'flash' dihydroxylation."^ Higher yields are shown for those substrates that contain one 
or more electron withdrawing groups in conjugation with, or adjacent to, the alkene 
moiety. 
^ ^ ^ C O s E t COgEt 
O H 
Scheme 35 Literature reactions. Cat. RUO4, NaI04; i . CH3CN, 0.5 min, 51 % ; " ' i i . 
CH3CN, 3 min, 69 %;"^ i i i . EtOAc / CH3CN / H2O, 3 min, 90 
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The ruthenium catalysed dihydroxylation of 76 was duly carried out and did afford 
racemic threo-diol 82, but again in a low (13 %) yield. Scheme 36. Attempts to improve 
the reaction by deviating from the reported conditions were unsuccessfiil, being hampered 
by over oxidation and glycol cleavage of 82. 
OH O 
Scheme 36 i . Cat. RUO4, NaI04, EtOAc / CH3CN / H2O, 3 min, 13 %. 
During efforts towards finding alternative syn dihydroxylation strategies, a number of 
relevant OSO4 dihydroxylation reactions on phosphonates were noted. In particular a 
previously reported^*^ reaction on 92 (Scheme 37, ii) had similarities to the current 
dihydroxylation reaction. Another report"' described the efficient dihydroxylation of the 
alkenic phosphonate 67, using reaction conditions developed by Sharpless and co-
lis 
workers. In an effort towards finding improved methods for the dihydroxylation of 76, 
these conditions were investigated ftjrther. 
P h - 0 
NHCbz P h - 0 NHCbz 
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Scheme 37 i . OSO4, NMO, THF, H2O, 12 h, 22 °C, 94 %;"^ i i . OSO4, NMO, dioxane, 
19 h, RT, 92 %;"^ i i i . OSO4, ^-BuOOH, Et4N0Ac, (CH3)2CO, 1 d, RT, 85 % . ' " 
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The reactions depicted in Scheme 37 focused attention on performing a standard OSO4 
mediated dihydroxylation reaction on 76, without addition of any chiral chelating agent. 
Accordingly 76 was treated with OSO4 as described"'' and within 24 h all of the starting 
material had been consumed. Purification afforded racemic threo diol 82 in 50 % yield 
and with > 99 % purity. This result clearly suggests that the dihydroxylation of 76 was 
inhibited by the chiral chelating agent and not the lack of reactivity of OSO4. 
2.2.2.4 Hydrolysis of threo diol 82 
The final step in the route to 24 involved phosphonate hydrolysis. TMSBr reactions have 
been repeatedly successful for such reactions under comparatively mild conditions. The 
TMSBr reaction on 82 however, afforded only decomposition products (Scheme 38). 
Deviations from the standard procedure by performing the reaction at low (-20 °C) 
temperature*^** or in the presence of mild base to neutralise traces of HBr, also failed to 
afford 82. The use of TMSI, as a more reactive substitute for TMSBr, also resulted in 
decomposition, and final attempts to dealkylate the phosphonate via traditional acid or 
base mediated hydrolysis protocols again afforded only decomposition products. 
O H 0 O H 0 
Scheme 38 Failed dealkylation of diethyl r/zreo-3,4-dihydroxy-5-oxohexylphosphonate 
82 to afford /'/2reo-3,4-dihydroxy-5-oxohexylphosphonic acid 24. 
All attempts at hydrolysing the phosphonate had failed to afford 24, resulting in only 
decompositon products. Although the synthesis to the diethyl precusor 82 had been 
successful, it was apparent that a different dialkyl phosphonate ester was required that 
would release 24 under neutral conditions. Such a dialkyl phosphonate is a dibenzyl 
phosphonate. 
59 
2.3 Synthesis of DXP analogue 24 via dibenzyl phosphonate 
Hydrogenation of benzyl phosphonates has been shown to provide facile access to 
phosphonic acids,'^ *"'^ -^* '^''* '^* and it was envisaged that this would provide a more suitable 
method of deprotection for the synthesis of 24. Preparation of the required penultimate 
compound dibenzyl r/?reo-3,4-dihydroxy-5-oxohexylphosphonate 93 was to follow the 
same route as that mapped out for diethyl phosphonate 82, with hydrogenation affording 
the desired compound 24 (Figure 20). Synthesis of the phosphono aldehyde 94, was the 
first objective towards preparing the target compound 24. 
B n - 0 
O H O 
93 
O H O 
Figure 20 Hydrogenation of the dibenzyl phosphonate 93 to afford 24. 
2.3.1 Preparation of dibenzyl 3-oxopropylphosphonate 94 
Following the preparation (Scheme 23) of the aldehydic intermediate 52 for the diethyl 
phosphonate, the corresponding reaction to generate 2-(dibenzoxyphosphonylpropyl)-l,3-
dioxolane 95 was now undertaken. However, tribenzyl phosphite 96 had to be prepared 
as it is not commercially available. This compound has been prepared from benzyl 
alcohol and PCI3 in 90 % yield,'^ '^*^ '^'^ "^ however in our hands this reaction proved 
problematic. A low yield of 20 % was obtained using what appeared to be a 
straightforward procedure (Scheme 39).'^^ Isolated 96 was found to be stable under 
nitrogen at ambient temperature but in the crude product mixture it decomposed to 
dibenzyl phosphite and tribenzyl phosphate. '^ 'P NMR indicated that 96 initially 
comprised 80 % of the phosphorus containing species in the crude mixture. After leaving 
this mixture for 12 h in the freezer, 96 comprised only 50 % of the product. This afforded 
an isolated yield of 20 % after dry column chromatography. 
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Scheme 39 i . Et3N, Et20 , 2 h, -78 °C, then 8 h, RT, 20 %. 
With 96 in hand it was treated with 2-(2-bromoethyl)-1,3-dioxolane 97 under the same 
conditions as previously described for other Michaelis-Arbuzov reactions with tribenzyl 
phosphite 96.'^ '^'^ ' This afforded 95, but only in low (< 20 %) yield (Scheme 40). A key 
sideproduct was the isomer dibenzyl benzylphosphonate 98 (> 30 % yield) which 
indicated that an efficient Michaelis-Arbuzov reaction with the in situ generated benzyl 
bromide, was competing with the intended reaction. The initial reaction conditions had 
utilised a ten-fold excess of 97, and lowering the proportion of 97 was found to 
consequentiy lower the yield of 95. 
(BnO)3P 
P h ^ " O ' l 
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Scheme 40 i . 5 h, 120 °C, 18 % for 95 and 31 % for 98. 
An alternative strategy was required that would afford the acetal 95. The Michaelis-
Becker reaction between dibenzyl phosphite and 2-(2-bromoethyl)-l,3-dioxane 73 
(Scheme 21) had been attempted before (2.2.1.3), but without success. Performing the 
reaction with the corresponding iodo dioxane offered a possibility of achieving a more 
efficient coupling reaction. Accordingly 73 was converted to 2-(2-iodoethyl)-l,3-dioxane 
99 under standard Finkelstein reaction conditions with Nal.'^^ This reaction proved 
straightforward and generated the desired (Scheme 41) iodide in 80 % yield. However, 
the subsequent reaction of 2-(2-iodoethyl)-1,3-dioxane 99 with dibenzyl phosphite in 
either a THF or DMF solvent at low (-15 °C) temperature, with NaH as a base, resulted in 
a maximum yield of 10 % for the coupled product 100. 
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Scheme 41 i . Nal, (CH3)2CO, 16 h, reflux, 80 %; i i . NaH, THF, 4 h, -15 °C, 10 %. 
In view of the unsatisfactory coupling reactions with the bromo and iodo acetals, use of a 
triflate group was then explored. It was important to identify a triflate which possessed a 
latent aldehyde three carbon atoms from the leaving group. A compound that satisfied 
this was 3,3-diethoxypropyl trifluoromethanesulphonate 101. An attempt to prepare this 
electrophile from commercially available 3,3-diethoxypropan-l-ol 102 and triflic 
anhydride was pursued. Figure 21. 
Tf,0 
Figure 21 Proposed preparation of 101 
Attempts to isolate the triflate 101 utilising 2,6-di-?err-butylpyridine as the base were 
unsuccessful due to the instability of 101 at ambient temperature. In situ formation of the 
triflate followed by addition of sodium dibenzyl phosphonate did not afford any 
detectable product. The triflic pyridinium salt 103 was isolated after attempted formation 
of the triflate from triflic anhydride and 102, using pyridine as the base. However, 
Michaelis-Becker reaction with 103 and sodium dibenzylphosphonate was also 
unsuccessful. 
TfO" OEt 
^OEt 
103 
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Formation of dibenzyl 3,3-diethoxypropylphosphonate 104 via a Michaelis-Arbuzov type 
reaction (Scheme 42) between the triflate 101 and tribenzylphosphite was also attempted. 
However, due to the weak nucleophilicity of the triflate anion, only the first step of the 
Michaelis-Arbuzov reaction takes place. These triflate phosphonuim ions have been 
noted before,'^ '^'^ **'*''* and in one case were used to form an organophosphonate.'^ ^ After 
formation of the phosphonium salt, addition of a nucleophile such as water is sufficient to 
induce formation of the phosphonate (Scheme 42).'^' The reaction was performed a 
number of times, but there was only a very low conversion to the desired product, with a 
number of side-products, most notably dibenzyl phosphite, produced in larger quantities. 
P h - ^ O - P - O - ^ ^ ^ + 
Ph TfO' 
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Scheme 42 Proposed route to form dibenzyl 3,3-diethoxypropylphosphonate 104. 
An alternative synthetic route to generate the key aldehydic intermediate dibenzyl 
3-oxopropylphosphonate 94 was explored. Scheme 43. This route utilised the reaction 
between dibenzyl phosphite and methyl iodide to generate dibenzyl methylphosphonate 
105.*^ " The reaction was reported to proceed in a yield of 85 %, and was found after 
purification by dry column chromatography, to afford 105 in about 70 % yield. The next 
step required allylation of the methyl group to afford dibenzyl but-3-enylphosphonate 106. 
This transformation, which is analogous to that performed in 2.2.1.3, was successftiUy 
carried out under the conditions developed by Savignac and co-workers,^'' to afford 106 in 
approximately 70 % yield. 
63 
o 
P h ^ ^ O ' P ^ O H P h ^ O ' P \ " . 
/ - O 
Ph 105 
Scheme 43 i . NaH, THF, -15 °C, Mel, then 2 h, 0 °C, then 20 h, RT, 68 %; i i . «-BuLi, 
THF, -60 °C, then Cu(l)I, 1 h, -35 °C, then C3H5Br, 4 h, -35 °C, 68 %; 
The remaining steps now focused on obtaining aldehyde 94 from the alkene 106. This 
had previously (2.2.1.3) been attempted by performing a one step reductive ozonolysis 
reaction. However, a new approach which utilised a two step process was investigated. 
Firstly dihydroxylation of the alkene moiety with OSO4, followed by a NaI04 glycol 
cleavage to yield the desired aldehyde 94. The dihydroxylation conditions that had been 
developed for the same reaction on diethyl but-3-enylphosphonate 67 (Scheme 37, iii) 
were explored. Performing the OSO4 reaction under these conditions"^ did indeed afford 
the desired dihydroxylated material dibenzyl 3,4-dihydroxybutyIphosphonate 107 in high 
(85 %) yield (Scheme 44). The second step required cleavage of the diol 107 with NaI04, 
to afford the aldehyde 94. This reaction was found to proceed very cleanly and in an 
excellent yield of 99 % (Scheme 44). In the event the crude product, dibenzyl 
3-oxopropylphosphonate 94, was reacted immediately as it gradually decomposed on 
storage. 
106 107 O H 
Scheme 44 i . OSO4, TBHP, Et4N0Ac, (CH3)2CO, 3 d, RT, 85 %; i i . NaI04, THF / H2O, 
I h, RT, 99 %. 
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2.3.2 Preparation of ^/i/'eo-3,4-dihydroxy-5-oxohexylphosphonic acid 24 
2.3.2.1 Synthesis of dibenzyl enone 108 
The successful preparation of dibenzyl 3-oxopropylphosphonate 94 now enabled the 
Wittig reaction with 48 to be carried out as described previously (2.2.2.1) for the 
analogous diethyl ester 76 (Scheme 24). As before the reaction proceeded cleanly 
generating the resultant enone, dibenzyl (£)-5-oxohex-3-enylphosphonate 108, however 
purification was not so straightforward. Changing the phosphonate ester from ethyl to 
benzyl significantly increased the phosphonate's boiling point. As a consequence 
distillation was not viable, and chromatography was explored. After optimisation a 
solvent system was developed that afforded sufficient Rf separation on tic to warrant 
purification by column chromatography. This method resulted in the recovery of 108 
(~ 93 % purity) in a 94 % yield, the main impurity (5 %) being triphenylphosphine oxide 
(Scheme 45). 
O 
Ph^P.; 
48 
Scheme 45 i . THF, 18 h, reflux, 94 %. 
2.3.2.2 Synthesis of dibenzyl threo diol 109 
The next step required the dihydroxylation of 108 to afford the penuhimate compound on 
the synthetic route to rAreo-3,4-dihydroxy-5-oxohexylphosphonate 24. Performing the 
reaction under the same OSO4 dihydroxylation conditions that had been successful for the 
diethyl analogue (2.2.2.3) afforded 109 in 66 % yield, with > 99 % purity (Scheme 46), as 
a stable creamy coloured solid. 
65 
OH O 
108 109 
Scheme 46 i . OSO4, r-BuOOH, Et4N0Ac, (CH3)2CO, 27 h, RT, 66 %. 
2.3.2.3 Hydrogenation of dibenzyl threo diol 109 
The final step in the synthesis of the target 24, required debenzylation by hydrogenation to 
release the phosphonic acid. The hydrogenation was initially carried out in MeOH 
mediated by 10 % palladium on carbon catalyst. Analysis of the reaction mixture showed 
only decomposition products. However, fortuitously changing the reaction solvent to a 
THF / water mix and repeating the reaction, otherwise under the same conditions, proved 
successful and did deliver the desired material 24 in about 80 % yield, with > 99 % purity 
(Scheme 47). After isolation, 24 was found to gradually decompose on standing over 
several days by visual inspection and NMR analysis. Formation of the disodium 
phosphonate sah was achieved by neutralising the filtered reaction product mixture with 
dilute NaOH(aq) to generate the more stable salt 110. This compound was also found to 
decompose within two weeks at ambient temperature. 
N a O ' ' 
NaO 
Scheme 47 i . H2 (2-3 atm), 10 % Pd on C, THF, H2O, 45 min, RT, then NaOH(aq), 77 % 
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2.4 Synthesis towards the CF2 analogue 39 of DXP 
O OH 
II -
HO'P-
F F OH O 
Threo-3{R),4(S)-\,\-difluoro-3,4-dihydroxy-5-oxohexylphosphonic acid 39 
In light of the experience for deprotection of 82 preparation of the diethyl ester of the CF2 
analogue of DXP was not pursued. Instead a synthesis was initiated towards the benzyl 
ester as this offered the more satisfactory protecting group. At the outset the preparation 
of dibenzyl l,l-dif[uoro-3-oxopropylphosphonate 111 was approached in an analogous 
manner to that of 94, the first step in the synthesis to 94 being a Michaelis-Arbuzov type 
reaction between triethyl phosphite and dibromodifluoromethane (2.2.1.1, Scheme 15). 
Accordingly tribenzyl phosphite (previously prepared in 2.2.2.3) was mixed with 
dibromodifluoromethane but a number of attempts at this reaction failed to afford the 
coupled phosphonate 112. The reaction is known to work for the ethyl and butyl 
phosphites,'''^ but only starting material was recovered from the tribenzyl phosphite 
reaction (Scheme 48). The failure of such reactions has been noted before,however no 
explanation for this was proposed. A Michaelis-Becker type reaction between 
dibromodifluoromethane and dibenzylphosphite also failed, again with only reactants 
being recovered. 
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Scheme 48 Failed Michaelis-Arbuzov and Michaelis-Becker reactions to form 112. 
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An alternative Michaelis-Becker reaction was then undertaken, designed to produce 
dibenzyl difluoromethylphosphonate 113. This involved treatment of the sodium salt of 
dibenzylphosphite with chlorodifluoromethane, a reaction which had been reported to 
afford 113 in 75 % yield.'^"^ Deprotonation of this phosphonate generates a rather 
unstable and weak nucleophile, which has however been shown to react with alkyl 
triflates in moderate yield.'"'^ Reaction details for the preparation of 113 are not provided 
in the literature but after some experimentation the formation of 113 was achievable in 
reproducible yields of about 60 %, with > 99 % purity (Scheme 49). 
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Scheme 49 i . NaH, THF, -15 °C, then 12 h, RT, 61 %. 
The successful generation of dibenzyl difluoromethylphosphonate provided access 
towards the synthesis of the target, 39. Successful allylation of 113 was now required for 
the synthesis of the benzyl CF2 aldehyde 111. Initial attempts used an excess of allyl 
bromide in a reaction with 113 as this had proven expedient during the synthesis of the 
diethyl analogue 56 (2.2.1.3, Scheme 19). On the first few attempts the reaction worked, 
producing dibenzyl l,l-difluorobut-3-enylphosphonate 114 in about a 20 % yield, 
however all attempts to improve on the initial successes failed. With the olefin 114 in 
hand, a trial OSO4 reaction using the previous conditions (2.3.2.2) was undertaken (the 
two step process of dihydroxylation followed by gylcol cleavage being preferred over the 
one step ozonolysis reaction), however this reaction yielded only decomposition products. 
Scheme 50. Because of the problems encountered in making the aldehydic precursor 111 
by this route, an altenative was sought. 
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Scheme 50 Attempted synthesis of dibenzyl 1,1-difluoro-3,4-dihydroxybutylphosphonate 
115. 
The alternative route towards the difluoro aldehyde 111, utilised an acetal protecting 
group. This general method of forming an phosphonoacetal had been previously 
attempted (2.2.1,3), using 2-bromomethyl-l,3-dioxolane 72 in a coupling reaction with 
dimethyl methylphosphonate 68 (Scheme 21). However, use of an acetal with a better 
leaving group, such as the triflate 116 was considered more promising. Hydrolysis of the 
acetal 117 would clearly afford the desired aldehyde 111 (Scheme 51). 
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Scheme 51 Proposed route to dibenzyl 1,1-difluoro-3-oxopropylphosphonate 111. 
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The formation of 116 from glycoladehyde diethylacetal 118 and triflic anhydride has been 
reported before, but no synthetic details were supp l i ed . In i t i a l attempts to form 116 
using pyridine as the base afforded the pyridinium triflate 119. It was envisaged that 
reaction of this salt 119 with dibenzyl lithiodifluoromethylphosphonate would deliver 
117, displacing pyridine as the leaving group. However, attempted coupling of these two 
reagents did not afford any product as determined by 'V and '^ 'P NMR analysis. In the 
end, the generation of 116 was achieved by use of the non-nucleophilic base 2,6-di-tert-
butylpyridine,'^' the triflate being isolated after column chromatography in ~ 65 % yield. 
The product was contaminated with some of the base (Scheme 52). The coupling 
reaction with 113 was carried out as described for other triflate reactions with 113,'^ '^'''* 
and after workup 'V and '^ 'P NMR analysis of the crude product mixture indicated that 
the required dibenzyl 3,3-diethoxy-l,l-difluoropropylphosphonate 117 had been 
generated, but in < 10 % yield, Scheme 52. Further work on this reaction was postponed 
due to the inefficiency of this process. 
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Scheme 52 i . DTBP, CH2CI2, 25 min, -20 °C, ~ 65 %; i i . LDA, THF / HMPA, 2 h, 
-78 ° C , < 1 0 % . 
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2.5 Synthesis of CHj analogue 40 of MEP 
3(i?,5),4(5)-3,4,5-trihydroxy-4-methylpentylphosphonic acid 40 
Synthesis of the methylene analogue of 2-C-methyl-D-erytlirito]-4-phosphate (MEP) 40, 
as a diastereomeric mixture, epimeric at the C-3 centre was envisaged to be accessible 
through diethyl 3-oxopropylphosphonate 52. Utilisation of the aldehyde 52 (prepared 
previously, 2.2.1.3, Scheme 23) in a Grignard reaction with isopropenylmagnesium 
bromide 120 should afford the racemic allylic alcohol 121. Asymmetric dihydroxylation 
mediated by OSO4 of 121 should yield the triol 122 with a diastereomeric excess. Finally 
it was envisaged that TMSBr deprotection would then provide access to the target 
compound 40, Scheme 53. 
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Scheme 53 Proposed route to 40. 
2.5.1 Synthesis of allylic alcohol 121 
Preparation of the Grignard reagent 120 was achieved most consistently using an iodine 
initiator in T H F at ambient temperature. Grignard reactions with 120 were first 
performed at 0 ° C and yielded a mixture of products. Analysis by ' H , '^C and '^P N M R 
suggested that Grignard attack took place at both the phosphonate and aldehydic centres, 
generating a number of products, including the desired allylic alcohol 121 (Scheme 54). 
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Scheme 54 Reaction products of diethyl 3-oxopropylphosphonate 52 with 
isopropenylmagnesium bromide 120 at 0 °C. 
The selectivity of this reaction was improved by conducting the reaction at the lower 
temperature of -78 °C. Reaction at this temperature afforded no detectable phosphonate 
addition product. However, only a low conversion of the aldehyde to the desired alcohol 
121 was achieved, even with the use of a large excess of Grignard reagent. This initially 
presented problems with purification of the product mixture, but after careful choice, a 
solvent system for column chromatography was found that separated 121 from the 
aldehyde 52, affording diethyl 3-hydroxy-4-methylpent-4-enylphosphonate 121 in 
approximately 45 % yield, with > 99 % purity. Scheme 55. 
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Scheme 55 i . THF, 40 min, -78 °C, 44 %. 
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2.5,2 Synthesis of triol 122 
The next step towards formation of 40 required dihydroxylation of the allylic alcohol 121 
in a stereoselective manner. An OSO4 AD-mix reaction could afford the triol 122, 
containing the desired stereochemistry at the C-4 centre, however a previous AD-mix 
reacfion on the related diethyl (£)-5-oxohex-3-enylphosphonate 76 (2.2.2.3) had not 
yielded product. After prolonged reaction of 121 under Sharpless AD-mix-P conditions, 
again no detectable product was formed (Scheme 56), thus prompting an investigation 
into standard racemic OSO4 mediated dihydroxylation reactions of allylic alcohols. 
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Scheme 56 Failed AD-mix reaction to form 122. 
Studies '^'^  have shown that OSO4 oxidation of allylic alcohols and ethers has a moderate to 
high stereoselectivity with 'the relative stereochemistry between the pre-existing hydroxyl 
or alkoxyl group and the adjacent newly introduced group of the major product, in all 
cases being erythro.'^^^ This relative stereochemistry was fortuitously that of the desired 
product 40. From the literature there are a few comparable examples of dihydroxylation 
reactions relevant to the system of interest (Scheme 56). Two of the osmylation reactions 
(Scheme 57, i and iii) have been reported as highly stereoselective. In the case of (i) this 
is due to the stereoelectronic effect of the carbomethoxyl substituent,''*" and in the case of 
(iii) it is most probably due to the steric influence of the pendent R group.*'*' Although 
the hydroxyl or alkoxyl group can have strong directing influences in osmylation reactions 
on its own, reaction (ii) 'showed considerably less stereoselectivity'*'**' highlighting a 
potential weakness of this methodology. 
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Scheme 57 Reported OSO4 reactions, (i),''"'(11)'"° and (iii) 
The dihydroxylation reaction of 121 may then generate the required triol 122 at best as a 
racemic mixture and at worst as a mixture of four diastereoisomers. The allylic alcohol 
121 was duly reacted with OSO4 utilising the previous conditions that had been successful 
(2.2.2.3), and the progress of the reaction was monitored by '^P NMR. After 121 had 
been consumed the reaction was quenched. Analysis of the isolated material showed that 
ketone 123 was the predominant product (Scheme 58), with pure (> 99 %) material 
isolated in 30 % yield after column chromatography. Formation of 123 is postulated to 
arise by oxidation of allylic alcohol 121 or the desired triol 122 by either TBHP or OSO4, 
Scheme 58. 
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Scheme 58 Possible routes for synthesis of 123. OSO4, TBHP, Et4N0Ac, (CH3)2CO, 
28 h, RT, 28 %. 
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Although the production of this ketone 123 had not been envisaged, it offered an 
intermediate for either generating 124, an isomer of the CH2 analogue of DXP or after 
reduction, the triol 122. However, ester hydrolysis under standard TMSBr conditions 
caused immediate decomposition of starting material. Conducting the NaBH4 reaction of 
123 was also found to generate only decomposition products from NMR analysis, 
Scheme 59. 
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Scheme 59 i . TMSBr, 2 h, RT, then H2O, 12 h, RT; i i . NaBH4, MeOH, 15 min, -20 °C. 
It was envisaged that the generation of ketone 123 may be suppressed i f the allylic alcohol 
121 was converted to an allylic ether prior to osmylation. To investigate this the THP 
protecting group was chosen due to its ease of introduction and removal. Formation of 
the THP protected alcohol 125, proceeded in a straightforward manner, the product being 
isolated in a yield of about 70 % after column chromatography (Scheme 60). A much 
higher crude yield was obtained but it was found that some of the THP protected alcohol 
125 decomposed on the column presumably due to its instability over mildly acidic silica. 
121 125 0 ^ 
Scheme 60 i . DHP, PTSA, CH2CI2, 25 min, RT, 66 %. 
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A preliminary OSO4 mediated dihydroxylation of 125 was followed by '^P NMR. Once 
the majority of the starting material had been consumed, the reaction mixture was 
quenched and extracted into CH2CI2. Partial purification of the crude sample from the 
organic phase via column chromatography did afford an impure sample of the intended 
dihydroxy ether 126 in about 30 % yield (Scheme 61), but also an impure sample of triol 
122 in about 5 % yield, most probably again due to the instability of the THP group over 
silica. 
Comparison of the main peaks in the '^P NMR spectra of the triol 122 and the aqueous 
fracfion from the OSO4 mediated dihydroxylation of 121 indicated that they had 
comparable chemical shifts. This prompted a continuous extraction of the aqueous phase 
from the reaction of 121, however the '^ 'P species could not be extracted from the water 
even under continuous extraction with EtOAc or CH2CI2. Freeze drying the aqueous 
solution enabled confirmation by ' H NMR that the species in the aqueous phase was the 
desired triol 122. The approximate amount of material isolated from freeze drying 
amounted to a yield of ~ 2 %. 
; 0 ^ P \ . - ^ X ^ 0 H 
O. 
126 
0 
II 
^O 'P 
125 O , OH 
^0 ' ' 
- O 
.P^ ^ ^ . O H 
OH 
122 
Scheme 61 i . OSO4, TBHP, Et4N0Ac, (CH3)2CO, 20 h, RT, ~ 30 % for 126 and ~ 5 % 
for 122. 
The low yields encountered for the dihydroxylation of the THP ether 125, prompted a 
re-analysis of the previous OSO4 dihydroxylation of the allylic acohol 121, and in 
particular an accurate assessment of how much product had been lost to the aqueous 
phase. After performing the reaction again, the mixture was quenched and solvent 
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removed using C H C I 3 to azeotrope the majority of the water. Freeze drying to remove the 
remaining water, and then purification by column chromatography gave 123 in about 
20 % yield, followed by the desired product 122, also in about 20 % yield, with > 99 % 
purity. Scheme 62. 
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Scheme 62 i . OSO4, TBHP, Et4N0Ac, (CH3)2CO, 5 h, RT, 18 % for 122 and ~ 20 % for 
123. 
2.5.3 Deprotection of 122 
The final step in the preparation of the CH2 analogue of MEP required hydrolysis of the 
diethyl phosphonate ester to yield the corresponding phosphonic acid 40. The first 
attempt at hydrolysis utilised TMSBr methodolgy. However, as had been found 
previously (2.2.2.4 and 2.6.2) addition of TMSBr to 122 caused decomposition. Due to 
the small amount of 122 remaining the reaction was not repeated, and an alternative, non 
acidic, deprotection strategy was sought. In the event, reaction of 122 with 
0.1 M NaOH(aq) for I h under reflux, cleanly afforded the monosodium salt 127, Scheme 
63. A further 5 h reflux with 2 M NaOH(aq) was then required to complete the hydrolysis 
and generate the target compound 40, as its disodium salt 128, > 99 % pure by '^ 'P NMR 
analysis, Scheme 63. An accurate yield was not attainable for the hydrolysis reaction due 
to contamination by NaCl, produced from neutralisation of the reaction mixture. 
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Scheme 63 i . 0.1 N NaOH(aq), 1 h, reflux; i i . 2 N NaOH(aq), 5 h, reflux 
2.6 Synthesis of reduced DXP analogue 46 
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r/2reo-5(i?,5)-3,4,5-trihydroxyhexylphosphonic acid 46 
Target compound 46 was next addressed. It was envisaged that 46 could be prepared by 
NaBH4 reduction of diethyl r/zreo-3,4-dihydroxy-5-oxohexylphosphonate 82 (2.2.2.3), to 
afford the triol diethyl 3,4,5-trihydroxyhexylphosphonate 129. Phosphonate deprotection 
with TMSBr should generate the desired phosphonic acid 46 (Scheme 64) as a mixture of 
diastereoisomers. 
OH 0 129 OH OH 
HO', ' 
46 
OH OH 
Scheme 64 
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In the event, treatment of 82 with NaBH4 in MeOH at 0 °C for 1 h generated two 
unforseen products. These were diethyl (£)-5-hydroxyhex-3-enylphosphonate 130 and 
diethyl 5-hydroxyhexylphosphonate 131 as the major and minor products respectively. 
Although these compounds were not isolated, '^ 'P NMR analysis indicated that they had 
been formed in near quantitative conversion and in an approximate ratio of 3 : 1, 
Scheme 65. Changing the reaction temperature to -78 °C also failed to afford the desired 
material, the reaction yielding a low mass recovery from the organic phase of a mixture of 
products. •^ 'P NMR Analysis also indicated a mixture of products in the aqueous phase. 
130 
OH 0 
82 
Scheme 65 i . NaBH4, MeOH, 0 °C, 1 h, ~ 75 % for 130 and -25 % for 131. 
Formation of the a, P-unsaturated alcohol 130 from NaBH4 reduction of 82 suggested an 
alternative route to triol 129 via reduction of the enone diethyl (£)-5-oxohex-3-
enylphosphonate 76 to generate 130, followed by dihydroxylation to afford the triol 129. 
Subsequent NaBH4 reactions with 76 did appear to have generated 130 by '^P NMR 
analysis of the crude reaction mixture, however only a crude yield of ~ 50 % was 
obtained. A more efficient route to 46 could potentially be achieved by other means, 
Scheme 66. Acetonide protection of 82, would afford threo-5-acetyl-4-(2-
diethoxyphosphonylethyl)-2,2-dimethyl-l,3-dioxolane 132 which could undergo NaBH4 
reduction to the alcohol 133. Finally, it was envisaged that deprotection with TMSBr 
would remove both the acetonide and phosphonate protecting groups in a single step. 
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Scheme 66 Proposed alternative synthesis of 46. 
Efficient acetonide protection of 82 using 2,2-dimethoxypropane with PTSA as the acid 
catalyst was achieved affording 132 (Scheme 67) after purification in 80 % yield with 
> 99 % purity. Reduction then of 132 with NaBH4 proceeded cleanly affording two 
diastereoisomers of 133 in a ratio of approximately 3 : 7 > 90 % yield, with a purity of 
> 99 %, Scheme 67. Deprotecfion of 133 with TMSBr followed a standard protocol and 
generated the target phosphonic acid 46 (Scheme 67), as its disodium salt 134, in about 
85 % purity. This was contaminated with the mono sodium salt 135, ~ 12 %, with both 
species containing the previous diastereomeric ratio of 3 : 7 as determined by NMR 
analysis. 
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Scheme 67 i . (CH3)2C(OMe)2, PTSA, 14 h, RT, 80 %; i i . NaBH4, MeOH, 15 min, RT, 
91 %; i i i . TMSBr, 4 h, H2O, 14 h, NaOH(aq). 
2.7. Synthesis of fosmidomycin analogue 47 
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3-(7\^-Acetyl-jV-hydroxyamino)-3-oxopropylphosphonic acid 47 
This work was carried out by Harmah F. Sore (4^ ^ year MSci project student) under my 
guidance. In developing a route towards 47, formation of the //-hydroxyimide functional 
group presented the main synthetic challenge. A significant amount of literature 
precedent exists for the formation of imides, but little work has been directed towards 
preparation of an 7V-hydroxyimide from an imide, and none for coupling either an imide or 
A'-hydroxyimide group to a phosphonate group. The methodologies that have been 
developed for the formation of imides are generally through the A^-acylation of amides, 
one A^-acyl group being in most cases an acetyl group, as is the case for 47. These 
methodologies have included the use of ketene,*'*^  but are normally achieved by acylation 
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of an amide through use of an acid chloride in conjuction with pyridine''*'' or NaH.^^ A 
more general method for A'^ -acetylating amides has also been developed that utilises 
H2SO4 and acetic anhydride.''*'* 
Of the above imide formation methods the most promising and straightforward method 
appeared to utilise an acyl chloride in conjuction with NaH. This method could be 
incorporated into a synthetic route towards 47 as delineated in Scheme 68. Synthesis of 
the acid chloride 136 from the commercially available triethyl 3-phosphonopropionate 55 
has been described, generating a reactive intermediate that could react with acetamide. 
Coupling would afford the imide 54, which could then be oxidised to the A'^ -hydroxyimide 
53, following a literature method.^' Finally, a TMSBr mediated hydrolysis reaction may 
afford the desired phosphonic acid 47. 
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Scheme 68 Proposed synthetic route towards 3-(A^-acetyl-iV-hydroxyamino)-3-
oxopropylphosphonic acid 47. i . NaHC03(aq), 30 min, reflux, 66 % for methyl ester;^ ^ 
i i . (C0C1)2, CH2CI2, 2 h, 35 °C, ~ 100 
Synthesis of the acid chloride 136 was readily achieved*'' in about 60 % yield from 55. 
Attempted acylation of the acetamide was not so straightforward. Neither pyridine or 
NaH as base at low (-60 °C) or ambient temperature respectively were able to mediate a 
coupling reaction to form A^-(3-diethoxyphosphonyl)propionyl-acetamide 54. Lack of 
success here prompted an investigation into an alternative coupling strategy using a 
phosphonoamide with a ketene or, as had been successflil for other workers, with acetic 
anhydride and a H2SO4 catalyst. 
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2.7.1 Revised synthetic strategy towards 47 
The phosphono amide 2-(diethoxyphosphonyl)propanamide 137 required for the modified 
strategy towards 47 had been reported in an 85 % yield from triethylphosphite and 
acrylamide in a Michael / Michaelis-Arbuzov type reaction.'''^ The reaction had been 
found to proceed most cleanly with phenol as the protic source, thereby producing 
phenetole (PhOEt) as side-product. The amide 137 was synthesised as described and after 
purification over silica was isolated in > 99 % purity with a yield of about 60 % 
(Scheme 69). Preliminary attempts to afford A^-acetylimide 54 by reaction with ketene, 
were not successful. The starting material 137 was recovered from the reaction, 
suggesting that ketene had not throughly mixed with 137. 
Reaction with acetic anhydride and H2SO4 catalyst, at 85 °C for 2 h however did afford 54 
in 33 % yield after distillation. During optimisation of this reaction, it was found that 
increasing the temperature or amount of sulphuric acid decreased the yield of 54. 
However, decreasing the duration of the reaction to 1 h maintained a yield of 33 %, but 
increasing the stochiometry of acetic anhydride to 5 equivalents was found to afford the 
most significant change, the yield of 54 improving to about 45 %, although the product 
was contaminated with ~ 5 % of an unidentified material. Scheme 69. 
/ O / 0 0 
137 54 
Scheme 69 i . PhOH, 1 d, 100 °C, 58 %; i i . (CHsCOjzO, H2SO4, 2 h, 84 °C, ~ 44 %. 
The next step towards formation of the iV-hydroxyimide 53 was now attempted using 
methodology that had been successful for formation of A^-hydroxyamides from secondary 
amides.*"*^  This utilised a peroxy-molybdenum complex, M0O5.DMF as the oxidant, 
requiring first the trimethylsilylation of the imide to activate it towards oxidation. 
Reaction of 54 was carried out under the conditions described, but analysis of the crude 
product mixture showed only decomposition products (Scheme 70). Further work on this 
reaction was postponed due to the failure of this methodology. 
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Scheme 70 i . NaH, THF, 15 min, RT, then TMSCl, 1 h, RT, then M0O5.DMF, CH2CI2, 
18 h, RT, then 1 M Na4(EDTA)(aq). 
In order to hydrolyse the esters of 54, a standard TMSBr reaction was duly performed. 
Care had to be taken in neutralising the reaction mixture immediately after addition of 
water to minimise hydrolysis of the imide, but otherwise the reaction proceeded cleanly 
generating the desired compound 3-(A'^-acetyl)-3-oxopropylphosphonic acid, as its 
disodium salt 138 in ~ 80 % purity. Scheme 71. An accurate yield for the reaction could 
not be obtained due to contamination by NaBr. 
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Scheme 71 i . TMSBr, 2 h, RT, then NaOH(an), 1 h, RT. 
2.8 Biological Testing 
The disodium salts 110 and 138 were tested (Biological Department, University of 
Durham) to assay their antibiotic activity against E. coli and S. aureus. The results 
indicated that these compounds did not elicit any antibacterial response. Compound 110 
was also assayed against DXP reductoisomerase by Prof H. Seto's group at the University 
of Tokyo, but was found not to display inhibitory activity or act as a substrate for the 
enzyme. However, 110 did act as a weak competitive inhibitor of DXP synthase. 
Assaying of 110 against the PNP synthase enzyme is currently being carried out by 
Prof D. Cane's group at Brown University, Rhode Island, USA. 
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Chapter 3 
Stereoelectronic effects 
of fluorine 
85 
3.1 Introduction 
This chapter is divided into two parts. Both are concerned with the stereoelectronic 
influence of the fluorine atom in determining the conformation of organofluorine 
compounds. Part A focuses on the conformation of fluoromethyl aromatics, and Part B 
describes the fluorine amide gauche effect in peptides. The X-ray crystal structures 
described in this chapter were obtained by Clare Bilton (and Dr D. S. Yufit, for benzyl 
fluoride) in a collaboration with Prof Judith Howard's research group. 
Incorporation of a fluorine atom into an organic compound as a hydrogen or hydroxy 
mimic is acknowledged as having a profound and sometimes unexpected effect on the 
biological activity of the fluorinated analogue. The success of the strategy can be 
attributed to the small size of the fluorine atom which generally does not distort the shape 
of the analogue relative to the parent substrate. However, the high electronegativity of the 
fluorine atom can dramatically alter the outcome of an enzymatic process. The van der 
Waals radius for fluorine is approximately 1.47 A, and is intermediate between that of 
hydrogen (1.2 A) and oxygen (1.57 A).''*'' The electronegativities differ more however 
with values based on the Pauling scale, of 4 for F, 2.2 for H and 3.5 for 0.''** Comparison 
of these values alone may suggest that fluorine will act as a better oxygen mimic. 
However, fluorine is a poor hydrogen bond acceptor relative to oxygen, and this 
significantly weakens fluorine's ability to replace a hydroxy group.'"*^ Amongst the subtle 
effects of replacing hydrogen for fluorine are the stereoelectronic implications of such a 
change.Organofluorine compounds are known to participate in the anomeric, Anh-
Eisenstein, and cis and gauche e f f e c t s . T h e Anh-Eisenstein and gauche effects are 
discussed in detail in Parts A and B respectively. 
86 
3.2 Part A 
3.2.1 The Anh-Eisenstein effect 
Various models have been put forward to rationalise observed facial attack at a carbonyl 
centre. The Felkin model is perhaps the most successful in rationalising experimental 
results.'^ "^ This model describes a preferred transition state based on a conformation in 
which the sterically most bulky (L) of the carbonyl's a-ligands takes up a position 
opposite and perpendicular to the incoming nucleophile, and the next largest (M) a-ligand 
is gauche to the carbonyl (Figure 22). The remaining small (S) a-ligand is then gauche to 
the group (R) attached to the carbonyl carbon. 
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Figure 22 Felkin transition state model of nucleophile attack to a carbonyl. 
Ambiguity can arise in assigning the order of ligands according to their size. Anh and 
Eisenstein have refined the Felkin model and have argued that electronic effects must also 
be considered when determining the order of ligands. This was exemplified by the 
outcome of a theoretical study of hydride attack on 2-chloropropionaldehyde 139 
(Figure 23).'^' For 139 the Felkin order of ligands for L > M > S would be Me > CI > H, 
however the study suggested that the most stable transition state will have the HOMO of 
the hydride nucleophile attacking the LUMO of the carbonyl in an an^Z-parallel approach 
to the C-Cl bond. It was rationalised that this approach will relax the electrostatic 
repulsion between chlorine and hydride and also allow for mixing of the developing 
a-bond electrons with the a*-orbital of the C-Cl bond. An analogous study was made for 
cyanide attack to 2-fluoropropionaldehyde 140 (Figure 23) by Paddon-Row and Wong.*^^ 
Here, the Felkin model has Me as the bulkiest ligand and thus anti to the incoming 
nucleophile, whereas the Anh-Eisenstein model requires that the best acceptor ligand, the 
C-F bond, be anti to the nucleophile. This study found that the lowest energy transition 
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state had the C-F bond anti, thereby affording strong support for the Anh-Eisenstein 
152 model of nucleophilic attack in such systems.' 
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Figure 23 Anh-Eisenstein stabilisation, rationalised through a molecular orbital approach 
for nucleophilic attack to 2-chloropropionaldehyde 139 and 2-fluoropropionaldehyde 140. 
3.2.2 Anh-Eisenstein effect in enzymatic reactions 
The enzymatic hydrolysis'^''''^'* of racemic or meso a-fluorinated esters (Figure 24) has 
been rationalised by considering Anh-Eisenstein type transition states. Classically lipase 
enzyme resolutions have been interpreted to arise by steric interactions of S, M and L 
groups with the surface of the protein. For the fluorinated substrates however, it is 
difficult to rationalise selectivity in terms of a size difference between fluorine and 
hydrogen. This deficiency, and the theoretical analysis of diastereoisomeric transition 
states for nucleophilic attack by lipases, suggests that the resolution is due to Anh-
Eisenstein type stabilisation and is essentially controlled stereo-electronically.'^^ This 
would occur in the lipase active site as the serine alkoxide nucleophile of the enzyme 
attacks the ester carbonyl (Figure 24). This stabilisation (estimated to be about 
10 kJ mof ' ) is sufficient to account for the observed enantioselectivity of 99 % ee.'^ ^ 
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Figure 24 Enzymatic lipase reactions with a-fluoro esters, with proposed Anh-Eisenstein 
diastereomeric transition state. 
3.2.3 Intramolecular stabilisation through n-a* hyperconjugation 
The Anh-Eisenstein effect has been used to rationalise the results of enzymatic reactions 
on fluorinated substrates, but there is little experimental evidence, beyond theoretical 
studies, which support these conclusions. Experimental evidence to demonstrate the n-o* 
interaction for fluorinated compounds has arisen from ab initio and microwave studies on 
the conformational preference of 2-(fluoromethyl)pyridine 141.'^^ Previous work'^^ on 
the related 2-(alkoxymethyl)pyridines 142 had shown from crystal structures that there is 
a strong preference for an a«ri-periplanar conformation, with an N-C-C-0 dihedral angle 
close to 180° (Figure 25). The observed anti conformation was rationalised to be largely 
due to orbital overlap between the ring nitrogen's lone pair and the C-0 antibonding (a*) 
orbital. This type of orbital overiap, between an incoming HOMO and an anti-bonding 
LUMO parallels the interaction in the Anh-Eisenstein transition states for Ti-facial 
selectivity. A gas phase analysis of 142 was now required to remove interactions arising 
from crystal packing forces. 2-(Alkoxymethyl)pyridines 142 however, were found not to 
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be suitable for gas phase studies owing to their large number of degrees of freedom and 
their low vapour pressure. 2-(Fluoromethyl)pyridine 141 however, was found to be a 
good model with ab initio calculations finding the same conformational preference as that 
calculated for 142. Microwave spectroscopic studies were found to be in strong 
agreement with the ab initio predictions, revealing a preferred a«//-periplanar 
conformation as shown in Figure 25 predominanting in the gas phase. This 
conformation arises by n-a* hyperconjugation and has an origin similar to the Anh-
Eisenstein model. 
Figure 25 The preferred conformation of 2-(alkoxymethyl)pyridines 142 and 
2-(fluoromethyl)pyridine 141. 
Seven different conformations of 141 can be envisaged (Figure 26). Ab initio 
calculations predict a theoretical energy difference between conformers A and G of 
20.2 kJ mol"', with C-F bond lengths of 1.396 A and 1.382 A for A and G respectively.*^*^ 
Conformers A and G have the C-F bond co-planar with the ring, B, C, E and F have C-F 
gauche to the ring, whereas for D the C-F is perpendicular. Conformation G is not an 
energy minimum due to electrostatic replusion between fluorine and nitrogen. 
Conformations A and D can both accommodate hyperconjugation between the a* orbital 
of the C-F bond and the lone pair on N in the former case, and with the n-orbitals of the 
aromatic ring in the latter case (Figure 26). As a consequence the most stable 
conformations should be either A or D. In the event A emerged as the most stable 
conformer of 141 suggesting that N lone pair donation into the C-F a* orbital is more 
stabilising than Ti-orbital donation. However, it must be noted that electrostatic repulsion 
between N and F wil l have an important part to play in determining the most stable 
conformation of 141, and N and F are maximally separated in A. 
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Figure 26 Seven different conformations of 2-(fluoromethyl)pyridine 141. 
3.2.4 Objectives 
In an effort to obtain further evidence to reinforce this conjugative hypothesis, 
crystallographic data to support the above conclusions was sought. Synthesis of 
2-(fluoromethyl)pyridine 141 and the 2-(fluoromethyl)pyridine derivatives 143-146 
(following page) were undertaken in anticipation of generating compounds for X-ray 
analysis. The N-C-C-F dihedral angles were clearly of interest. A dihedral angle of 180° 
would suggest n-a* stabilisation, with the C-F bond parallel and anti to the N-C bond. 
Also i f significant donation was occurring from the N lone pair into the a* orbital of the 
C-F bond, then the length of the C-F bond might become extended as the antibonding 
orbital is populated. However, secondary intermolecular interactions may well also 
perturb the length of the C-F bond and / or the conformation of the fluoromethyl group in 
the solid state relative to the gaseous state. For this reason analysis of the intermolecular 
interactions wil l also be undertaken. 
91 
141 143 
N + ^ N + 
I I 
o - 0 -
145 146 
3.2.5 Synthesis 
In general fluoromethylpyridines can be prepared from the corresponding chlorinated 
compounds by halogen exchange. 2-(Fluoromethyl)pyridine 141 was prepared via halide 
exchange of 2-(chloromethyl)pyridines as previously described*^^ using KF in conjunction 
with 18-crown-6 in CH3CN (Scheme 72).*" After 8 days the reaction was worked up and 
the product purified by distillation. In the event 141 was isolated in 14 % yield. 
Bis-2,6-(fluoromethyl)pyridine 143 was prepared in a similar manner after a 10 day 
reaction. Distillation afforded 143 as a low melting solid in 50 % yield, and 
recrystallisation from an acetone / petrol mix at -20 °C gave crystals of 143 suitable for 
X-ray analysis. Reaction of 2-(chloromethyl)quinoline with KF also afforded the 
corresponding fluorinated compound 2-(fluoromethyl)quinoline 144. This reaction was 
sluggish, and after 14 days reaction distillation afforded a fraction of 144 as a clear 
colourless oil, in about a 50 % yield. Scheme 72. 
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Scheme 72 A l l reactions, KF, 18C6, MeCN, reflux; for i . 8 d, 14 %; for i i . 10 d, 50 %; 
fo r i i i . 14d,~50%. 
The iV-oxide of the pyridines 141 and 143 were prepared following conditions developed 
by Ochiai (Scheme 73).*^ * Accordingly, treament of 141 in an acetic acid / hydrogen 
peroxide mixture, followed by distillation, afforded 2-(fluoromethyl)pyridine-jV-oxide 145 
as an oil, in 46 % yield. Likewise, the formation of bis-2,6-(fluoromethyl)pyridine-A^-
oxide 146, was achieved in 61 % yield, affording a white solid. Recrystallisation of 146 
gave crystals which were suitable for X-ray analysis. 
141 
N 
^ . F 
I 
0 
145 
143 
N N4-
I 
0 " 
146 
Scheme 73 i . AcOH, H2O2, 2 h, 70 °C, 46 %; i i . AcOH, H2O2, 3 h, 70 °C, 61 %; 
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3.2.6 X-ray crystal structures 
3.2.6.1 2-(FluoromethyI)pyridine 141 
At the outset obtaining an X-ray structure of 2-(fluoromethyl)pyridine 141 was a priority, 
as this parent structure could be compared directly to the structure obtained from ab initio 
and microwave studies.'^^ However, 141 is an oil at ambient temperature and attempts at 
low temperature crystallisation on the diffractometer failed, generating an amorphous 
glass rather than a crystalline material. In view of this, other structures were sought that 
were analogous to 141. 
3.2.6.2 Bis-2,6-(fluoromethyl)pyridine 143 
Bis-2,6-(fluoromethyl)pyridine 143 was found to be a low melting solid ( -35 °C) at 
ambient temperature. Crystallisation in the fridge only generated a waxy solid. 
Fortunately however, low temperature (-20 °C) recrystallisation did afford a sample 
suitable for X-ray crystal structure analysis and the X-ray diffraction data was solved with 
a R-factor < 7 %. The structural data are presented in Appendix 1. Figure 27 clearly 
shows that both of the fluoromethyl groups adopt fl«//-planar conformations, relative to 
nitrogen. The dihedral angles and C-F bond lengths differ for the two fluoromethyl 
groups, with one having a N-C-C-F dihedral angle of 175.9° and a C-F bond length of 
1.401 A, whereas the other has values of 174.3° and 1.385 A respectively. 
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F(2) 
C(l)-F(l) = 1.401 A C(7)-F(2) = 1.385 A 
N-C(2)-C(l)-F(l) = 175.9° N-C(6)-C(7)-F(2) = 174.3° 
Figure 27 50 % Probability ellipsoid plot of bis-2,6-(fluoromethyl)pyridine 143. 
The crystal packing shows a potential intermolecular H-F bond between H(5) and F(l) 
(Figure 28 and Figure 29). However, the distance of 2.56 A between these H and F 
atoms suggests that this is at best a weak H-F bond. Possibly, this mteraction may 
contribute to the difference in the N-C-C-F dihedral angles and C-F bond lengths. 
H-F = 2.560 A 
Figure 28 50 % Probability ellipsoid plot of bis-2,6-(fluoromethyl)pyridine 143, 
indicating potential H-F intermolecular interaction. 
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Figure 29 50 % Probability ellipsoid plot of bis-2,6-(fluoromethyl)pyridine 143, 
indicating stacking in crystal. 
3.2.6.3 Bis-2,6-(fluoromethyl)pyridine-A^-oxide 146 
The A^-oxide of 143 has a higher mp (81 °C vs 35 °C) than the parent pyridine 143 most 
probably due to the highly ionic nature of the i¥-oxide bond. Figure 30 clearly shows that 
again, both of the fluoromethyl groups adopt an a«//-planar conformation, with respect to 
the nitrogen. The dihedral angles of the fluoromethyl groups being 176.0° and 176.1°, 
with the C-F bond lengths both being at 1.412 A. The structural data for 146 are 
presented in Appendix 2. 
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C-F = 1.412 A 
N-C(2)-C(2')-F(2') = 176.0° N-C(2A)-C(2'A)-F(2'A) = 176.1° 
Figure 30 50 % Probability ellipsoid plot of bis-2,6-(fluoromethyl)pyridine-7V-oxide 146. 
The crystal packing depicted in Figure 31 shows head to tail intermolecular hydrogen 
bonding (2.191 A) from H(4) to O, with a C-H-O-N dihedral angle of 180°. Further 
analysis of the molecular packing shows that there are symmetrical interactions around 
the fluoromethyl groups with all methylene hydrogens having a H bond to O. This 
symmetry affords a C2 axis for bis-2,6-(fluoromethyl)pyridine-A^-oxide 146, consistent 
with the identical C-F bond lengths. 
H-0 = 2.490 A H-0 = 2.191 A 
Figure 31 50 % Probabihty ellipsoid plots of bis-2,6-(fluoromethyl)pyridine-A^-oxide 
146, indicating potential intermolecular interactions. 
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Figure 32 Stacking plot of bis-l.e-CfluoromethyOpyridine-A'-oxide 146. 
3.2.6.4 2-(Fluoromethyl)quinoline 144 
2-(Fluoromethyl)quinoline 144 is an oil at ambient temperature, therefore attempts were 
made at obtaining in situ crystal growth on the diffractometer at low temperature. This 
however failed, but crystallisation from a MeOH / H2O mix at -10 °C afforded a sample 
of the monohydrate 147 from which a X-ray structure could be solved (Figure 33). The 
hydrate 147 structure had a fluoromethyl conformation with a N-C-C-F dihedral angle of 
172.0° and a C-F bond length of 1.392 A. The structural data for 147 are presented in 
Appendix 3. 
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I 0(11 
C(1)-F(1)= 1.392A N-C(2)-C(l)-F(l)= 172.0"^  
Figure 33 50 % Probability ellipsoid plot of 2-(fluoromethyl)quinoline monohydrate 147. 
Analysis of the intermolecular interactions for 147 reveals the presence of a short 
(2.026 A) and presumably strong hydrogen bond between nitrogen and the hydrogen of a 
water molecule, Figure 34. The water molecule is also H-bonded to another molecule of 
water which then in turn H-bonds to another molecule of 144, Figure 35. The water 
molecules in the structure of 147 in Figure 35 have one hydrogen disordered, giving rise 
to the appearance of water as H3O molecules. There is also a potential intermolecular 
interaction between fluorine and H(3), of 2.498 A, but again due to the distance between 
the atoms this must be considered a weak interaction. 
k 
N-H = 2.026 A H-F = 2.498 A 
Figure 34 50 % Probability ellipsoid plot of 2-(fluoromethyl)quinoline monohydrate 147, 
indicating potential intermolecular interactions. 
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Figure 35 Stacking plot of 2-(fluoromethyl)quinoline monohydrate 147. The broader 
dotted lines depict water molecules that are hydrogen bonded to each other. 
3.2.7 Discussion of crystal structures 
The structures of the bis-(fluoromethyl) systems of 143 and 146, were solved. Despite 
some effort, the structure of 2-(fluoromethyl)pyridine 141 remained elusive. In order to 
investigate an analogous system, a crystal structure of 2-(f[uoromethyl)quinoline 144 was 
sought. Attempts at crystallisation of 144 on the diffractometer at low temperature were 
unsuccessful, however a suitable crystal of 144 as its monohydrate 147 was obtained for 
X-ray analysis. The C-F bond lengths and dihedral angles obtained from the crystal 
structures of compounds 143, 146 and 147 are tabulated below in Table 2. All of the 
dihedral angles are within 10° of the ideal angle (180°) calculated from ab initio and 
microwave studies for 2-(fluoromethyl)pyridine 141. The C-F bond lengths are also 
found to be close to that predicted for 141, within 0.016 A of the predicted bond length. 
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Compound N-C-C-F angles / ° C-F Bond lengths / A 
143 
F ( l ) = 175.9 F ( l ) = 1.401 
F(2) = 174.3 F(2)= 1.385 
146 
F(2')= 176.0 F(2')= 1.412 
F(2'A)= 176.1 F(2'A)= 1.412 
147 172.0 1.392 
Table 2 C-F bond lengths and the dihedral angles in the N-C-C-F crystal structures 143, 
146 and 147. 
From the above data for structures 143 and 146 there appears to be a correlation between 
the N-C-C-F dihedral angle and the C-F bond length. An explanation for this could be 
that a higher degree of planarity enables an increased level of hyperconjugation into the 
C-F a* orbital. However, this analysis does not extend to 147 which has the lowest 
dihedral angle and would be anticipated to have the shortest C-F bond. 
In order to place the length of these C-F bonds in a broader context, a comparison of C-F 
bond lengths was made with other X-ray structures. The Cambridge Structural Database 
(CSD) provides an excellent archive for doing this. A selective search of all CH2F groups 
yielded 68 hits (Figure 36), although none of these were fluoromethyl aromatics. It is 
interesting, and perhaps surprising to note therefore that 143, 146 and 147 are the first 
fluoromethyl aromatic X-ray structures yet recorded. 
f 
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Histogram of C-F bond lengths 
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Bond Length / A 
Figure 36 Histogram of all fluoromethyl C-F bond lengths in the CSD. 
Refining the dataset in Figure 36 by removing all those structures that were inorganic, 
showed disorder or had a R-factor > 10 %, reduced the dataset to 37 separate C-F bond 
lengths. These are correlated in the histogram in Figure 37. 
Refined histogram of C-F bond lengths 
i 
Bond Length / A 
Figure 37 Refined histogram of fluoromethyl C-F bond lengths in the CDS. 
102 
Comparison of the C-F bond lengths for 143, 146 and 147 to the mean C-F bond length of 
1.381 A in the histogram of Figure 37 shows all of the fluoromethyl aromatics have 
longer than average C-F bond lengths. Perhaps n-a* hyperconjugation and N-F repulsion 
contributes to this phenomenon. In the next section fluoromethyl aromatics, such as 
benzyl fluoride 148, which do not have N-F replusion are shown to adopt an orthogonal 
conformation. 
3.2.8 The conformation of benzyl fluoride 
The minimum energy conformation of the C-F bond in benzyl fluoride 148 has been 
discussed extensively in the literature and contrary conclusions have emerged. Brownlee 
and Craik'^' has reported that there is a significant temperature dependence of the '^ F 
NMR chemical shift for 148 and a series of 4-substituted benzyl fluorides. It was 
concluded that this is due to a temperature dependence on the different populations of 
planar and perpendicular conformations. A spectroscopic study afforded very similar 
results for 148 and benzyl alcohol, suggesting that 148 would have the same orthogonal 
conformation as that determined for benzyl alcohol.'^" A microwave spectroscopic study 
has recently reported a preferred orthogonal conformation (by 0.7 kJ mol'') for benzyl 
fluoride.'^' This contradicts early ab initio calculations, which indicated that the 
perpendicular conformation is preferred by 1.7 kJ mol"'.'^^ However, more recent 
theoretical studies'^ '^'^ ^ concluded that for 148 the perpendicular conformation is lower in 
energy in solution, yet the calculations arriving at this conclusion suggested that the 
planar form was preferred in the gas phase. Until very recently the discrepancy between 
theoretical and experimental studies remained. This has now been resolved by 
Dr. D. Tozer (Durham University) using a higher level of basis sets in the computational 
analysis. It emerged that the orthogonal conformer had the lower energy, with a 
calculated rotational energy barrier of 2.1 kJ mol"' and a C-F bond length of 1.412 A, 
Figure 38.*^ '* It remained an objective of this research programme to obtain the first 
X-ray structure showing this conformation in such a system. 
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2.1 kJ mol"'' 
a * i a * 
C-F = 1.412 A 
Figure 38 Conformation of benzyl fluoride 148, as predicted by recent computational 
data.'^ '* 
3.2.9 The preparation of fluoromethyl benzyl aromatics 
Benzyl fluoride 148, 4-bromobenzyl fluoride 149 and /rfl«i'-4-fluoromethyIstilbene ISO, 
were selected as target molecules (Scheme 74) for X-ray structure analysis. Benzyl 
fluoride 148 has been synthesised via halogen exchange of benzyl bromide by treatment 
with CsF and NBu4F.'^^ Fluorination of the alcohols 151 and 152 with CAST was judged 
to offer an appropriate preparation of 4-bromobenzyl fluoride 149 and 
^ra/75'-4-fluoromethylstilbene 150.'^ ^ 
148 
151 149 
Scheme 74 Synthesis of benzyl fluoride 148, 4-bromobenzyl fluoride 149 and 
rrara-4-fluoromethylstilbene 150. i . CsF, TBAB, 3 h, 85 °C, 94 %; i i . DAST, CH2CI2, 
-78 °C. 
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Benzyl fluoride was indeed prepared in 64 % yield following the literature method. 
Redistillation afforded a sample which was > 99.9 % pure as judged by GCMS analysis. 
4-Bromobenzyl fluoride 149 was successfully prepared from 151 by reacfion with DAST 
at -78 °C in CH2CI2 to afford the fluoromethyl product in 30 % yield, as a low melting 
solid. Recrystallisation from CH2CI2 gave crystals of 149 suitable for X-ray analysis. 
Formation of 150 proved problematical. Treatment with DAST at -78 °C in CH2CI2 
resulted in an inseparable mixture of products. A change of solvent to THF proved 
expedient in affording the desired material, however it was contaminated, mainly with 
starting material. Purification by column chromatography did afford 150 in 24 % yield, as 
a solid, contaminated with 152 (~ 10 %) . Recrystallisation from CHCI3 gave suitable 
crystals from which X-ray diffraction data was collected. 
3.2.10 Crystal structures of benzyl fluorides 
3.2.10.1 4-Bromobenzyl fluoride 149 
Analysis of the diffraction pattern from a suitable crystal of 149 indicated that the crystal 
was twinned affording poor data, from which only a poorly determined structure could be 
obtained. The structure that was solved was disordered with the C-F bond of the 
fluoromethyl group in two conformafions in approximately equal proportions (Figure 39). 
The conformers present in the crystal structure however clearly show that the C-F bond 
does not lie planar with the aromafic ring. One conformer is nearly orthogonal (83.5°), 
and the other occupies a more gauche conformation (56.7°). Both C-F bonds seem very 
short, however this is due to the computed values being an average of a C-F and a much 
shorter C-H bond length. 
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C(5)-C(4)-C(7)-F(l A) = 83.5° C(5)-C(5)-C(7)-F(1B) = 56.7^ 
C(7)-F(1A) = 1.23 A C(7)-F(1B) = 1.32 A 
Figure 39 50 % Probability ellipsoid plot of 4-bromobenzyl fluoride 149. 
The crystal packing diagram of 149 shows a potential intermolecular H-F bond between 
H(2) and F(B) of 2.547 A. A fluorine to hydrogen bond of this length is anticipated to be 
a weak interaction. 
^ ^ v w - ^^^^ 
'-^ . AY 
Figure 40 50 % Probability ellipsoid plot of 4-bromobenzyl fluoride 149, indicating 
stacking in crystal. 
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3.2.10.2 7>a«5-4-fluoromethylstilbene 150 
Diffraction data was collected for rra«5-4-fluoromethylstilbene 150, but all attempts to 
obtain a sufficiently resolved structiire failed. Thus the conformation of the fluoromethyl 
group could not be accurately assessed in this case. 
3.2.10.3 Benzyl fluoride 148 
Numerous attempts at obtaining a X-ray diffraction pattem from low temperature 
crystallisation of 2-(fluoromethyl)quinoline 144 and 2-(fluoromethyl)pyridine 141 were 
unsuccessful. However, the first attempt at obtaming in situ crystal growth on the 
diffractometer at about 230 K succeeded for benzyl fluoride, yielding a crystal which 
defracted well at 150 K in the X-ray beam. The resultant highly solved structure 
(Figure 41) shows benzyl fluoride with a C(3)-C(2)-C(l)-F dihedral angle of 76.6° and a 
C-F bond length of 1.419 A. The crystal packing in Figure 42 does not show an 
apprecible intermolecular contact to suggest that this conformation is perturbed by such 
interactions. 
C( l ) -F( l )= 1.419A C(3)-C(2)-C(l)-F(l) = 16.6° 
Figure 41 50 % Probability ellipsoid plot of benzyl fluoride 148. 
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Figure 42 50 % Probability ellipsoid plots of benzyl fluoride 148, in the stacking 
diagram. 
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3.2.11 Discussion of crystal structures of benzyl fluorides 
The solid state structures of benzyl fluoride 148, and 4-bromobenzyl fluoride 149 have 
shown a strong correlation with the spectroscopic and theoretical experiments revealing 
the predicted lower energy perpendicular conformation of the C-F bond. This 
conformation can again be rationalised through electron donation into the a* orbital of the 
C-F bond, but now from the n orbitals. This conjugation could perhaps have contributed 
to the relatively long C-F bond of 1.419 A found for 148. 
3.2.12 Summary 
Solid state X-ray structures have been determined for the first time for several 
fluoromethyl aromatics. Comparison of the C-F bond lengths in benzyl fluoride 148 and 
bis-2,6-(fluoromethyl)pyridine-A'^-oxide 146 to those found in the CSD suggest that they 
have relatively long C-F bonds. This is consistent with electron donation into the C-F a* 
orbital from either the n electrons of 148 or the 0 lone pair of 146. The fluoromethyl 
group in the benzyl systems has been found to adopt an orthogonal conformation whereas 
the fluoromethylpyridine systems adopt a planar conformation with the fluorine anti to the 
ring nitrogen. The different conformations in the two systems can be rationalised in at 
least two ways: donation from the N lone pair into the C-F a* orbital will be more 
efficient than from the n orbitals of the aromatic, and secondly, electrostatic replusion 
between F and N will also favour an anti conformation to minimise this interaction. 
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3.3 Part B 
3.3.1 Introduction to the gauche effect 
The term gauche effect describes the 'tendency (of a molecule) to adopt that structure 
(conformation) which has the maximium number of gauche interactions between the 
adjacent electron pairs and / or polar bonds'.'^' This effect, which seems to contradict the 
basic principles of steric interactions has been shown to exist for a number of structures 
that contain electronegative atoms vicinal to each other.'^*''^' It is well known for 
example that 1,2-difluoroethane 153 prefers a gauche rather than anti conformation by 
approximately 3 kJ mol"' (Figure 43).'^" 
> w 
H F 
Figure 43 The gauche effect in 1,2-difluoroethane 153. 
The origin of the gauche effect has been rationalised in two different ways. One 
explanation suggests that the energy difference between the conformers lies to some 
extent in bent bonding in the C-C bond between adjacent electronegative groups.'" 
Comparison of this bent-bond contribution (Figure 44) has shown that the anti 
conformation has the C-C bond paths lying in opposite directions, whereas the gauche 
conformation has the bond paths bent towards the same direction. For the gauche 
conformation this leads to greater orbital overlap and a stronger C-C bond. 
/ ' . . X . . - . . / 
Figure 44 Comparsion of the sp^  orbital overlap (dashed lines) for the anti and gauche 
conformers of 1,2-difluoroethane 153. 
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An alternative and widely promulgated explanation for the gauche effect considers again 
electron donation into the C-F a* orbitals. The preference for conformations in which the 
best donor bond (eg C-H) is antiperiplanar to the best acceptor bond (eg C-F) being now 
invoked to rationalise the gauche effect.''^ This holds true for a range of 
1,3-interactions.'^^ For example, crystal structures of X-CH2-CH2-OY for a variety of Y 
in which X=F or SiRs have all shown the X=F structures to have gauche conformations, 
whereas for X=SiR3 the structures display anti conformations, Figure 45. This preferred 
gauche conformation most probably arises due to the C-SiRa bond being a better donor 
than the C-H bond, ie. the best electron donating bond is still anti to the best electron 
acceptor bond. 
X-CH2-CH2-OY 
X=F X=SiR3 
H H 
F H 
R,Si 
H H 
H H 
YO 
R3S 
YO 
Figure 45 1,3-Interactions in determining the conformation of a molecule. 
The gauche effect has generally been demonstrated in a few small, well defined 
compounds such as difluoroethane 153. Recently however, the gauche effect has been 
cited as a potential origin from which one of the strongest protein chains, collagen, partly 
derives its stability. Collagen, the most abundant protein in animals, is present as 
chains wound in tight triple helices which are organised into fibrils of great tensile 
strength and thermal stability. Collagen is composed of the repeat amino acid sequence of 
X-Y-Gly, where X and Y are often L-proline (Pro) and L-4(i?)-hydroxyproline residues 
respectively. The collagen triple helix mimics, (ProProGly)io, (ProHypGIy)io and 
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(ProFlpGly)io (Flp = L-4(7?)-fluoroproline) were prepared by Holmgren and co-workers, 
and their midpoint thermal transitions evaluated as, 41±1, 69±1 and 91±1 °C 
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respectively. The results indicated that increasing the electronegativity of the Y 
residue's 4{R) substituent, from H to OH to F, dramatically increased the thermal stability 
of the collagen mimic. Holmgren identified the strong inductive effect of the 
electronegative element O and more so F, to be responsible for this increased stability. It 
was proposed that the inductive effect increased collagens stability in at least three 
separate ways, one being the gauche effect, which controls the conformation of the 
pyrrolidine ring. This had not been invoked before to explain any aspect of protein 
structure. In an effort to provide additional evidence for this effect, crystal structures of a 
more conformationally felixible mimic of 4(/?)-fiuoroproline residues, 
ie. P-fluoroethylamides, were sought (Figure 46). 
Ox" 
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HN 
Figure 46 P-Fluoroethylamides as 4(i?)-fluoroproline residue mimics. 
3.3.2 P-Fluoroethylamides and synthesis 
Conformationally felixible P-fluoroethylamides were required that would afford crystals 
suitable for X-ray analysis. The nitrobenzamides, A^-(2-fluoroethyl)-3,5-dinitrobenzamide 
154 and A^-(2-fluoroethyl)-4-nitrobenzamide 155 were selected as suitable compounds, as 
they contain polar functionality that should afford a crystalline material. 
7V-(2-Fluoroethyl)acetamide 156 was also selected as a substrate. Although anticipated to 
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be a liquid, i f low temperature X-ray analysis was successful for this compound, 
information could be obtained for the core (3-fluoroethylamide structural motif. 
O 
156 
155 
154 
The amides were synthesised by reaction of their respective acid chlorides with 
2-fluoroethylamine hydrochloride in the presence of base.''"* The benzamides were 
formed in low but unoptimised yields of about 4 and 6 % for 154 and 155 respectively. 
Recrystallisation of 154 from CH2CI2 / C H C I 3 afforded a crystal which defracted well in 
the X-ray beam. A crystal of 155 was also found to be suitable for X-ray defraction after 
recrystallisation from THF. iV-(2-Fluoroethyl)acetamide 156 was prepared from acetyl 
chloride and pyridine in about 20 % yield, with ~ 90 % purity. 
3.3.3 Crystal structures and ab initio studies of p-fluoroethylamides 
3.3.3.1 A^-(2-Fluoroethyl)-3,5-dinitrobenzamide 154 
The X-ray structure of 154 clearly shows a gauche (63.9°) relationship between the C-F 
and the C-N (of the amide) bonds. Figure 47. The stacking plot of 154 (Figure 48) 
reveals an intermolecular H-bond of 2.346 A, between amide groups in adjacent 
molecules. 
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N(3)-C(8)-C(9)-F(l) = 63.9° 
C(7)-F(1B)= 1.415 A 
Figure 47 50 % Probability ellipsoid plots of A^-(2-fluoroethyl)-3,5-dinitroberLzamide 
154. 
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Figure 48 50 % Probability ellipsoid plot of A^-(2-fluoroethyl)-3,5-dinitrobenzamide 154, 
indicating stacking in crystal. 
3.3.3.2 7V-(2-Fluoroethyl)-4-nitrobenzamide 155 
Analysis of the diffraction data afforded a structure of 155 which indicated disorder in the 
fluoromethyl group (Figure 49). However, both of the conformers retain the gauche 
relationship between C-N and C-F bonds with dihedral angles of 57.2° and 50.6°. One of 
the C-F bonds has an a«//-parallel relationship to the amide C=0 bond, whilst the other 
C-F bond is orthogonal to this bond. Again the C-F bond lengths appear short as a 
consequence of this disorder. 
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C(l)-F(l) = 1.305 A C(7)-F(2) = 1.270 A 
N(2)-C(8)-C(9)-F(l) = 57.2° N(2)-C(9)-C(8)-F(2) = 50.6° 
Figure 49 50 % Probability ellipsoid plots of iV-(2-fluoroethyl)-4-nitrobenzamide 155. 
The stack plot of 155 shows a H-bond (2.056 A) linking the amides of adjacent 
molecules. There is also a potential intermolecular bond (2.560 A) between F(2) and 
H(l ) . 
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Figure 50 50 % Probability ellipsoid plot of jV-(2-fluoroethyl)-3,5-dinitrobenzamide 153 
indicating molecular stacking. 
3.3.3.3 A'-(2-Fluoroethyl)acetamide 156 
A number of attempts were made at obtaining in situ growth of a crystal of 156 on the 
diffractometer at low temperature, but none succeeded in providing a crystal of sufficient 
quality for X-ray analysis. Although crystallographic data was not available for this 
compound, ab initio calculations were carried out by Dr. D. Tozer on 156 as a model 
system for p-fluoroethylamides.'^^ A high level of theory for the ab initio calculations 
yielded a gauche minimum conformation for 156 (Figure 51, a) that was 7.5 kJ mof' 
lower in energy than the analogous anti minimum conformation (Figure 51, b). This 
value is over twice that found in the classical system of 1,2-difluoroethane 153. 
H 
H 
7.5 kJ mol -1 
O 
H 
(a) (b) 
Figure 51 Calculated energy difference between gauche (a) and anti conformations (b) 
for A^-(2-fluoroethyl)acetamide 156. 
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A complication arose when comparing the two conformers in 156 due to the orientation of 
the amide carbonyl. To assess the influence of the carbonyl orientation on the energy of 
the different conformers, additional calculations were performed on 156, that allowed 
only the gauche to anti interconversion (Figure 52). These calculations again showed the 
gauche conformation to be lower in energy, by 9.2 kJ mol"'. 
H F H H 
9.2 kJ mol"^ 
Figure 52 Calculated energy difference for the gauche (a) and anti conformations (b) of 
A^-(2-fluoroethyl)acetamide 156 with the CCNH, CNCO and CCNC dihedral angles 
constrained at 0, 0 and 180° respectively. 
3.3.4 Discussion of crystal structures 
The X-ray determined solid state structures of both 154 and 155 exhibit a gauche 
relationship between the C-F and C-N bonds, with all of the N-C-C-F dihedral angles 
being close to 60° (±10). Structure 155 has the C-F bonds of the fluoromethyl group 
disordered, thereby affording two conformers. Ab initio calculations suggested that the 
conformation with the C-F bond anti-para.\\e\ to the C=0 bond was the lower in energy. 
3.3.5 Summary 
Crystal structures of A/^-(2-fluoroethyl)-3,5-dinitrobenzamide 154, and A^-(2-fluoroethyl)-4-
nitrobenzamide 155 have, for the first time, shown the fluorine amide gauche effect in the 
solid state for P-fluoroethylamides. Ab initio studies performed on 
A^-(2-fluoroethyl)acetamide 156 have revealed a preference for the gauche over the anti 
conformation by 7.5 kJ mol''. It is anticipated that the gauche effect in 
P-fluoroethylamides could clearly influence the conformation of appropriate peptides, 
although this remains to be fully evaluated. 
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Chapter 4 
Experimental 
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4.1 General Section 
Optical rotations were measured on an Optical Activity Ltd AA-10 Automatic Polarimeter 
and are recorded in units of 10'' deg cm'^  g"'. Melting points were measured on a 
Gallenkamp variable heater and are uncorrected. NMR spectra were recorded on Bruker 
AC-250 (250.133 MHz) and Varian Inova (499.779 MHz), VXR-400S (399.958 MHz), 
Unity (299.908 MHz) and Mercury (199.991 MHz) spectrometers in deuterochloroform 
solution unless stated otherwise, using the deuterated solvent as a lock and residual 
solvent as an internal reference. IR spectra were recorded with absorption values in cm'' 
on a Perkin-Elmer 257 Spectrometer as a neat film between NaCl plates or as a KBr disc. 
GCMS analysis was performed on a VG TRIO 1000 spectrometer (under EI or ammonia 
gas CI conditions) equipped with a HPl capillary column (25 m long, 0.22 mm i.d., 
0.2 [im film thickness) connected to a H.P. 5890 series I I oven. Mass spectra were also 
recorded with a Micromass Autospec spectrometer (at low and high resolution, under EI 
or ammonia gas (or where stated methane gas) CI conditions) or with a VG ZAB 
spectrometer (at low resolution, under FAB conditions) or by the EPSRC National Mass 
Spectrometry Service Centre at Swansea, with a Finnigan MAT 900 XLT (at high 
resolution, under EI or arrunonia gas CI) or with a Micromass Autospec spectrometer 
(at high resolution, under FAB conditions). 
Reacfion glassware was dried in an oven at 120 °C and cooled in a dry atmosphere of 
nitrogen immediately prior to use or heated by a hot air gun to about 200 °C under high 
(< 0.1 mbar) vacuum. Reaction solvents were dried and freshly distilled prior to use. 
Petrol refers to the fraction of petroleum ether boiling at 40-60 °C. Unless stated 
otherwise reactions were carried out at ambient temperature under a nitrogen atmosphere 
with stirring. Thin layer chromatography (tic) was carried out on Merck, Kieselgel 60, 
F254 aluminium and glass backed plates. Visualisation of plates was achieved by use of a 
UV lamp at wavelengths of 254 or 366 nm or by use of permanganate, phosphomolybdic 
acid or iodine stains. Column chromatography was carried out over silica gel Merck, 
Kieselgel 60, 230-400 mesh. 
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4.2 Experimental Procedures 
4.2.1 Experimental section for Chapter 2 
4.2.1.1 Diethyl bromodifluoromethylphosphonate'*'* 58 
0 
Triethyl phosphite (12.82 g, 77.2 mmol) was added to an ice cold solution of 
dibromodifluoromethane (17.00 g, 81.0 mmol) in EtjO (40 ml). After 45 min the mixture 
was warmed to ambient temperature and 1 h later was heated under reflux for 20 h. After 
cooling, solvent was removed under reduced pressure and distillation (43-45 °C 
/ 0.01 mbar, Lit.*" 99-102 °C / 21 mbar) afforded 58 (20.05 g, 97.3 %) as a clear 
colourless oil. GCMS analysis indicated > 99 % purity. 
' H N M R (400.0 MHz) 5 1.37 (6H, dt, VH-H = 7.1 Hz, V P = 0.5Hz, CH3) 4.25-4.38 (4H, 
m, CH2). 
'^C NMR (100.6 MHz) 6 16.2 (2C, d, ^JC-P = 5.7 Hz, CH3), 66.2 (2C, d, VC-P = 6.5 Hz, 
CH2), 116.6 (IC, dt, 'Jc-F ^  328.6 Hz, 'JC-P = 238.0 Hz, CFjBr). 
'^F NMR (376.3 MHz) 5 -61.5 (2F, d, VF-P = 93.4 Hz, (EtO)2P(0)CF2Br). 
^^ P NMR (161.9 MHz) 6 2.3 (IP, t, VF-P = 93.4 Hz, (EtO)2P(0)CF2Br). 
IR: 2986, 1280, 1016, 877, 626. 
m/z (CI): 286 ([M+NH4]^ 97.2 %) , 284 ([M+NH4]* 100 %) . 
4.2.1.2 [(Diethoxyphosphonyl)difluoromethyl]zinc bromide 59 
O 
O'P-^ .ZnBr 
Diethyl bromodifluoromethylphosphonate 58 (25.98 g, 97.3 mmol) was added dropwise 
to a solution of activated zinc powder (6.50 g, 99.4 mmol) (zinc washed with I M HCl(aq), 
distilled water then acetone and dried overnight at 120 °C) in monoglyme (50 ml) at 0 °C. 
After warming to ambient temperature and leaving for 20 h the solution was filtered 
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through a medium frit Schlenk filter to afford a monoglyme solution of 59 in 95 % yield 
from '^F and '^P NMR analysis. 
'^F NMR (Monoglyme, 235.3 MHz) 5 -128.5 (2F, d, VF-P = 93.0 Hz, PCF2ZnBr). 
'^P NMR (Monoglyme, 101.3 MHz) 5 13.4 (IP, t, VF-P = 93.0 Hz, PCF2ZnBr). 
4.2.1.3 Diethyl l,l-difluorobut-3-enylphosphonate*'' 56 
Allyl bromide (11.78 g, 96.6 mmol) was added in two equal portions to a solution of 
copper (I) bromide (60 mg, 0.43 mmol) and [(diethoxyphosphonyl)difluoromethyl]zinc 
bromide 59 (freshly prepared from 4.2.1.2) in monoglyme. After leaving for 14 h, 
approximately half of the solvent was removed under reduced pressure. The remainder 
was washed with water (50 ml), and extracted into CH2CI2 (3 x 50 ml), the organic 
extracts combined, dried over MgS04 and solvent removed under removed pressure. 
Distillation (55-57 °C / 0.08 mbar, Lit.*'* 34 °C / 0.03 mbar) with a 10 cm Vigreux column 
afforded 56 (17.03 g, 76.7 %) as a clear colourless oil. GCMS analysis indicated a purity 
> 93 % with the main impurities being diethyl difluoromethylphosphonate, ~ 5.5 % and 
triethyl phosphate, ~ 1.5 %. 
' H NMR (400.0 MHz) 5 1.34 (6H, t, VH-H = 7.3 Hz, CH3), 2.79 (2H, tt, VH-F = 19.4 Hz, 
VH-P = 6.6 Hz, VH-H = 6.6 Hz, CF2CH2CH), 4.23 (4H, p, VH-P = 7.3 Hz, %.H = 7.3 Hz, 
OCH2), 5.21-5.26 (2H, m, CHCH2), 5.75-5.86 ( IH, m, CHCH2). 
'^C NMR (100.6 MHz) 5 16.3 (2C, d, VC-P = 5.3 Hz, CH3), 38.6 (IC, dt, VC-F = 21.4 Hz, 
Vc-P = 15.3 Hz, CF2CH2), 64.3 (2C, d, VC-P = 6.8 Hz, OCH2), 119.5 (IC, dt, 'JC-F = 260.4 
Hz, 'Jc-p = 215.4 Hz, PCF2), 121.7 (IC, s, CHCH2), 126.8 (IC, q, VC-F/P = 5.5 Hz, CH). 
'^F NMR (376.3 MHz) § -111.3 (2F, dt, VF-P = 107.5 Hz, VH-F = 19.4 Hz, P(0)CF2CH2). 
^^ P NMR (161.9 MHz) 6 10.0 (IP, t, VF-P = 107.5 Hz, (EtO)2F(0)CF2CH2CHCH2). 
IR: 2988, 1646, 1261, 1014, 793. 
m/z (EI): 229 ([M+H]^ 5.5 % ) , 228 ([M]+ 2.3 %) , 109 ([(EtO)(HO)P(0)]^ 100 %) . 
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4.2.1.4 Diethyl l,l-difluoro-3-oxopropyIphosphonate'^ 50 
O 
Ozone was bubbled through (at a flow rate of ~ 60 1 / h) a solution of diethyl 1,1 -difluoro-
3-butenephosphonate 56 (8.02 g, 35.2 mmol) in CH2CI2 (140 ml) and MeOH (30 ml) at 
-78 °C until the solution turned blue (after ~ 45 min). Nitrogen was then bubbled through 
at a steady rate, for 5 min after the blue colour had disappeared. Dimethyl sulphide 
(5.00 g, 76.8 mmol) was added, then the solution was left to warm to ambient temperature 
over 12 h. Solvent was removed under reduced pressure and the product distilled 
(75-76 °C / 0.03 mbar, Lit.^* 80-83 °C / 0.08 mbar) to afford 50 (6.19 g, 26.9 mmol, 
76.5 %, > 99 % purity from •''P NMR analysis) as a clear colourless oil. This compound 
gradually decomposed to a dark red viscous oil on storage. 
' H NMR (400.0 MHz) 5 1.38 (6H, t, VH-H = 7.3 Hz, CH3), 3.08 (2H, ddt, VH-F = 19.1 Hz, 
VH-P = 7.1 Hz, VH-H = 2.5 Hz, CF2CH2CHO), 4.29 (4H, p, VH-P = 7.3 Hz, VH-H = 7.3 Hz, 
OCH2), 9.79 ( IH , s, CH2CHO). 
'^C NMR (100.6 MHz) 5 16.3 (2C, d, VC-P - 5.3 Hz, CH3), 47.5 (IC, dt, VC-F = 20.2 Hz, 
Vc-P = 14.1 Hz, CF2CH2), 65.0 (2C, d, VC-P = 6.8 Hz, OCH2), 118.2 (IC, dt, 'JC-F = 261.8 
Hz, 'Jc-p - 218.5 Hz, PCF2), 194.1 (IC, s, CHO). 
'^ F NMR (376.3 MHz) 5 -118.9 (2F, dt, VF-P = 103.2 Hz, VH-F = 19.1 Hz, P(0)CF2CH2). 
'^P NMR (161.9 MHz) 6 8.3 (IP, t, VF-P = 103.2 Hz, (EtO)2P(0)CF2CH2CHO). 
IR: 2988, 1733, 1253, 1011,794. 
m/z (CI): 248 ([M+NH4]* 65.7 % ) , 231 ([M+H]^ 26.9 %) , 228 ([M-H2]^ 100 %) . 
4.2.1.5 Diethyl dibromofluoromethylphosphonate^^ 61 
0 
/ F Br 
Tribromofluoromethane (6.13 g, 22.6 mmol) in THF (5 ml) was added to a THF (5 ml) 
solution of triethyl phosphite (3.60 g, 21.7 mmol) and the mixture was then heated under 
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reflux for 12 h. After cooling the solvent was removed under reduced pressure and the 
product disfilled (58-60 °C / 0.01 mbar, Lit.*^ 170-175 °C I 27 mbar) to afford 61 (6.01 g, 
84.6 %, > 99 % pure from NMR analysis) as a clear colourless oil. 
' H NMR (400.0 MHz) S 1.37 (6H, dt, VH-H = 7.1 Hz, VH-P = 0.9Hz, CH3) , 4.30-4.40 (4H, 
m, CH2). 
'^C NMR (62.9 MHz) 5 16.3 (2C, s, CH3), 66.7 (2C, d, VC-P = 6.3 Hz, CH2), 88.2 (IC, 
dd, 'Jc-F = 333.9 Hz, 'Jc-p = 202.1 Hz, PCFBr2). 
19F NMR (235.3 MHz) § -76.7 (IF, d, VF-P = 77.4 Hz, (EtO)2P(0)CFBr2). 
'^P NMR (161.9 MHz) 6 4.6 (IP, d, VF-P = 77.1 Hz, (EtO)2(0)FCFBr2), Lit.*^ 6 1.6. 
m/z (EI): 331 ([M+H]* 10.4 % ) , 329 ([M+H]^ 19.5 %) , 327 ([M+H]^ 10.4 %) , 137 
([(EtO)2P(0)]^ 47.4 % ) , 109 ([(EtO)(HO)P(0)]^ 54.9 %) , 81 ([(H0)2P(0)]^ 30.5 %) , 29 
([Et]^ 100%). 
4.2.1.6 Diethyl l-fluorobut-3-enylphosphonate*^ 60 
I . 6 M Butyllithium in n-hexane (16 ml, 25.6 mmol) was added dropwise to a solution of 
diethyl dibromofluoromethylphosphonate 60 (3.67 g, 11.2 mmol) and TMSCl (1.22 g, 
I I . 2 mmol) in THF (16 ml) at -78 °C. After 10 min at -78 °C, allyl iodide (1.90 g, 
11.3 mmol) was added, then 2 h later EtOH (4.7 ml, 80.1 mmol) then 1.6 M butyl lithium 
in n-hexane (7.7 ml, 12.3 mmol) were added. After a further 2 h at -78 °C the reaction 
was allowed to warm up to 0 °C and was then quenched with sat. NH4Cl(aq) (2 ml), 
washed with water (10 ml), and extracted into Et20 (3 x 50 ml). The organic extracts 
were combined, washed with sat. NaHC03(aq), dried over MgS04 and solvent removed 
under reduced pressure followed by kugelrohr bulb to bulb distillation (65-75 °C 
/ 0.02 mbar, Lit.*^ 165-170 °C / 21 mbar) to afford 60 (1.87 g, 79.3 %) as a clear 
colourless oil. GCMS analysis gave purity as > 94 % with the main impurities being 
diethyl fluoromethylphosphonate, ~ 2 % and triethyl phosphate, ~ 1 %. 
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' H NMR (400.0 MHz) 6 1.33 (6H, t, VH-H = 7.0 Hz, CH3), 2.55-2.70 (2H, m, CHFCH2), 
4.13-4.03 (4H, m, OCH2), 4.63-4.80 ( IH, m, CHF), 5.11-5.21 (2H, m, CHCH2), 5.78-
5.89 ( IH , m, CHCH2). 
'^C NMR (100.6 MHz) 5 16.35, 16.39 (2C, d, VC-P = 5.5 Hz, CH3), 34.5 (IC, d, VC-F = 
20.6 Hz, CHFCH2), 62.8, 63.1 (2C, d, VC-P = 6.6 Hz, OCH2), 87.9 (IC, dd, 'Jc-p = 182.2 
Hz, 'JC-F = 169.9 Hz, PCHF), 118.6 (IC, s, CHCH2), 131.9 (IC, dd, VC-P = 13.8 Hz, VC-F 
= 3.8 Hz, CHCH2). 
'•^ F NMR (376.3 MHz) 5 -(208.2-208.7) (IF, m, (EtO)2P(0)CHFCH2CHCH2). 
'^P NMR (161.9 MHz) 5 20.6 (IP, d, VF-P = 75.0 Hz, (EtO)2P(0)CHFCH2CHCH2), Lit.^^ 
§ 18.0, VF.P = 74.2 Hz). 
m/z (CI): 228 ([M+NH4]^ 100 % ) , 211 ([M+H]* 100 %) . 
4.2.1.7 Diethyl but-3-enylphosphonate*^^ 67 
Diethyl methylphosphonate (2.21 g, 14.5 mmol) was added dropwise to a solution of 
lithium diisopropyl amide (prepared by addition of 1.6 M butyl lithium in n-hexane 
(10 ml, 16.0 mmol) to diisopropyl amine (2.35 ml, 16.8 mmol) at ambient temperature) in 
THF (10 ml) at -78 °C. After 15 min a solution of allyl bromide (6.3 ml, 72.2 mmol) in 
THF (14 ml) was added dropwise and after 5 h at -78 °C the reaction was allowed to 
warm to ambient temperature. The reaction was quenched with EtOH (10 drops) and sat. 
NH4Cl(aq) (10 ml) and extracted into Et20 (3 x 100 ml). The organic extracts were 
combined, dried over MgS04 and the solvent removed under reduced pressure. 
Distillation (62-64 °C / 0.13 mbar, Lit. ' '^ 70 °C / 1.3 mbar) afforded 67 as a clear 
colourless oil (1.45 g, 52.0 %) . GCMS analysis indicated > 97 % purity, with an 
unknown impurity, ~ 2 %. 
' H NMR (250.1 MHz) 5 1.46 (6H, t, VH-H = 7.1 Hz, CH3), 1.94-2.04 (2H, m, PCH2), 
2.52-2.56 (2H, m, PCH2CH2), 4.16-4.32 (4H, m, OCH2), 5.10-5.25 (2H, m, CHCH2), 
5.90-6.06 ( IH , m, CHCH2). 
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'^C NMR (100.6 MHz) § 16.3 (2C, d, VC-P - 6.0 Hz, CH3), 24.9 (IC, d, 'JC-P - 140.8 Hz, 
PCH2), 26.4 (IC, d, Vc-P = 4.5 Hz, PCH2CH2), 61.4 (2C, d, VC-P = 6.5 Hz, OCH2), 115.0 
(IC, s, CHCH2), 137.2 (IC, d,Vc-p= 141.0 Hz, CH). 
'^P NMR (161.9 MHz) 5 34.6 (IP, s, (EtO)2P(0)CH2CH2CHCH2). 
IR:3078, 2982, 2931,2910, 1641, 1444, 1392, 1243, 1218, 1163, 1098, 1056, 1029, 965, 
821,791. 
m/z (EI): 193 ([M+H]^ 16.6 % ) , 192 ([M]^ 14.9 %) , 177 ([M-CH3]'' 2.5 %) , 165 ([M-
C2H3]'" 8.9 % ) , 164 ([M-C2H4]^ 10.0 %) , 149 ([M-C2H4,-CH3]^ 8.7 %) , 148 ([M-EtO]^ 
15.3 % ) , 138 ([(EtO)2POH]^ 17.4 %) , 137 ([(EtO)2PO]'' 28.4 %) , 136 ([M-C2H4,-C2H4]^ 
31.7 % ) , 135 ([M-Et,-C2H4]* 36.5 %) , 111 ([(EtO)P(OH)(OH2)]^ 62.9 %) , 110 
([(EtO)P(OH)2]'' 24.4 % ) , 109 ([(EtO)PO(OH)]^ 25.6 %) , 83 ([(H0)3PH]'" 33.7 %) , 82 
([(H0)3P]^ 100 % ) , 81 ([(HO)PO]^ 67.4 %) , 65 ([(H0)2P]^ 44.4 %) , 55 
([CH2CH2CHCH2]^ 92.1 % ) , 54 ([CH2CHCHCH2]^ 70.5 %) . 
4.2.1.8 Diethyl 3-oxopropylphosphonate^' 52 
4.2.1.8.1 From diethyl but-3-enylphosphonate 67 
O3 was bubbled through (flow rate of 50 1/h) a solution of diethyl 3-butenephosphonate 67 
(1.52 g, 7.9 mmol) in CH2CI2 (35 ml) at -78 °C until the solution turned blue (after about 
20 min). N2 was then bubbled through til l the blue colour disappeared, and dimethyl 
sulphide (1.17 g, 18.8 mmol) added, and the solufion was left to warm to ambient 
temperature over 12 h. Solvent was then removed under reduced pressure and distillation 
(80-81.5 °C / 0.045 mbar. Li t . ' ' 104-106 °C / 0.27 mbar) afforded 52 as a clear colourless 
oil (0.60 g, 3.1 mmol, 39.1 %, purity > 97 % from GCMS analysis). 
' H NMR (400.0 MHz) S 1.27 (6H, t, VH-H = 7.0 Hz, CH3), 1.99 (2H, dt, VH-P - 18.1 Hz, 
VH-H = 7.7 Hz, PCH2), 2.73 (2H, dt, VH-P = 12.4 Hz, VH-H = 7.7 Hz, CH2CH2CHO), 3.99-
4.14 (4H, m, OCH2), 9.74 ( IH, s, CHO). 
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'^C NMR (100.6 MHz) 5 16.2 (2C, d, VC-P = 6.1 Hz, CH3), 17.7 (IC, d, 'Jc-p = 146.0 Hz, 
PCH2), 36.7 (IC, d, Vc-P = 4.2 Hz, PCH2CH2), 61.7 (2C, d, VC-P = 6.4 Hz, OCH2), 199.1 
(IC, d, Vc-P= 15.3 Hz, CHO). 
'^P NMR (161.9 MHz) 5 33.8 (IP, s, (EtO)2F(0)CH2CH2CHO). 
IR : 2984, 2933, 2909, 2732, 2235, 1724 (C=0), 1443, 1393, 1237, 1163, 1098, 1058, 
1029, 967, 828, 791,733,645. 
m/z (CI): 195 ([M+H]^ 100 % ) , 166 ([M-C2H4]^ 24.4 % ) , 149 ([M-EtO]* 4.8 % ) , 139 
([(EtO)2POH2]* 6.8 % ) , % ) , 138 ([(EtO)2POH]^ 14.1 %) , 121 ([(EtO)2P]^ 4.9 %) , 111 
([(EtO)P(OH)(OH2)]^ 8.0 % ) . 
4.2.1.8.2 From 2-(2-Diethoxyphosphonylethyl)-l,3-dioxolane 75 
2-(2-Diethoxyphosphonylethyl)-l,3-dioxolane 75 (2.00 g, 8.40 mmol) was added to 
0.1 M HCl(aq) (100 ml) and was then placed in a preheated oil bath set at 120 °C and 
heated under reflux for 3 h. After cooling, the organics were extracted into CH2CI2 
(3 X 200 ml), the organic fractions were combined, dried over MgS04 and solvent 
removed under reduced pressure to afford 52 (1.60 g, 8.25 mmol, 98.2 %) as a clear 
colourless oil. '^P NMR analysis indicated > 97.5 % purity. 
Analytical data was identical to that described in 4.2.1.8.1. 
4.2.1.9 Dimethyl but-3-enylphosphonate 69 
4.2.1.9.1 With L i counterion 
Dimethyl methylphosphonate (1.79 g, 14.4 mmol) was added dropwise to a solution of 
lithium diisopropyl amide (prepared by addition of 1.6 M butyl lithium in n-hexane 
(10 ml, 16.0 mmol) to diisopropyl amine (2.35 ml, 16.8 mmol) at 0 °C) in THF (10 ml) at 
-78 °C, and after 1 h allyl bromide (3.50 g, 28.9 mmol) was added dropwise and the 
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reaction allowed to warm to ambient temperature after 100 min at -78 °C. The reaction 
was quenched with sat. NaCl(aq) (10 ml), then the aqueous phase was separated and 
extracted into Et20 (3 x 70 ml). The organic extracts were combined, dried over MgS04 
and solvent was removed under reduced pressure. Distillation (29-32 °C / 0.1 mbar) 
afforded 69 as a clear colourless oil (1.02 g, 43 %) . GCMS analysis indicated > 98 % 
purity. 
' H NMR (400.0 MHz) § 1.72-1.82 (2H, m, PCH2), 2.22-2.33 (2H, m, PCH2CH2), 3.67 
(6H, d, VH-P = 10.8 Hz, CH3), 4.92-5.03 (2H, m, CHCH2), 5.71-5.83 ( IH, m, CHCH2). 
'^C NMR (100.6 MHz) § 23.9 (IC, d, 'JC-P = 141.1 Hz, PCH2), 26.2 (IC, d, VC-P = 4.6 
Hz, PCH2CH2), 52.1 (2C, d, Vc-P = 6.4 Hz, CH3), 115.1 (IC, s, CHCH2), 136.9 (IC, d, 
Vc-p = 8.8 Hz, CH). 
'^P NMR (161.9 MHz) 5 37.2 L i t . ' ' ' 33.5 (IP, s, (MeO)2P(0)CH2CH2CHCH2). 
IR: 3079, 2955,2853, 1642, 1447, 1247, 1221, 1185, 1058, 1033,918, 820. 
m/z (EI): 164 ([M]^ 21.4 % ) , 149 ([M-CH3]^ 4.0 %) , 124 ([(Me0)3P]^ 8.5 %) , 111 
([(Me0)2P0H2]^ 8.3 % ) , 110 ([(MeO)2POH]^ 100 %) , 109 ([(Me0)2P0]^ 14.1 %) , 95 
([(MeO)2PH2]* 12.8 % ) , 94 ([(MeO)2PH]^ 8.5 %) , 93 ([(Me0)2P]^ 10.6 %) , 80 
([(MeO)POH2]* 19.3 % ) , 79 ([(MeO)POH]^ 23.9 %) . 
HRMS: (EI) Calcd. for CgHnOsP: 164.0602, found: 164.0603. 
4.2.1.9.2 With Cu counterion 
Dimethyl methylphosphonate (12.50 g, 0.10 mol) was added dropwise to a solution of 
1.6 M butyl lithium in n-hexane (69 ml, 0.11 mol) in THF (70 ml) at -78 °C, and after 
5 min at this temperature copper (I) iodide (21.1 g, 0.11 mol) was added. After 10 min at 
-78 °C the solution was allowed to warm to -35 °C, then after 1 h allyl bromide (3.50 g, 
28.9 mmol) was added dropwise and the reaction allowed to warm to ambient temperature 
after 4 h at -35 °C. The reaction was quenched with H2O (100 ml), the solution fiUered 
through celite, and the cake washed with CH2CI2 (3 x 100 ml). The organic washings 
were combined, dried over MgS04 and the solvent was removed under reduced pressure. 
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Distillation (42-44 °C / 0.3 mbar) afforded 69 as a clear colourless oil (15.63 g, 95.3 %) . 
GCMS analysis indicated > 99 % purity. 
Analytical data was identical to that described in 4.2.1.9.1. 
4.2.1.10 Dimethyl 3-oxopropylphosphonate''* 70 
O3 was bubbled through (flow rate of 50 1/h) a solution of dimethyl 
but-3-enylphosphonate 69 (0.93 g, 5.7 mmol) in CH2CI2 (25 ml) at -78 °C until the 
solution turned blue (after about 10 min). N2 was then bubbled through to remove ozone, 
and dimethyl sulphide (0.85 g, 13.7 mmol) added, then the solution was left to warm to 
ambient temperature over 12 h. The solvent was removed under reduced pressure and 
disfillation (68-72 °C / 0.11 mbar, Lit.*'* 103-105 °C / 3.7 mbar) afforded 70 as a clear 
colourless oil (0.329 g, 2.0 mmol, 35 % ) . GCMS analysis indicated > 98 % purity. 
' H NMR (400.0 MHz) 6 2.05 (2H, dt, VH-P = 18.3 Hz, VH-H = 7.7 Hz, PCH2), 2.76 (2H, 
ddt, VH-P = 14.5 Hz, VH-H = 7.7 Hz, VH-H = 0.6 Hz, CH2CH2CHO), 3.72 (6H, d, VH-P -
10.8 Hz, CH3), 9.76 ( IH, d, VH-P = 2.0 Hz, CHO). 
'^C NMR (100.6 MHz) 5 16.2 (IC, d, VC-P = 146.1 Hz, PCH2), 36.6 (IC, d, VC-P = 4.2 
Hz, PCH2CH2), 52.5 (2C, d, VC-P = 6.4 Hz, CH3), 198.9 (IC, d, VC-P = 14.9 Hz, CHO). 
^^ P NMR (161.9 MHz) 5 36.6 (IP, s, (MeO)2P(0)CH2CH2CHO). 
m/z (EI): 167 ([M+H]^ 49.7 %) , 138 ([M-CO]^ 25.7 %) , 135 ([M-CHaO]^ 12.8 %) , 110 
([(MeO)2POH]^ 100 % ) , 109 ([(MeO)2PO]^ 45.1 % ) , 95 ([(MeO)2PH2]^ 20.8 % ) , 93 
([(MeO)2P]"' 10.0 % ) , 80 ([(MeO)POH2]^ 24.7 % ) , 79 ([(MeO)POH]* 77.9 %) . 
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4.2.1.11 2-(2-Diethoxyphosphonylethyl)-l,3-dioxane 73 
O 
r-O T 
/ 0 ^ 
2-(2-BromoethyI)-l,3-dioxane (0.50 g, 2.56 mmol) was added to triethyl phosphite 
(0.85 g, 5.12 mmol) in a flask attached to a distillation apparatus equipped with a 10 cm 
Vigreux column, and heated at 145 °C for 4 h, then at 165 °C for 30 min. After cooling, 
then stirring for 12 h at ambient temperature, distillation (96-99 °C / 0.02 mbar) afforded 
73 (0.44 g, 1.76 mmol, 68.5 %) as a clear colourless oil. GCMS analysis indicated 
> 97 % purity, with the main impurity being diethyl ethylphosphonate, ~ 2 %. 
' H N M R (400.0 MHz) 5 1.29 (6H, t, VH-H = 7.0 Hz, CH3) , 1.31-1.34 ( I H , m, 
OCHSCHAHB), 1.77-1.89 (4H, m, PCH2CH2), 1.96-2.05 ( I H , m, OCHZCHAHB), 3.69-
3.77 (2H, m, O C H A H B C H J ) , 4.01-4.11 (6H, m, POCH2, 0CHAHBCH2), 4.60 ( I H , t, VH-H 
= 4.4 Hz, CH). 
'^C NMR (100.6 MHz) 5 16.4 (2C, d, VC-P = 6.0 Hz, CH3), 19.8 ( I C , d, 'Jc-p =143.4 Hz, 
PCH2), 25.6 ( I C , s, CH2CH2CH2), 28.1 ( I C , d, VC-P = 4.5 Hz, PCH2CH2), 61.4 (2C, d, 
Vc-P = 6.4 Hz, POCH2), 66.8 (2C, s, OCH2CH2CH2O), 100.9 ( I C , d, VC-P = 18.3 Hz, 
CH). 
'^P NMR (161.9 MHz) 5 33.2 ( I P , s, (EtO)2P(0)CH2CH2CH(0(CH2)30)). 
IR: 2977,2855, 1657, 1443, 1391, 1279, 1244, 1216, 1146, 1127, 1055, 1033,964, 871. 
m/z (CI): 253 ([M+1]^ 100 % ) . 
HRMS: (CI) Calcd. for (M+1) C,oH2205P: 253.1205, found: 253.1203. 
4.2.1.12 2-(2-Diethoxyphosphonylethyl)-l,3-dioxoIane''^ 75 
2-(2-Bromoethyl)-l,3-dioxolane (5.00 g, 27.6 mmol) was added to triethyl phosphite 
(9.17 g, 55.2 mmol) in a flask attached to a distillation apparatus equipped with a 10 cm 
Vigreux column, and heated at 145 °C for 3 h, then at 165 °C for 1 h. Distillation 
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(90.5-93.5 °C / 0.01 mbar) afforded 75 (5.61 g, 23.6 mmol, 85.4 %) as a clear colourless 
oil. GCMS analysis indicated > 99 % purity. 
' H N M R (400.0 MHz) § 1.31 (6H, t, d, VH-H = 7.0 Hz, CH3) , 1.79-1.98 (4H, m, 
PCH2CH2), 3.83-3.97 (4H, m, OCH2CH2O), 4.03-4.13 (4H, m, POCH2), 4.93 (IH, t, VH-
H = 4.0 Hz, CH). 
'^C NMR (100.6 MHz) 6 16.4 (2C, d, VC-P = 6.1 Hz, CH3) , 19.5 (IC, d, 'JC-P = 144.2 Hz, 
PCH2) , 26.9 (IC, d, Vc-P = 4.2 Hz, PCH2CH2), 61.5 (2C, d, VC-P = 6.4 Hz, POCH2) , 65.1 
(2C, s, O C H 2 C H 2 O ) , 103.3 (IC, d, Vc-P = 19.5 Hz, CH). 
'^P NMR (161.9 MHz) § 33.1 (IP, s, (EtO)2P(0)CH2CH2CH(OCH2)2). 
IR: 2983,2938, 2898, 1641, 1443, 1393, 1244, 1140, 1031,963,867, 828,789. 
m/z (CI): 239 ([M+1]^ 100 % ) , 193 ([M-EtO]* 4.2 %) . 
HRMS: (CI) Calcd. for (M+1) C9H20O5P: 239.1048, found: 239.1059. 
4.2.1.13 Diethyl (£)-5-oxohex-3-enylphosphonate 76 
Diethyl 3-oxopropylphosphonate 52 (4.29 g, 22.1 mmol) was added to 
l-triphenylphosphoranylidene-2-propanone (7.04 g, 22.1 mmol) in THF (130 ml) and the 
mixture heated under reflux for 16 h. After cooling, the solvent was removed under 
reduced pressure and the residue throughly mixed with petrol (4 x 100 ml). The petrol 
washings were combined, and then the solvent was removed under reduced pressure and 
kugelrohr bulb to bulb distillation (125-155 °C / 0.1 mbar) afforded 76 (3.66 g, 
15.6 mmol, 71 %) as a clear colourless oil. GCMS analysis indicated > 99 % purity. 
' H NMR (400.0 MHz) 5 1.31 (6H, t, VH-H = 6.8 Hz, POCH2CH3) , 1.82-1.92 (2H, m, 
PCH2) , 2.24 (3H, s, COCH3), 2.46-2.56 (2H, m, PCH2CH2), 4.04-4.15 (4H, m, POCH2) , 
6.09 ( I H , d, VH-H = 16.0 Hz, C H C O C H 3 ) , 6.80 ( IH, dt, VH-H = 16.0 Hz, VH-H = 6.6 Hz, 
C H 2 C H ) . 
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'^C NMR (100.6 MHz) 6 16.4 (2C, d, VC-P = 5.7 Hz, POCH2CH3), 24.2 (IC, d, 'Jc-p = 
142.6 Hz, PCH2), 25.4 (IC, d, VC-P = 4.2 Hz, PCH2CH2), 27.0 (IC, s, COCH3), 61.7 (2C, 
d, Vc-P = 6.5 Hz, POCH2), 131.4 (IC, s, CHCOCH3), 145.9 (IC, d, VC-P = 16.0 Hz, 
CH2CH), 198.3 (IC, s, CHCOCH3). 
'^P NMR (161.9 MHz) 6 31.1 (IP, s, (EtO)2P(0)CH2CH2CHCHCOCH3). 
IR: 2983,2931,2909, 1697, 1675, 1629, 1364, 1243, 1163, 1097, 1055, 1029, 965,732. 
m/z (CI): 254 ([M+NH4+2H]^ 10.1 %) , 253 ([M+NH4+H]^ 6.7 %) , 252 ([M+NH4]^ 86.7 
% ) , 238 ([M+4H]^ 14.9 % ) , 237 ([M+3H]^ 100 %) , 236 ([M+2H]^ 35.3 %) , 235 ([M+H]"" 
100 % ) , 221 ([M+2H-CH3]^ 13.1 %) , 219 ([M-CH3]^ 8.7 %) , 193 ([M+2H-COCH3]* 10.4 
% ) , 191 ([M-COCH3]'' 17.2 % ) . 
HRMS: (CI) Calcd. for (M+1) C10H20O4P: 235.1099, found: 235.1102. 
4.2.1.14 3-ChIoro-2-oxopropyltriphenylphosphoniuni chloride'"^ 79b 
ci- o 
P h 3 P \ ^ A ^ C I 
l,3-Dichloropropan-2-one (4.84 g, 38.1 mmol) was added dropwise to a solution of 
triphenylphosphine (10.0 g, 38.1 mmol) in THF (40 ml). After heating under reflux for 
4 h (precipitation occuring after 15 min) the solvent was removed under reduced pressure. 
The solid was then precipated from a refluxing MeOH solution with addition of EtOAc. 
The product was filtered and dried under high vacuum to afford 79b (12.44 g, 32.0 mmol, 
84 %) as a cream white powder. 
' H NMR (299.9 MHz) (CD3OD) 6 4.89 (2H, s, PCH2), 4.53 (2H, s, CH2CI), 7.70-7.95 
(15H, m, Ph). 
'^P NMR (81.0 MHz) (CD3OH) 6 21.4 (IP, s, Ph3P^CH2COCH2Cl CI"). 
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4.2.1.15 3-Chloro-2-oxopropylidenetriphenylphosphorane"'^ 80 
O 
A solution of Na2C03 (1.68 g, 15.8 mmol) in H2O (10 ml) was added rapidly to a 
vigorously stirred solution of (l-chloroacetonyl)-triphenylphosphonium chloride 79b 
(12.44 g, 32.0 mmol) in MeOH (20 ml). The reaction was then diluted with H2O (25 ml) 
and stirred for 30 min. After filtering the mixture, the solid was washed with H2O, then 
dried under high vacuum to afford 80 (9.01 g, 25.5 mmol, 80 %) as a white powder 
(mp dec. 170 °C, Lit.'"^ mp 179 °C). 
' H NMR (400.0 MHz) 5 4.01 (2H, s, CH2CI), 4.28 (IH, d, VH-P = 24.0 Hz, PCH), 7.42-
7.71 (15H, m, Ph). 
'^C NMR (100.6 MHz) 5 8.3 (IC, d, VC-P =16.1 Hz, CH2CI), 51.4 (IC, d, 'Jc-p = 109.8 
Hz, PCH), 126.1 (3C, d, 'Jc-p = 91.6 Hz, aPh), 128.9 (6C, d, VC-P = 12.2 Hz, yPh), 132.3 
(3C, d, Vc-p = 3.0 Hz, SPh), 133.0 (6C, d, VC-P = 10.4 Hz, pPh), 185.1 (IC, d, VC-P = 4.6 
Hz, CO). 
'^P NMR (161.9 MHz) 5 17.3 (IP, d, VF-P = 7.1 Hz, Ph3PCHCOCH2Cl). 
IR: (KBr) 3048, 3015, 2958, 2927, 2855, 1575, 1551, 1481, 1435, 1395, 1107, 953, 861, 
751,719, 692, 520, 509. 
m/z (EI): 354 ([M]^ 1.6 % ) , 352 ([M]"*" 4.5 % ) , 304 ([M-CHCl]^ 2.7 %) , 303 ([M-CH2C1]^ 
100 % ) , 278 ([PhsPO]^ 1.8 %) , 262 ([Fh^Pt 4.1 %) , 108 ([PhP]^ 6.3 %) , 77 ([Ph]^ 10.6 
%),51 ([C4H3f 6.7%). 
4.2.1.16 l-ChIoro-3-fluoropropan-2-ol"" 78 
Epichlorohydrin (9.57 g, 0.103 mol) was added to triethylamine trihydrofluoride (24.9 g, 
0.154 mol) and stirred at 100 °C for 4 h. After cooling, H2O (50 ml) was added and the 
mixture washed with Et20 (3 x 125 ml). The organic washings were combined, 
neutralised with NaHCOs, washed with H2O (40 ml) then dried over MgS04 and the 
solvent removed under reduced pressure. Distillation (49-56 °C / 15 mmHg, 
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Lit.'"^ 62 °C / 15 mmHg) with a 10 cm Vigreux column afforded 78 (6.05 g, 0.054 mol, 
52.0 %) as a clear colourless oil. GCMS analysis indicated > 99 % purity. 
' H NMR (400.0 MHz) 6 2.62 ( IH, s, CHOH), 3.60-3.69 (2H, m, CH2CI), 4.02-4.12 ( IH, 
m, CHOH), 4.51 (2H, dd, VH-F = 47.0, VH-F = 4.6 Hz, CH2F). 
'^C NMR (100.6 MHz) 5 44.7 (IC, d, VC-F = 6.4 Hz,CH2Cl), 69.9 (IC, d, VC-F = 20.6 Hz, 
CHOH), 83.3 (IC, d, 'Jc-F = 170.6 Hz, CH2F). 
'^F NMR (376.3 MHz) 5 -232.5 (IF, dt, VH-F = 47.0, VH-F = 17.4 Hz, CH2F). 
IR: 3386 (br, OH), 2964, 2904, 1704, 1433, 1233, 1112, 1093, 1080, 1021, 944, 919, 753, 
629. 
m/z (EI): 115 ( [ M + H f 1.2 % ) , 113 ( [ M + H f 4.0 % ) , 81 ([HC0HCH2CI]^ 13.3 % ) , 79 
([HCOHCH2CI]* 42.5 % ) , 63 ([HCOHCH2F]* 100 %) , 49 ([CH2CI]* 52.0 %) , 43 
([HC0CH2]^ 89.9 % ) , 33 ([CH2F]* 51.4 %) . 
4.2.1.17 l-ChIoro-3-fluoropropan-2-one^''^ 77 
50 % H2S04(aq) (26 ml) was added dropwise over 1 h to a vigorously stirred solution of 
l-chloro-3-fluoropropan-2-ol 78 (6.00 g, 53.3 mmol), K2Cr207 (15.83 g, 53.8 mmol) and 
TBAB (0.867 g, 2.69 mmol) in CH2CI2 (50 ml) and H2O (50 ml). After 5 d K2Cr207 
(10.00 g, 34.0 mmol) was added and 1 d later '^ F NMR indicated that was present 
comprising ~ 25 % of the product. The organic layer was separated and 40 % Na2S205(aq) 
(50 ml) added. The aqueous layer was acidified with I M H2S04(aq) unfil effervescence 
ceased, and it was then continuously extracted into Et20 for 2 d. The organic layer was 
then separated, the solvent removed under reduced pressure and distillation (35-40 °C 
I 15 mmHg, Lit.'"^ 52 °C / 20 mmHg) afforded 77 (0.80 g, 7.24 mmol, 13.6 %) as a clear 
colourless oil. '^F NMR analysis indicated > 99 % purity. 
' H NMR (400.0 MHz) § 4.34 (2H, d, VH-F = 2.0 Hz, CH2CI), 5.07 (2H, d, VH-F = 47.1 Hz, 
CH2F). 
'^C NMR (100.6 MHz) S 45.8 (IC, s, CH2CI), 84.2 (IC, d, 'JC-F = 184.2 Hz, CH2F), 
198.1 (IC, d, Vc-F = 20.6 Hz, CO). 
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'^ F NMR (376.3 MHz) 5 -232.0 (IF, tt, J^H-F = 47.1, VH-F = 2.1 Hz, CH2F). 
m/z (EI): 112 ([M+2]'" 4.60 %) , 110 ([M]^ 14.3 %) , 79 ([C0CH2C1]'' 10.9 %) , 77 
([COCHsCl]^ 33.0 % ) , 61 ([COCHsF]^ 53.1 %) , 51 ([CH2C1]^ 25.2 %) , 49 ([CH2C1]^ 
84.8 % ) , 42 ([COCHz]^ 100 % ) , 33 ([CH2F]* 89.7 %) . 
4.2.1.18 3-FIuoro-2-oxopropyltriphenylphosphonium chloride'"" 77b 
l-Chloro-3-fluoropropan-2-one (0.80 g, 7.24 mmol) was added dropwise to a solution of 
triphenylphosphine (1.90 g, 7.25 mmol) in THF (15 ml). After heating under reflux for 
5 h (precipitation occuring after 15 min) the solvent was removed under reduced pressure. 
The solid was then washed with EtOAc and dried under high vacuum to afford 77b 
(1.88 g, 5.04 mmol, 69.6 %) as a white powder. 
'H NMR (200.0 MHz) (CD3OD) 5 4.88 (2H, s, PCH2), 5.09 (2H, d, VH-F = 46.5 Hz, 
CH2F), 7.65-7.95 (15H, m, Ph). 
'^F NMR (188.2 MHz) (CD3OD) 5 -227.8 (IF, dt, VH-F = 46.5 Hz, VF-P = 6.7 Hz, CH2F). 
4.2.1.19 3-Fluoro-2-oxopropylidenetriphenylphosphorane'"" 49 
0 
A solution of Na2C03 (280 mg, 2.7 mmol) in H2O (1.6 ml) was added rapidly to a 
vigorously stirred solution of (l-fluoroacetonyl)-triphenylphosphonium chloride 77b 
(1.88 g, 5.04 mmol) in MeOH (2.5 ml). The reaction was then diluted with H2O (12 ml) 
and stirred for 30 min. After filtering the mixture, the solid was washed with H2O, then 
dried under high vacuum to afford 49 (1.56 g, 4.65 mmol, 92.3 %) as a white powder 
(dec). 
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'H NMR (400.0 MHz) 5 4.15 ( IH, d, VH-P = 24.8 Hz, PCH), 4.75 (2H, d, VH-F = 48.4 Hz, 
CH2F), 7.45-7.70 (15H, m, Ph). 
'^C NMR (100.6 MHz) 5 49.4 (IC, d, VC-P = 110.3 Hz, PCH), 84.6 (IC, dd, 'JC-F = 185.2 
Hz, Vc-P = 13.5 Hz, CH2F), 126.3 (3C, d, 'JC-P = 91.2 Hz, aPh), 128.9 (6C, d, VC-P = 12.6 
Hz, yPh), 132.3 (3C, d, VC-P = 3.0 Hz, 5Ph), 133.1 (6C, d, VC-P = 10.4 Hz, pPh), 187.1 
(IC, dd, Vc-F = 17.4 Hz, Vc-P = 3.6 Hz, CO). 
'^F NMR (376.3 MHz) 5 -216.5 (dt, VH-F = 48.4 Hz, VF-P = 6.3 Hz, CH2F), Lit.""" -216.7. 
'^P NMR (161.9 MHz) 5 17.2 (IP, d, VF-P = 7.1 Hz, Ph3PCHCOCH2F). 
m/z (CI): 337 ( [ M + H f 31.8 % ) , 336 ([M]^ 25.3 % ) , 304 ([M-CHF]^ 45.0 % ) , 303 ([M-
CH2F]'' 100 % ) , 278 ([Ph3P0]^ 12.4 % ) , 262 ([Ph3P]^ 12.6 % ) , 108 ([PhP]"" 7.4 %) , 77 
([Ph]^ 14.2 % ) , 51 ([C4H3]'" 4.1 % ) . 
4.2.1.20 Diethyl 3-ethoxy-5-oxohexylphosphonate 83 
Diethyl (F)-5-oxohex-3-enylphosphonate 76 (106 mg, 0.45 mmol) was added to a 
solution of PTSA.H2O (10 mg, 0.05 mmol) and triethylorthoformate (180 mg, 1.21 mmol) 
in EtOH (0.1 ml). After 30 min the solvent was removed under reduced pressure, H2O 
(10 ml) was added and the mixture was extracted into CH2CI2 (3 x 50 ml). The organic 
extracts were combined, dried over MgS04 and solvent was removed under reduced 
pressure. The residue was purified over silica gel (CH2CI2 / EtOAc / IP A, 3:1:0.2, 
Rf= 0.28 for 83, KMn04 stain as visualiser) affording 83 (91 mg, 0.32 mmol, 71.8 %) as a 
clear colourless oil. G C analysis indicated > 95 % purity. 
' H NMR (400.0 MHz) 6 1.11 (3H, t, VH-H = 7.0 Hz, C H O C H 2 C H 3 ) , 1.28 (6H, t, VH-H = 
7.0 Hz, POCH2CH3) , 1.63-1.89 ( 4 H , m, PCH2CH2) , 2.14 (3H, s, C O C H 3 ) , 2.40 ( IH, dd, 
VH-H = 5.2 Hz, VH-H = 16.0 Hz, C H A H B C 0 C H 3 ) , 2.67 ( IH, dd, VH-H = 7.2 Hz, VH-H = 
16.0 Hz, C H A H B C 0 C H 3 ) , 3.44 (2H, q, VH-H = 7.1 Hz, C H O C H 2 C H 3 ) , 3.74-3.81 ( IH, m, 
C H O C H 2 C H 3 ) , 4.00-4.11 ( 4 H , m, POCH2CH3) . 
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C NMR (100.6 MHz) 5 15.3 (IC, s, CHOCH2CH3), 16.4 (2C, d, VC-P = 5.7 Hz, 
POCH2CH3), 21.1 (IC, d, '/c-p = 142.6 Hz, PCH2), 30.0 (IC, d, VC-P = 4.6 Hz, 
PCH2CH2), 31.0 (IC, s, COCH3), 47.9 (IC, s, CH2COCH3), 61.4 (2C, d, VC-P = 6.4 Hz, 
POCH2), 64.8 (IC, s, CHOCH2CH3), 74.7 (IC, d, VC-P = 17.5 Hz, CHOCH2CH3), 207.1 
(IC, s, CH2COCH3). 
'^P NMR (161.9 MHz) 5 33.3 (IP, s, (EtO)2P(0)CH2CH2CH(OEt)CH2COCH3). 
IR: 2977, 2931, 2905, 2875, 1713, 1443, 1391, 1369, 1245, 1163, 1097, 1055, 1027, 963, 
832, 787. 
m/z (CI): 281 ([M+H]^ 29.0 % ) , 252 ([M-C2H4]* 17.5 %) , 237 ([M-C2H3O]* 30.4 %) , 236 
([M-C2H4O]* 7.1 %) , 235 ([M-C2H50]^ 100 %) . 
HRMS: (CI) Calcd. for (M+1) C12H26O5P: 281.1518, found: 281.1515. 
4.2.1.21 (^-2-(4-Diethoxyphosphonylbut-l-enyl)-2-methyl-l,3-dioxoIane 84 
l,2-Bis[(trimethyIsilyl)oxy]ethane (1.27 g, 6.15 mmol) was added to trimethylsilyl 
trifluoromethanesulphonate (~ 30 mg, -0.13 mmol) in CH2CI2 (5 ml) at -78 °C followed 
by diethyl (£)-5-oxohex-3-enylphosphonate 76 (1.06 g, 4.55 mmol). The solufion was 
then stirred for 28 h at -60 °C. The reaction was quenched with dry pyridine (0.1 ml) and 
sat. NaHC03(aq) (10 ml), and was then extracted into CH2CI2 (3 x 20 ml). The organic 
extracts were combined, dried over MgS04 then solvent removed under reduced pressure. 
The residue was purified over silica gel (IPA / Et20, 1:12, KMn04 stain as visualiser) 
affording 84 (0.70 g, 2.51 mmol, 55 %) as a clear colourless oil. '^ 'P NMR analysis 
indicated ~ 90 % pure, with the major impurity being 2-(2-diethoxyphosphonylethyl)-l,3-
dioxolane 75, ~ 8 %. 
' H NMR (400.0 MHz) 5 1.29 (6H, t, VH-H = 7.2 Hz, POCH2CH3), 1.41 (3H, s, 
CO(OCH2)2CH3), 1.73-1.83 (2H, m, PCH2), 2.26-2.35 (2H, m, PCH2CH2), 3.82-3.94 
(4H, m, OCH2CH2O), 4.01-4.11 (4H, m, POCH2), 5.44 ( IH, d, VH-H = 15.6 Hz, 
CHC(OCH2)2CH3), 5.81 ( IH, dt, VH-H = 15.6 Hz, VH-H = 6.6 Hz, PCH2CH2CH). 
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'^C NMR (100.6 MHz) 5 16.4 (2C, d, VC-P = 6.1 Hz, POCH2CH3), 24.7 (IC, d, VC-P = 4.6 
Hz, PCH2CH2), 24.8 (IC, s, COCH3), 25.1 (IC, d, VC-P = 141.2 Hz, PCH2), 61.5 (2C, d, 
Vc-p = 6.4 Hz, POCH2), 64.4 (2C, s, OCH2CH2O), 107.1 (IC, s, CHC(OCH2)2CH3), 
129.6 (IC, d, Vc-P = 17.9 Hz, PCH2CH2CH), 131.0 (IC, d, VC-P = 0.7 Hz, 
CHC(OCH2)2CH3). 
'^P NMR (161.9 MHz) § 32.3 (IP, s, (EtO)2P(0)CH2CH2CHCHC(OCH2)2CH3). 
IR: 2984, 2933, 2904, 1671, 1443, 1392, 1372, 1242, 1213, 1163, 1097, 1053, 1032, 966, 
863. 
m/z (EI): 279 ([M+H]^ 0.6 % ) , 278 ([M]^ 0.8 %) , 264 ([M-CH2]'' 6.4 % ) , 263 ([M-CH3]'" 
54.5 % ) , 235 ([M-C2H50]^ 9.2 % ) , 191 ([M-C(OCH2)2CH3]* 9.0 %) , 125 ([M-CH3-
(EtO)2POH]^ 87.8 % ) , 87 ([C(OCH2)2CH3]^ 100 %) , 43 ([C2H50]^ 50.2 %) . 
HRMS: (CI) Calcd. for (M+1) C12H24O5P: 279.1361, found: 279.1357. 
4.2.1.22 J/i/'eo-2-(l(5),2(/f)-4-Diethoxyphosphonyl-l,2-dihydroxybutyl)-2-
methyI-l,3-dioxolane 90 
(£)-2-Methyl-2-(4-diethoxyphosphonylbut-3-enyl)-l,3-dioxolane 84 (297 mg, 1.07 mmol) 
was added to a biphasic mixture of AD mix-P (1.51 g) and methanesulphonamide 
(102 mg, 1.08 mmol) in tert-hutano\ (5.4 ml) and H2O (5.4 ml). After vigorous stirring 
for 22 h, the reaction was quenched with Na2S03 (1.62 g, 11.4 mmol in H2O (10 ml)) and 
extracted into CH2CI2 (3 x 30 ml). The organic extracts were combined, washed with 
I M KOH (10 ml), dried over MgS04 and then solvent was removed under reduced 
pressure. Purificafion of the residue over silica gel (MeOH / Et20, 1:6, KMn04 stain as 
visualiser) afforded 90 (61.5 mg, 0.20 mmol, 18.5 %) as a clear colourless oil ([a]D^° 
+10.5 ° (c. 1.0, CHCI3)). '^P NMR analysis indicated > 95 % purity. 
' H NMR (299.9 MHz) 6 1.32 (6H, t, VH-H = 7.0 Hz, POCH2CH3), 1.36 (3H, s, 
CO(OCH2)2CH3), 1.71-2.07 (4H, m, PCH2CH2), 2.77 ( IH, d, VH-H = 6.9 Hz, 
CH(0H)C0CH3) 3.22 ( IH, d, VH-H = 3.0 Hz, PCH2CH2CH(OH)), 3.40 ( IH, dd, VH-H = 
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6.9 Hz, VH-H = 1.5 Hz, CH(0H)C0CH3), 3.87-3.94 ( IH, m, PCH2CH2CH(OH)), 3.99-
4.05 (4H, m, OCH2CH2O), 4.05-4.17 (4H, m, POCH2). 
'^C NMR (75.4 MHz) S 16.4 (2C, d, VC-P = 6.1 Hz, POCH2CH3), 20.8 (IC, s, 
C(OCH2)2CH3), 21.9 (IC, d, VC-P = 142.1 Hz, PCH2), 27.2 (IC, d, VC-P = 4.5 Hz, 
PCH2CH2), 61.6 (2C, d, Vc-P = 6.4 Hz, POCH2), 65.06, 65.13 (2C, s, OCH2CH2O), 69.5 
(IC, d, Vc-P = 15.0 Hz, PCH2CH2CH(OH)), 75.4 (IC, s, CH(OH)C(OCH2)2CH3), 110.7 
(IC, s, C(OCH2)2CH3), 
^ 'P NMR (161.9 MHz) 5 33.8 (s, (EtO)2P(0)CH2CH2CH(OH)CH(OH)C(OCH2)2CH3). 
IR: 3385, 2983, 2935, 2905, 1654, 1478, 1444, 1393, 1225, 1166, 1097, 1031, 965, 871, 
827, 793. 
m/z (FAB): 314 ([M+2H]^ 16.1 % ) , 313 ( [M+Hf 100 %) , 295 ( [M-OHf 5.3 %) , 280 
([M-0H-CH3]^ 4.5 % ) , 279 ([M-H20-CH3]^ 30.1 %) , 278 ([M-OH-OH]^ 5.7 %) , 277 
([M-H20-0H]^ 37.9 % ) , 251 ([M-HOCH2CH20]^ 13.2 %) , 249 ([M-H20-Et]'" 6.1 %) , 
239 ([M-EtO-C2H4]^ 17.2 %) , 235 ([M-HOCH2CH20H-CH3]^ 21.0 %) , 233 ([M-
HOCH2CH2OH-OH]* 4.7 %) . 
HRMS: (FAB) Calcd. for (M+1) C,2H2607P: 313.1416, found: 313.1437. 
4.2.1.23 Diethyl /A/'^o-3,4-dihydroxy-5-oxohexylphosphonate 82 
4.2.1.23.1 RUO4 dihydroxylation 
RUO4.XH2O (85 mg, 0.64 mmol) and NaI04 (1.37 g, 6.41 mmol) were added 
simultaneously to a vigorously stirred solution of diethyl (£)-5-oxohex-3-
enylphosphonate 76 (1.00 g, 4.27 mmol) in EtOAc / CH3CN / H2O (26 ml / 26 ml / 
8.5 ml) at 0 °C. After 3 min the reaction was quenched with sat. Na2S203(aq) (45 ml), the 
aqueous layer separated and extracted into EtOAc (3 x 65 ml). The organic extracts were 
combined, dried over MgS04 and solvent removed under reduced pressure. Purification 
of the residue over silica gel (CH2CI2 / EtOAc / IPA, 3:1:0.5, KMn04 stain as visualiser) 
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afforded 82 (153 mg, 0.57 mmol, 13.4 %) as a clear colourless oil. GCMS analysis 
indicated > 99 % purity. 
' H NMR (400.0 MHz) 5 1.33 (6H, t, VH-H = 7.0 Hz, POCH2CH3) , 2.00-2.18 (4H, m, 
P C H 2 C H 2 ) , 2.29 (3H, s, C O C H 3 ) , 3.23 ( IH, d, VH-H = 8.4 Hz, CH(OH)), 3.87 (IH, d, VH-
H = 4.8 Hz, CH(OH)), 4.02-4.16 (6H, m, POCH2, CH(OH)CH(OH)). 
'^C NMR (100.6 MHz) 5 16.4 (2C, d, VC-P = 6.0 Hz, POCH2CH3) , 22.3 (IC, d, VC-P = 
141.9 Hz, PCH2) , 25.6 (IC, s, C O C H 3 ) , 27.0 (IC, d, VC-P = 4.5 Hz, PCH2CH2), 61.85, 
61.92 (2C, d, Vc-P = 6.9 Hz, POCH2) , 71.6 (IC, d, VC-P = 11.9 Hz, PCH2CH2CH(OH)), 
79.4 (IC, s, CH(0H)C0CH3), 208.3 (IC, s, C O C H 3 ) . 
'^P NMR (161.9 MHz) 5 33.8 (IP, s, (EtO)2P(0)CH2CH2CH(OH)CH(OH)COCH3). 
IR: 3373, 2984, 2934, 2912, 1715 (C=0), 1654, 1443, 1392, 1225, 1163, 1098, 1054, 
1026, 967, 795. 
m/z (FAB): 269 ([M+H]'' 100 % ) , 252 ([M-0]^ 10.7 %) , 251 ([M-OH]^ 74.4 %) , 249 
( [M-H3O]* 11.7 % ) , 239 ([M-Et]^ 100 %) , 235 ([M-H20-CH3]^ 32.5 %) , 225 ([M-
C0CH3]^ 24.3 % ) , 223 ([M-EtO]^ 10.2 %) , 209 ([M-02CCH3]^ 15.2 %) , 207 ([M-CH3-
C2H4-H2O]"' 14.2 % ) . 
HRMS: (FAB) Calcd. for (M+1) C,oH2206P: 269.1154, found: 269.1177. 
4.2.1.23.2 OSO4 dihydroxylation 
Diethyl (£)-5-oxohex-3-enylphosphonate 76 (1.01 g, 4.30 mmol) was added to a solution 
of tetraethylammonium acetate tetrahydrate (273 mg, 1.04 mmol) in acetone (8.6 ml) and 
tert-hutyl hydroperoxide (70 % w/w in water, 1.0 ml, 8.26 mmol). After cooling the 
solmion to 0 °C, OSO4 (~ 0.2 ml, of a 0.39 M solution in PhMe, ~ 0.08 mmol) was added 
and after 1 h the solution was allowed to warm to ambient temperature, the reaction was 
then quenched 17 h later at 0 °C with sat. Na2S203(aq) (3 ml). H2O (20 ml) was added, the 
aqueous layer separated and washed with EtOAc (3 x 200 ml), the organic fractions were 
then combined, dried over MgS04 and solvent removed under reduced pressure. 
Purification of the residue over silica gel (CH2CI2 / EtOAc / IPA, 3:1:0.5, KMn04 stain as 
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visualiser) afforded 82 (574 mg, 2.14 mmol, 49.7 %) as a clear colourless oil. '^P NMR 
analysis indicated > 99 % purity. 
Analytical data was identical to that described in 4.2.1.23.2. 
4.2.1.24 Tribenzyl phosphite'^ ^ 96 
Et3N (12.4 ml, 89.0 mmol) was added dropwise to a mechanically stirred solution of PCI3 
(2.5 ml, 28.7 mmol) in EtsO (150 ml) at -78 °C, then a solution of benzyl alcohol (8.9 ml, 
86.0 mmol) in Et20 (30 ml) was added over 5 min at this temperature. After 2 h the 
reaction was allowed to warm up to ambient temperature and after a fiarther 8 h it was 
filtered, the residue washed with Et20 (0.5 1), and solvent removed under reduced 
pressure to give a crude product 96 (1.22 g, ~ 80 % pure by '^P NMR). After leaving for 
~ 12 h at -20 °C the sample decomposed (to ~ 50 % purity by '^P NMR). Dry column 
chromatography over silica gel (solvent gradient of petrol / EtsN, < 1 %, to petrol / Et20 / 
Et3N, 1:2:< 1 %, KMn04 stain as visualiser, Rf= 0.75 for 96 using petrol / Et20 / Et3N, 
2:5:0.05) afforded 96 as a clear colourless oil (1.95 g, 5.54 mmol, 19.3 %) which was 
stable under nitrogen on storage. '^P NMR analysis indicated > 95 % purity. 
' H NMR (200.0 MHz) 5 4.89 (6H, d, VH-P = 8.0 Hz, 0CH2Ph), 7.20-7.60 (15H, m, Ph). 
'^C NMR (75.4 MHz) S 64.4 (3C, d, VC-P = 11.2 Hz, 0CH2Ph), 127,5 (6C, s, yPh), 127.7 
(3C, s, SPh), 128.4 (6C, s, pPh), 138.1 (3C, d, VC-P = 4.8 Hz, aPh). 
'^P NMR (81.0 MHz) 5 140.7 (IP, s, (BnO)3P), Lit.'^" 140.5. 
IR: 3064, 3033, 2953, 2927, 2891, 1497, 1455, 1415, 1379, 1312, 1241, 1215, 1081, 
1035,998, 922, 828, 733,697. 
m/z (EI): 352 ([M]^ 0.2 % ) , 262 ([M-C7H6f 3.9 % ) , 261 ([M-Dnf 25.7 % ) , 182 (19.9 % ) , 
171 ([M-Bn-CjUet 10.6 % ) , 107 ([BnOf 19.6 % ) , 92 ([BnH]* 23.4 %) , 91 ([Bn]* 100 
% ) , 77 ([Ph]"" 8.2 % ) , 65 ([C5H5T 35.7 % ) , 51 ([C4H3]"' 9.8 %) , 39 ([C3H3]^ 9.3 %) . 
141 
4.2.1.25 2-(2-Dibenzoxyphosphonylethyl)-l,3-dioxolane 95 and 
dibenzyl benzylphosphonate'^^ 98 
2-(2-Bromoethyl)-l,3-dioxolane (1.54 g, 8.51 mmol) was added to tribenzyl phosphite 
(305 mg, 0.87 mmol) and heated at 120 °C for 5 h. After cooling, purification over silica 
gel (Et20 / CH2CI2, 1:10, KMn04 stain as visualiser) afforded first tribenzyl phosphate 
(18.1 mg, 0.05 mmol, 5.7 % ) , then dibenzyl benzylphosphonate 98 (93.4 mg, 0.27 mmol, 
30.6 %) both as clear colourless oils. Increasing the polarity of the solvent system 
(EtOAc / petrol / CH2CI2, 4:1:1, KMn04 stain as visualiser) afforded 95 (55.6 mg, 
0.15 mmol, 17.7 %) also as a clear colourless oil. '^ 'P NMR analysis indicated > 95 % 
purity. 
' H NMR (400.0 MHz) 5 1.83-1.98 (4H, m, PCH2CH2), 3.79-3.96 (4H, m, OCH2CH2O), 
4.88 ( IH , t, VH-H = 3.8 Hz, CH), 4.96 (2H, dd, VH-P = 8.3 Hz, VH-H = 11.9 Hz, 
CHAHePh), 5.04 (2H, dd, VH-P = 8.3 Hz, VH-H = 11.9 Hz, CHAHsPh), 7.28-7.37 (lOH, m, 
Ph). 
'^C NMR (100.6 MHz) 5 19.8 (IC, d, 'JC-P = 144.2 Hz, PCH2), 26.7 (IC, d, VC-P = 4.5 
Hz, PCH2CH2), 65.0 (2C, s, OCH2CH2O), 67.1 (2C, d, VC-P = 6.1 Hz, POCH2), 103.1 
(IC, d, Vc-P = 19.8 Hz, CH), 127.8 (4C, s, yPh), 128.3 (2C, s, 5Ph), 128.5 (4C, s, pPh), 
136.3 (2C, d, Vc-p = 6.1 Hz, aPh). 
'^P NMR (161.9 MHz) 5 35.7 (IP, s, (BnO)2P(0)CH2CH2CH(CH20)2). 
IR: 3089, 3063, 3032, 2955, 2886, 1497, 1455, 1441, 1410, 1381, 1248, 1215, 1139, 
1081, 1036, 1023, 996, 920, 879, 737, 698. 
m/z (EI): 363 ([M+H]^ 0.3 % ) , 362 ([M]^ 0.1 %) , 361 ([M-H]* 0.3 %) , 271 ([M-Bn]"" 2.7 
% ) , 261 ([(BnO)2PO]^ 1.0 % ) , 211 ([M-Bn-C2H402]^ 4.1 %) , 199 ([M-CvHg-
CH(OCH2)2]^ 11.6 % ) , 165 ([M-BnO-CvHe]"" 85.3 %) , 121 ([M-Bn-C7H6-C2H402]^ 27.7 
% ) , 92 ([BnH]^ 8.7 % ) , 91 ([Bn]^ 100 % ) , 73 ([CH(OCH2)2]^ 66.0 % ) , 65 {[C5H5T 18.3 
% ) . 
HRMS: (CI) Calcd. for (M+1) C19H24O5P: 363.1361, found: 316.1362. 
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Data for dibenzyl benzylphosphonate'''^ 98 
' H NMR (400.0 MHz) 5 3.09 (2H, d, VH-P = 21.6 Hz, PCHiPh), 4.82 (4H, d, VH-P = 8.4 
Hz, PhCH20), 7.24-7.38 (15H, m, Ph). 
'^ C NMR (100.6 MHz) 6 33.9 (IC, d, 'JC-P = 137.7 Hz, PCH2Ph), 67.5 (2C, d, VC-P = 6.8 
Hz, 0CH2Ph), 126.9 (IC, d, VC-P = 3.4 Hz, 8PhCH2P), 127.8 (4C, s, yPhCH20P), 128.2 
(2C, s, 5PhCH20P), 128.4 (4C, s, pPhCH20P), 128.5 (2C, d, VC-P = 3.0 Hz, yPhCHjP), 
129.8 (2C, d, Vc-P = 6.4 Hz, pPhCH2P), 131.0 (IC, d, VC-P = 9.6 Hz, aPhCH2P), 136.2 
(2C, d, Vc-p = 6.1 Hz, aPhCH20P). 
'^P NMR (161.9 MHz) 6 30.7 (IP, s, (BnO)2P(0)Bn), L i t . ' " 28.1. 
IR: 3087, 3062, 3031, 2953, 2889, 1496, 1454, 1379, 1251, 1215, 1080, 1035, 1021, 996, 
917, 872, 737, 697. 
m/z (EI): 353 ([M+H]^ 0.2 % ) , 262 ([M-CyHs]"*" 16.7 %) , 261 ([M-Bn]-" 83.7 %) , 180 
(11.7 % ) , 107 ([BnO]^ 45.4 % ) , 92 ([BnH]+ 11.1 % ) , 91 ([Bn]'' 100 % ) , 77 ([Ph]^ 5.4 %) , 
65 ([Cslist 34.7 % ) , 51 ([C4H3]^ 4.3 %) , 39 ([C3H3]^ 6.2 %) . 
4.2.1.26 2-(2-Iodoethyi)-l,3-dioxane'^' 99 
O' 
0 
2-(2-Bromoethyl)-l,3-dioxane (2.00 g, 10.3 mmol) and pyridine (2 drops) were added to a 
solufion of Nal (6.15 g, 41.0 mmol) in freshly disfilled acetone (40 ml) and the mixture 
heated under reflux for 16 h. The solvent was removed under reduced pressure and then 
Et20 (250 ml) was added to the residue. The mixture was washed with 50 % NaCl(aq) 
(50 ml) followed by sat. NaCl(aq) (25 ml), then dried over MgS04. Solvent was removed 
under reduced pressure and disfiUation (33-36 °C / 0.07 mbar) afforded 99 (2.01 g, 
8.3 mmol, 81.0 %) as a dark red oil. ' H NMR analysis indicated > 95 % purity, with the 
main impurity being 2-(2-bromoethyl)-l,3-dioxane , < 5 %. 
' H NMR (400.0 MHz) 5 1.30-1.35 ( IH, m, 0CH2CHAHB), 1.97-2.08 ( IH, m, 
0CH2CHAHB) , 2.09 (2H, dt, VH-H = 7.2 Hz, VH-H = 5.2 Hz, ICH2CH2CH), 3.18 (2H, t, 
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VH-H = 7.2 Hz, ICH2), 3.72-3.79 ( I H , m, 0CHAHBCH2), 4.05-4.10 ( I H , m, 
0CHAHBCH2) , 4.60 ( I H , t, VH-H = 5.2 Hz, C H ) . 
'^C NMR (100.6 MHz) § -0.7 ( I C , s, ICH2), 25.7 ( I C , s, OCH2CH2CH2O), 38.6 ( I C , s, 
ICH2CH2), 66.8 ( I C , s, OCH2CH2CH2O), 101.5 ( I C , s, CH). 
IR: 2965, 2926, 2852, 2736, 1430, 1377, 1239, 1143, 1127, 1088, 1072, 1006, 870. 
m/z (EI): 243 ([M+H]^ 5.5 %) , 242 ([M]^ 5.1 %) , 241 ([M-H]^ 5.5 % ) , 199 ([M-
CH3CH2CH2]^ 3.7 % ) , 183 ([M-HOCH2CH2CH2]^ 4.2 %) , 169 ([ICH2CH2CH2]^ 3.5 %) , 
155 ([ICH2CH2]'' 11.0 % ) , 128 ( [ H l f 7.5 %) , 127 ( [ i f 12.4 %) , 115 ([M-I]^ 13.5 %) , 114 
([M-HI]* 5.4 % ) , 88 ([M-ICH2CH]^ 5.1 %) , 87 ([M-ICH2CH2]^ 100 %) , 41 
([CH2CHCH2]^ 28.3 % ) . 
4.2.1.27 Dibenzyl methylphosphonate'^ '* 105 
A solufion of dibenzyl phosphite (7.00 g, 26.7 mmol) in THF (15 ml) was added dropwise 
over 10 min to a solution of NaH (60 % mineral oil dispersion, 1.175 g, 29.4 mmol, 
mineral oil removed with petrol ( 2x5 ml)) in THF (15 ml) at -15 to -20 °C. lodomethane 
(4.55 g, 32.1 mmol) was then added dropwise over 5 min and the solution allowed to 
warm up to 0 °C over 2 h, and then to ambient temperature. After 20 h, H2O (10 ml) was 
added and the THF removed under reduced pressure. The residue was then washed with 
CH2CI2 (3 X 100 ml), the organic washings were combined, dried over MgS04 and the 
solvent removed under reduced pressure. Dry column chromatography of the residue over 
silica gel (solvent gradient of petrol / EtOAc, 4:1, to neat EtOAc, KMn04 stain as 
visualiser, Rf= 0.15 for 105 using petrol / EtOAc, 2:3) afforded 105 as a clear yellow oil 
(5.02 g, 18.2 mmol, 68.1 % ) . GC analysis indicated > 99 % purity. 
' H NMR (400.0 MHz) 5 1.47 (3H, d, VH-P = 17.6 Hz, CH3), 4.96 (2H, dd, VH-P = 8.6 Hz, 
VH-H = 12.0 Hz, CHAHePh), 5.06 (2H, dd, VH-P = 8.6 Hz, VH-H = 12.0 Hz, CHAHBPh), 
7.31-7.36 (lOH, m, Ph). 
'^C NMR (100.6 MHz) 5 11.6 (IC, d, VC-P = 144.2 Hz, PCH3), 66.9 (2C, d, VC-P = 6.0 
Hz, 0CH2Ph), 127.8 (4C, s, yPh), 128.3 (2C, s, §Ph), 128.5 (4C, s, pPh), 136.2 (2C, d, 
Vc-p = 6.1 Hz, aPh). 
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'^P NMR (161.9 MHz) 6 32.8 (IP, s, (BnO)2P(0)CH3), Lit.'^^ 32.2. 
IR: 3064, 3033, 2953, 2927, 2891, 1497, 1455, 1415, 1379, 1312, 1241, 1215, 1081, 
1035, 998, 922, 828, 733,697. 
m/z (CI): 294 ([M+NH4]^ 13.5 %) , 277 ([M+H]+ 26.5 %) , 108 ([BnOH]^ 100 %) , 107 
([BnO]+ 18.6 % ) , 106 ([PhCHO]^ 41.3 % ) , 91 ([PhCH2]^ 25.0 %) , 78 ([PhH]^ 9.5 %) . 
4.2.1.28 Dibenzyl but-3-enyIphosphonate 106 
Dibenzyl methylphosphonate (4.80 g, 17.4 mmol) in THF (10 ml) was added dropwise to 
a solution of 1.6 M butyl lithium in n-hexane (12.5 ml, 20.0 mmol) in THF (25 ml) at 
-60 °C, and after 10 min at this temperature copper (1) iodide (3.54 g, 19.1 mmol) was 
added. The solufion was allowed to warm to -35 °C over 5 min, then after 1 h allyl 
bromide (2.31 g, 19.1 mmol) in THF (7.5 ml) was added dropwise and the reaction 
allowed to warm slowly to ambient temperature after 4 h at -35 °C. The reaction was 
quenched with H2O (30 ml), the solution filtered through Hyflo, and the cake washed with 
CH2CI2 (3 X 50 ml). The eluent was filtered through the cake again and was washed with 
CH2CI2 (50 ml) and the washings were combined. The aqueous layer was separated, 
washed with CH2CI2 (50 ml) then the organic fractions were combined, dried over MgS04 
and solvent removed under reduced pressure. Dry column chromatography over silica gel 
of the residue (solvent gradient of neat petrol to petrol / EtOAc, 1:1, KMn04 stain as 
visualiser, Rf = 0.43 for 106 using petrol / EtOAc, 2:3) afforded 106 (3.73 g, 11.8 mmol, 
68.0 %) as a clear yellow oil. GCMS analysis indicated > 99 % purity. 
' H NMR (499.8 MHz) 5 1.80-1.88 (2H, m, PCH2), 2.27-2.35 (2H, m, PCH2CH2), 4.94-
5.08 (6H, m, CHCH2, CHsPh), 5.74-5.82 ( IH, m, CHCH2), 7.30-7.37 (lOH, m, Fh). 
'^C NMR (125.7 MHz) 5 25.3 (IC, d, VC-P = 140.1 Hz, PCH2), 26.3 (IC, d, VC-P = 4.4 
Hz, PCH2CH2), 67.0 (2C, d, Vc-P = 6.5 Hz, 0CH2Ph), 115.1 (IC, s, CHCH2), 127.8 (4C, 
s, yPh), 128.3 (2C, s, 5Ph), 128.5 (4C, s, pPh), 136.3 (2C, d, VC-P = 5.9 Hz, aPh), 136.9 
(IC, d,Vc.p= 18.0 Hz, CH). 
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'^P NMR (161.9 MHz) 5 33.8 (IP, s, (BnO)2P(0)CH2CH2CHCH2). 
IR: 3065, 3033, 2979, 2952, 2893, 1702, 1641, 1497, 1455, 1379, 1283, 1247, 1215, 
1081, 1037, 997, 919, 861, 735, 697. 
m/z (EI): 317 ([M+H]^ 0.4 %) , 225 ([M-Bn]^ 29.9 %) , 180 (7.0 %) , 144 (5.1 %) , 143 
(37.9 % ) , 108 ([BnOH]* 5.7 %) , 107 ([BnO]^ 54.2 %) , 92 ([PhMe]+ 11.3 %) , 91 ([Bn]* 
100 % ) , 79 ([CfiHy]^ 12.7 % ) , 65 ([CsUsT 19.5 %) , 55 ([C4H7]^ 8.0 %) , 39 ([CiUsT 8.1 
% ) . 
HRMS: (CI) Calcd. for (M+1) C18H22O3P: 317.1306, found: 317.1292. 
4.2.1.29 Dibenzyl 3,4-dihydroxybutyIphosphonate 107 
Dibenzyl but-3-enylphosphonate 106 (3.57 g, 11.31 mmol) was added to a solution of 
tetraethylammonium acetate tetrahydrate (715 mg, 2.74 mmol) in acetone (23 ml) and 
tert-huty\ hydroperoxide (70 % w/w in water, 2.65 ml, 21.90 mmol). After cooling the 
solution to 0 °C, OSO4 (~ 0.1 ml, of a 0.39 M solution in PhMe, ~ 0.04 mmol) was added 
and after 1 h the solution was allowed to warm to ambient temperature. The reaction was 
followed by tic (IPA / CH2CI2, 1:6, Rf = 0.8 for 106 and 0.37 for 107, KMn04 stain as 
visualiser). After 48 h the solution was cooled to 0 °C and OSO4 (~ 0.1 ml, of a 0.39 M 
solution in PhMe, ~ 0.04 mmol) was added. After 1 h the solution was allowed to warm 
to ambient temperature and 24 h later CH2CI2 (50 ml) was added, then the reaction 
quenched at 0 °C with 10 % Na2S203(aq) (6 ml). H2O (10 ml) was then added, the aqueous 
layer separated and washed with CH2CI2 (3 x 200 ml). The organic extracts were 
combined, dried over MgS04 and solvent removed under reduced pressure. Dry column 
chromatography over silica gel of the residue (solvent gradient of neat CH2CI2 to IPA / 
CH2CI2, 1:2) afforded 107 (3.36 g, 9.60 mmol, 85.0 %) as a clear colourless oil. 
^'P NMR analysis indicated > 99 % purity. 
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' H N M R (499.8 MHz) 5 1.64-1.73 (2H, m, PCH2), 1.80-2.01 (2H, m, PCH2CH2), 3.40 
( I H , dd, VH-H = 6.7 Hz, VH-H = 11.2 Hz, C H A H B O H ) , 3.55 ( IH , dd, VH-H = 3.2 Hz, VH-H 
= 11.2 Hz, C H A H B O H ) , 4.91-5.05 (4H, m, 0CH2Ph), 7.29-7.37 (lOH, m, Ph). 
'^C N M R (125.7 MHz) 5 22.1 (IC, d, VC-P = 141.1 Hz, PCH2), 25.8 (IC, d, VC-P = 4.4 
Hz, PCH2CH2), 66.3 (IC, s, CH2OH), 67.4 (2C, d, VC-P = 6.4 Hz, 0CH2Ph), 71.6 (IC, d, 
Vc-P = 13.0 Hz, CH(OH)), 127.9 (4C, s, yPh), 128.5 (2C, s, 5Ph), 128.6 (4C, s, pPh), 
136.1 (2C, d, Vc-p = 5.9 Hz, aPh). 
'^P NMR (161.9 MHz) 5 35.4 (IP, s, (BnO)2P(0)CH2CH2CH(OH)CH20H). 
IR: 3379, 3090, 3064, 3033, 2936, 2891, 1958, 1887, 1816, 1712, 1497, 1455, 1407, 
1380, 1215, 1081, 1035, 996, 921, 873, 735, 697. 
m/z (CI): 351 ([M+H]^ 24.8 %) , 350 ([M]"" 100 %) , 260 ([M-C7H6]* 14.2 %) , 243 ([M-
B n O f 7.1 %) . 
HRMS: (CI) Calcd. for C18H24O5P: 351.1361, found: 351.1370. 
4.2.1.30 Dibenzyl 3-oxopropylphosphonate 94 
NaI04 (2 .06 g, 9.63 mmol) was added to a solution of dibenzyl 
3,4-dihydroxybutylphosphonate 107 (3 .06 g, 8.73 mmol) in THF (30 ml) and H2O 
(30 ml). After 1 h, THF was removed under reduced pressure and the organics were 
extracted into CH2CI2 (3 x 200 ml). The organic extracts were combined, dried over 
MgS04 and the solvent was removed under reduced pressure to afford 107 as a clear 
colourless oil (2 .76 g, 8.66 mmol, 99.2 % ) . '^P NMR analysis indicated > 99 % purity. 
' H NMR (499.8 MHz) 5 2.00-2.08 ( 2 H , m, PCH2), 2.66-2.73 ( 2 H , m, PCH2CH2), 4.96 
( 2 H , dd, VH-P = 8.5 Hz, VH-H = 11-7 Hz, CHAHePh), 5.05 ( 2 H , dd, VH-P = 8.5 Hz, VH-H = 
11.7 Hz, CHAHePh), 7.30-7.38 (lOH, m, Ph), 9.68 ( IH, d, VH-P = 2.0 Hz, C H O ) . 
'^C NMR (125.7 MHz) S 18.3 (IC, d, 'Jc-p = 145.7 Hz, PCH2), 36.7 (IC, s, PCH2CH2), 
67.4 (2C , d, Vc-P = 5.9 Hz, 0CH2Ph), 128.0 (4C, s, yPh), 128.5 (2C, s, 6Ph), 128.6 (4C, s, 
pPh), 136.1 (2C, d, Vc-P = 5.9 Hz, aPh), 198.9 (IC, s, CHO). 
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'^P NMR (161.9 MHz) 6 33.2 (IP, s, (BnO)2P(0)CH2CH2CHO). 
IR: 3064, 3033, 2953, 2894, 2833, 2732, 1959, 1888, 1723, 1497, 1455, 1410, 1383, 
1243, 1215, 1081, 996, 869, 736, 698. 
m/z (EI): 317 ([M+H]+ 0.4 %) , 225 ([M-Bn]^ 29.9 %) , 180 (7.0 %) , 143 (37.9 %) , 108 
([BnOH]^ 5.7 % ) , 107 ([BnO]^ 54.2 % ) , 92 ([PhMe]^ 11.3 % ) , 91 ([Bn]^ 100 % ) , 79 
([CfiHy]^ 12.7 % ) , 65 ([CsHst 19.5 % ) , 55 ([C4H7]^ 8.0 %) , 39 ([CsHa]^ 8.1 %) . 
4.2.1.31 Dibenzyl (jE)-5-oxohex-3-enylphosphonate 108 
Dibenzyl 3-oxopropylphosphonate 94 (2.72 g, 8.55 mmol) was added to a solution of 
l-triphenylphosphoranylidene-2-propanone (2.73 g, 8.56 mmol) in THF (50 ml) and the 
mixture heated under reflux for 18 h. The solvent was removed under reduced pressure 
and the residue purified over silica gel (acetonitrile / CH2CI2, 1:2.5, UV lamp as 
visualiser, Rf = 0.23 for triphenylphosphine oxide and 0.33 for 108) affording 108 (2.88 g, 
8.03 mmol, 94.0 %) as a clear pale yellow oil. '^ 'P NMR analysis indicated > 93 % purity, 
with the main impurity being triphenylphosphine oxide, ~ 5 %. 
' H NMR (400.0 MHz) 5 1.81-1.90 (2H, m, PCH2), 2.15 (3H, s, COCH3), 2.40-2.49 (2H, 
m, PCH2CH2), 4.95 (2H, dd, VH-P = 8.8 Hz, VH-H =11.7 Hz, CHAHePh), 5.06 (2H, dd, 
VH-P = 8.8 Hz, VH-H = 11.7 Hz, CHAHePh), 5.98 (IH, dt, VH-H = 16.0 Hz, VH-H = 1.6 Hz, 
CHCOCH3), 6.69 ( IH, dt, VH-H = 16.0 Hz, VH-H = 6.6 Hz, PCH2CH2CH), 7.31-7.37 
(lOH, m, Ph). 
'^C NMR (100.6 MHz) 5 24.6 (IC, d, 'JC-P - 141.8 Hz, PCH2), 25.2 (IC, d, VC-P = 4.5 
Hz, PCH2CH2), 26.8 (IC, s, COCH3), 67.3 (2C, d, VC-P = 6.4 Hz, 0CH2Ph), 128.0 (4C, s, 
yPh), 128.5 (2C, s, 5Ph), 128.6 (4C, s, pPh), 131.5 (IC, s, CHCOCH3), 136.1 (2C, d, VC-P 
= 5.7 Hz, aPh), 145.6 (IC, d, VC-P = 16.4 Hz, PCH2CH2CH), 198.2 (IC, s, CHCOCH3). 
^'P NMR (161.9 MHz) § 34.1 (IP, s, (BnO)2P(0)CH2CH2CHCHCOCH3). 
IR: 3064, 3033, 2953, 2894, 1696, 1673, 1628, 1497, 1455, 1426, 1361, 1252, 1214, 
1081, 1035,995,866, 737, 697. 
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m/z (EI): 358 ([M]^ 1.0 % ) , 267 ([M-Bn]^ 9.6 %) , 225 ([M-Bn-C2H20]^ 2.5 %) , 161 ([M-
PhCHO-Bn] + 35.5 % ) , 122 (9.2 % ) , 108 ([BnOH]* 5.7 %) , 107 ([BnO]^ 17.2 %) , 106 
([PhCHO]- 7.3 % ) , 105 ([PhCO]^ 18.6 % ) , 92 ([PhCHa]^ 8.4 %) , 91 ([Bn]^ 100 %) , 83 
([C5H7O]* 56.2 % ) , 85 (41.1 % ) , 79 ([CeHy]^ 10.2 % ) , 65 ([CjHsf 10.3 %) . 
HRMS: (EI) Calcd. for C20H23O4P: 358.1334, found: 358.1331. 
4,2.1.32 Dibenzyl ^ A/-eo-3,4-dihydroxy-5-oxohexyIphosphonate 109 
OH O 
Dibenzyl (£)-5-oxohex-3-enylphosphonate 108 (2.55 g, 7.10 mmol) was added to a 
solution of tetraethylammonium acetate tetrahydrate (450 mg, 1.72 mmol) in acetone 
(14 ml) and tert-hutyl hydroperoxide (70 % w/w in water, 1.66 ml, 13.72 mmol). After 
cooling the solution to 0 °C, OSO4 (~ 0.2 ml, of a 0.39 M solution in PhMe, ~ 0.08 mmol) 
was added and after 1 h the solution was allowed to warm to ambient temperature. The 
reaction was followed by tic (MeOH / Et20, 0.2:5, Rf = 0.55 for 109, KMn04 stain as 
visualiser) and after 26 h, CH2CI2 (30 ml) was added then the reaction was quenched at 
0 °C with 10 % Na2S203(aq) (10 ml). H2O (15 ml) was then added, the aqueous layer 
separated and washed with CH2CI2 (3 x 200 ml). The organic fractions were combined, 
dried over MgS04 and the solvent was removed under reduced pressure. Purification of 
the residue over silica gel (MeOH / Et20, 1:15, Rf = 0.35 for 109, KMn04 stain as 
visualiser) afforded 109 (1.85 g, 4.71 mmol, 66.4 %) as a creamy coloured solid 
(mp 60.5-61.5 °C). '^P NMR analysis indicated > 99 % purity. 
' H NMR (400.0 MHz) 5 1.79-2.04 (4H, m, PCH2CH2), 2.18 (3H, s, COCH3), 3.29 (IH, s, 
OH), 3.92-4.01 (3H, m, CH(OH)CH(OH)), 4.91-5.07 (4H, m, CH2Ph), 7.29-7.37 (lOH, 
m, Ph). 
'^C NMR (100.6 MHz) 6 22.4 (IC, d, VC-P = 141.5 Hz, PCH2), 25.5 (IC, s, COCH3), 
26.7 (IC, d, Vc-P = 4.5 Hz, PCH2CH2), 67.3, 67.4 (2C, d, VC-P = 6.5 Hz, 0CH2Ph), 71.3 
(IC, d, Vc-P = 13.3 Hz, CH2CH(0H)), 79.3 (IC, s, CH(0H)C0CH3), 127.91 (2C, s, yPh), 
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127.94 (2C, s, yPh), 128.4 (2C, s, SPh), 128.5 (4C, s, pPh), 136.0 (2C, d, VC-P = 6.1 Hz, 
aPh), 208.3,(IC, s, CH(0H)C0CH3). 
'^P NMR (161.9 MHz) 6 34.9 (IP, s, (Bn0)2P(0)CH2CH2CH(0H)CH(0H)C0CH3). 
IR: (KBr) 3473, 3249, 3063, 3029, 2950, 2921, 1713, 1455, 1393, 1351, 1209, 1143, 
1117, 1080, 1038, 1023, 996, 971, 924, 869, 847, 741, 696, 589. 
m/z (CI): 411 ([M+NH4+H]'' 3.7 % ) , 410 ([M+NH4]^ 14.4 %) , 394 ([M+2H]+ 23.6 %) , 
393 ([M+H]^ 100 % ) , 392 ([M]^ 9.4 % ) , 376 ([M-0]^ 3.8 % ) , 375 ([M-OH]^ 8.7 %) , 374 
([M-HzO]"" 1.6 % ) , 336 (19.2 % ) , 319 (16.0 %) , 303 ([M-PhCO]^ 5.5 %) , 302 ([M-
PhCHO]^ 26.0 % ) , 285 ([M-BnO]^ 5.8 %) . 
HRMS: (CI) Calcd. for (M+1) C20H26O6P: 393.1467, found: 393.1465. 
4.2.1.33 Disodium ^^reo-3,4-dihydroxy-5-oxohexylphosphonate 110 
0 QH 
II z 
10 % Pd on carbon (59 mg, 55.4 mmol) was added to a solution of dibenzyl 
3,4-dihydroxy-5-oxohexylphosphonate 109 (206 mg, 0.52 mmol) in THF (10 ml) and 
H 2 O (10 ml) and the suspension stirred under hydrogen (2-3 atm) on a Parr shaker for 
45 min. After filtering through Hyflo the reaction was neutralised with I M NaOH(aq) and 
centrifuged (14000 rpm for 30 min) to remove residual particulate catalyst. The H2O / 
THF supernatant was separated and the solvent was removed under reduced pressure 
followed by freeze drying to afford 110 (103 mg, 0.40 mmol, 76.6 %) as a hygroscopic 
creamy coloured solid. This compound was unstable to storage and was found to have 
decomposed within two weeks at ambient temperature. 
' H NMR (400.0 MHz) (D2O) 6 1.29-1.60 (4H, m, PCH2CH2) , 1.98 (3H, s, COCH3), 
3.85-3.91 ( IH , m, CH2CH(0H)) , 4.07-4.10 ( IH, m, CH(0H)C0CH3). 
'^C NMR (100.6 MHz) (D2O) 5 25-28 (br, PCH2) , 25.9 (s, COCH3), 27.5 (s, PCH2CH2), 
72.0 (d, Vc-P = 16.8 Hz, CH2CH(0H)) , 79.1 (s, CH(0H)C0CH3), 213.3 (s, 
CH(0H)C0CH3). 
^'P NMR (161.9 MHz) D 2 O § 20-33 (br, (NaO)2P(0)CH2CH2CH(OH)CH(OH)COCH3). 
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4.2.1.34 Dibenzyl difluoromethylphosphonate"'* 113 
O 
II 
/ - o T 
Dibenzyl phosphite (6 ml, 27.2 mmol) was added dropwise to a solution of NaH (1.30 g, 
32.5 mmol) in THF (60 ml) at -15 to -10 °C over 20 min. After 5 min 
chorodifluoromethane (23.0 g, 0.27 mol) was steadily bubbled through the reaction, and 
the solution allowed to warm to ambient temperature over 15 min. 
Chlorodifluoromethane was bubbled through for a further 30 min, then the mixture was 
left to stir for 12 h. THF was removed under reduced pressure then H2O (70 ml) added 
and washed with CH2CI2 (3 x 200 ml). The organic washings were combined, dried over 
MgS04 then the solvent was removed under reduced pressure. Dry column 
chromatography over silica gel of the residue with solvent gradient of neat petrol to petrol 
/ EtOAc, 6:1, (impurity at Rf = 0.65, 113 at Rf = 0.20, petrol / EtOAc, 6:1, KMn04 stain 
as visualiser) followed by dry column chromatography over silica gel with neat CH2CI2 to 
CH2CI2 / EtOAc, 12:1, (impurity at Rf = 0.45, 113 at Rf = 0.68 for CH2CI2 / EtOAc, 6:1, 
KMn04 stain as visualiser) afforded 113 (5.44 g, 16.4 mmol, 60.5 %) as a clear colourless 
oil. •^ 'P NMR analysis indicated > 99 % purity. 
' H NMR (400.0 MHz) 5 5.16 (4H, d, V P = 8.4 Hz, CH2Ph), 5.84 ( IH, dt, VH-P = 27.9 
Hz, VH-F = 48.7 Hz, PCF2H), 7.33-7.39 (lOH, m, Fh). 
'^C NMR (100.6 MHz) 5 69.6 (2C, d, VC-P = 6.4 Hz, CH2OP), 111.3 (IC, dt, VC-F = 
258.5 Hz, Vc-P = 213.7 Hz, PCH2F), 128.2 (4C, s, yPh), 128.7 (4C, s, pPh), 128.9 (2C, s, 
5Ph), 135.0 (2C, d, VC-P = 5.7 Hz, aPh). 
'^ F NMR (376.3 MHz) 5 -135.2 (2F, dd, VF-P = 92.4 Hz, VF-P = 48.7 Hz, CH2F). 
'^P NMR (161.9 MHz) 5 6.8 (IP, t, VF-P = 92.3 Hz, (BnO)2P(0)CF2H), Lit.'^^ 6.4. 
IR: 3090, 3065, 3034, 2961, 2897, 1958, 1884, 1814, 1498, 1456, 1380, 1341, 1271, 
1215, 1114, 1061, 1009, 997, 967, 738, 696. 
m/z (CI): 330 ([M+NH4]^ 20.3 % ) , 108 ([BnOH]^ 57.2 %) , 107 ([BnO]* 83.4 %) , 106 
([PhCHO]^ 47.1 % ) , 105 ([PhCO]^ 64.7 % ) , 92 ([PhCHa]* 34.2 % ) , 91 ([Bn]"" 100 %) , 90 
([PhCH]"" 82.4 % ) , 77 ([CgHj]^ 7.6 % ) , 65 ([CsUsT 13.2 %) . 
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4.2.1.35 2,2-Diethoxyethyl trifluoromethanesulphonate'^^ 116 
OEt 
o o 
2,6-Di-/'e/"/-butylpyridine ( 0 . 1 7 ml, 0.76 mmol) was added to a solution of 
2,2-diethoxyethanol (99 mg, 0.74 mmol) in CH2CI2 (3 ml), the mixture was cooled to 
-25 ° C and trifluoromethanesulphonic anhydride (0 .15 ml, 0.89 mmol) was added 
dropwise. After 25 min at -25 to -20 °C, H2O (5 ml) was added and the mixture allowed 
to warm to ambient temperature. The mixture was washed with CH2CI2 (3 x 40 ml), the 
organic washings combined, dried over MgS04 and the solvent removed under reduced 
pressure. Purification over siHca gel (acetonitrile / CH2CI2, 0.1:5, Rf = 0.57 for 116, PMA 
stain as visualiser) afforded 116 (136 mg) as a clear colourless oil. NMR analysis 
indicated 116 was ~ 80 % pure, with the main impurity being 2,6-di-/ert-butylpyridine, 
~ 2 0 %, therefore 116 was afforded in ~ 65 % yield. 
' H NMR (400.0 MHz) 5 1.67 ( 6 H , t, VH-H = 7.0 Hz, CH3) , 3.55-3.64 ( 2 H , m, OCHAHB) , 
3.71-3.79 ( 2 H , m, O CHA H B) , 4 .31 ( 2 H , d, VH-H = 5.2 Hz, CH2CH), 4.67 ( I H , t, VH-H = 
5.2 Hz, CH2CH). 
'^C NMR (100.6 MHz) 6 15.1 (2C, s, CH3), 63.6 (2C, s, OCH2), 73.9 ( I C , s, CH2CH), 
98.7 ( I C , s, CH(0Et)2), 118.5 ( I C , q, VC-F = 319.5 Hz, CF3). 
'^F NMR (376.3 MHz) 6 -75.1 (3F, s, CF3S03CH2CH(OEt)2). 
IR: 2 9 8 1 , 2936, 2903, 1616, 1577, 1481, 1448, 1417, 1377, 1360, 1348, 1247, 1209, 
1145, 1075, 1031 ,973 , 895, 8 4 0 , 8 1 6 , 762, 7 5 2 , 6 1 7 . 
4.2.1.36 Diethyl 3-hydroxy-4-methylpent-4-enylphosphonate 121 
O 
II 
OH 
A solution of diethyl 3-oxopropylphosphonate 52 (1.60 g, 8.24 mmol) in THF (20 ml) 
was added dropwise over 15 min to a -78 ° C solution of isopropenylmagnesium bromide 
in THF (23.5 ml) (prepared from dropwise addition of 2-bromopropene (1.20 g, 
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9.92 mmol) in THF (20 ml) to I2 (5 mg) activated magnesium (0.24 g, 9.88 mmol) in THF 
(3.5 ml)). After 40 min, H2O (30 ml) was added, and the mixture was extracted into 
CH2CI2 (3 X 100 ml). The organic extracts were .combined, dried over MgS04 and the 
solvent removed under reduced pressure. Purification of the residue over silica gel 
(Rf= 0.36 for 121, and 0.25 for 52, petrol / EtzO / IPA, 1.5:1.5:0.5, KMn04 stain as 
visualiser) afforded 121 (0.85 g, 3.61 mmol, 43.8 %) as a clear colourless oil. '^P NMR 
analysis indicated > 99 % purity. 
' H NMR (400.0 MHz) 6 1.27 (6H, t, VH-H = 7.0 Hz, POCH2CH3) , 1.67 (3H, s, CH3) , 
1.68-1.88 (4H, m, PCH2CH2) , 3.13 ( IH, s, CH(OH)), 3.99-4.10 (5H, m, POCH2CH3, 
CH(OH)), 4.82 ( IH, s, C (CH3)CHAHB) , 4.93 ( IH, s, C(CH3)CHAHB) . 
'^C NMR (100.6 MHz) 5 16.3 (2C, d, VC-P = 6.1 Hz, POCH2CH3) , 17.8 (IC, s, CH3), 
21.4 (IC, d, Vc-P = 142.3 Hz, PCH2) , 27.5 (IC, d, VC-P = 4.1 Hz, PCH2CH2), 61.52, 
61.53 (2C, d, Vc-P = 6.4 Hz, POCH2) , 74.7 (IC, d, VC-P = 16.0 Hz, CH(OH)), 111.2 (IC, 
s, C(CH3)CH2) , 146.5 (IC, s, C(CH3)CH2). 
'^P NMR (161.9 MHz) 5 34.2 (IP, s, (EtO)2F(0)CH2CH2CH(OH)C(CH3)CH2). 
IR: 3379, 3073, 2982, 2935, 2911, 2871, 1731, 1651, 1444, 1393, 1370, 1230, 1163, 
1097, 1059, 1029, 965, 899, 792, 732. 
m/z (CI): 236 ([M]'*' 17.0 % ) , 195 ([M-C(CH3)CH2]^ 13.1 %) , 191 ([M-EtO]'' 8.3 %) , 166 
([M-C(OH)C(CH3)CH2]' ' 100 % ) , 165 ([M-CH(OH)C(CH3)CH2]^ 33.9 %) , 139 
([(EtO)2P(0)H2]^ 33.7 % ) , 138 ([M-C(OH)C(CH3)CH2-C2H4]'' 63.4 %) , 137 
([(EtO)2PO]^ 13.1 % ) , 122 ([M-C(CH3)CH2-EtO-C2H4]^ 17.0 % ) , 121 ([M-C(CH3)CH2-
EtO-Et]^ 15.9 % ) , 111 ([(EtO)(HO)POH2]^ 45.9 %) , 110 ([(EtO)(HO)POH]^ 17.9 %) , 
109 ([(EtO)(HO)PO]* 20.8 % ) , 82 ( [ ( H 0 ) 2 P 0 H ] ^ 25.3 %) . 
HRMS: (EI) Calcd. for C10H21O4P: 236.1177, found: 236.1177. 
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4.2.1.37 2-(3-Diethoxyphosphonyl-l-isopropenylpropoxy)-tetrahydropyran 125 
O 
II 
^O'P-
-o 
Dihydropyran (0.1 ml, 1.10 mmol) was added to a solution of PTSA.H2O (1 mg, 
0.01 mmol) and diethyl 3-hydroxy-4-methylpent-4-enylphosphonate 124 (56 mg, 
0.24 mmol) in CH2CI2 (2 ml). After 25 min, tic indicated that 124 had been consumed 
(petrol / Et20 / IPA, 1.5:1.5:0.5, Rf = 0.36 for 124 and 0.53 for 125, KMn04 stain as 
visualiser), sat. NaHC03(aq) (5 ml) was then added and the mixture extracted into CH2CI2 
(3 X 30 ml). The organic extracts were combined, dried over MgS04 and solvent 
removed under reduced pressure. Purification of the residue over silica gel (neat EtOAc, 
KMn04 stain as visualiser, Rf= 0.3 for 125) afforded 125 (50 mg, 0.16 mmol, 65.9 %) as 
a clear colourless oil. '^P NMR analysis indicated > 99 % purity. NMR resolved two 
diastereoisomers in the approximate ratio 45 : 55. 
' H NMR (400.0 MHz) 6 1.30 (6H, t, VH-H = 7.2 Hz, POCH2CH3), 1.45-2.03 (13H, m, 
PCH2CH2, CH3, O2CHCH2CH2CH2), 3.39-3.50 ( IH, m, 0CHAHBCH2) , 3.78-3.86 ( IH, 
m, 0CHAHBCH2) , 3.98-4.12 (5H, m, POCH2CH3, CH(OTHP)), 4.52n,aj, 4.65,in ( IH, t, 
VH-H = 6.8n,aj, 7.2,in Hz, O2CH), 4.85-4.97 (2H, m, C(CH3)CH2). 
'^C NMR (100.6 MHz) 8 16.4 (2C, d, VC-P = 6.0 Hz, POCH2CH3), 16.8n,aj, 17.9niin(lC, s, 
CH3), 19.4 (IC, s, OCH2CH2CH2), 21.1niin, 22.1„,aj (IC, d, Vc-P = 142.7 Hz, PCH2), 
25.1,in, 26.4maj (IC, d, Vc-P = 4.6 
minj 4.1maj Hz, PCH2CH2), 25.36,in, 25.43n,aj (IC, s, 
OCH2CH2), 30.66n,aj, 30.72n,in (IC, S, O2CHCH2), 61.42^aj, 61.45n,in (2C, d, Vc-P = 6.4 
Hz, POCH2), 62.3n,aj, 62.6n,in (IC, S, OCH2CH2), 78.6„,aj, 79.6n,|n (IC, d, Vc-P = 19.8maj, 
18.7n,in Hz, CH(OTHP)), 94.9n,aj, 97.5n,in (IC, S, O2CH), 112.5„in, 114.5,aj (IC, s, 
C(CH3)CH2), 143.2niaj, 144.3,in (IC, S, C(CH3)CH2). 
^'P NMR (161.9 MHz) 5 33.8min, 33.6maj (s, (EtO)2P(0)CH2CH2CH(OTHP)C(CH3)CH2). 
IR: 3073, 2977, 2941, 2869, 1649, 1442, 1391, 1375, 1351, 1285, 1245, 1202, 1184, 
1163, 1130, 1116, 1097, 1058, 1024, 963,907, 869,813,788,710. 
m/z (CI): 320 ([M]^ 2.2 % ) , 236 ([M-DHP]* 31.0 %) , 235 ([M-DHP-H]* 24.8 %) , 220 
([M-DHP-0]* 33.6 % ) , 219 ([M-OTHP]^ 96.5 %) , 195 ([M-DHP-C(CH3)CH2]'' 13.2 %) , 
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191 ([M-DHP-EtO]^ 21.3 % ) , 166 ([M-C(OTHP)C(CH3)CH2]'" 100 %) , 165 ([M-
CH(OTHP)C(CH3)CH2]^ 17.4 % ) , 163 ([M-OTHP-C(CH3)CH2-CH3]^ 39.1 %) , 139 
([(EtO)2P(0)H2]* 17.5 % ) , 138 ([M-C(OH)C(CH3)CH2-C2H4]^ 35.6 %) , 137 
([(EtO)2PO]^ 4.7 % ) , 111 ([(Et0)(H0)P0H2]* 14.5 %) , 110 ([(EtO)(HO)POH]^ 5.1 %) , 
109 ([(EtO)(HO)PO]^ 12.3 % ) , 85 ([DHP+H]^ 96.3 %) , 81 ([(H0)2P0]'' 38.7 %) . 
HRMS: (CI) Calcd. for (M+1) C15H30O5P: 321.1831, found: 321.1825. 
4.2.1.38 Diethyl 3,4,5-trihydroxy-4-methylpentylphosphonate 122 and 
diethyl 4,5-dihydroxy-4-methyl-3-oxopentylphosphonate 123 
O V OH 
Diethyl 3-hydroxy-4-methylpent-4-enylphosphonate 121 (0.3 g, 1.27 mmol) was added to 
a solution of tetraethylammonium acetate tetrahydrate (81 mg, 0.31 mmol) in acetone 
(2.55 ml) and tert-hutyl hydroperoxide (70 % w/w in water, 0.3 ml, 2.17 mmol). After 
cooling the solufion to 0 °C, OSO4 (~ 0.05 ml, of a 0.39 M solution in PhMe, 
~ 0.02 mmol) was added and after 3 h the solution was allowed to warm to ambient 
temperature. The reaction was monitored by '^P NMR, and after 2 h was quenched at 
0 °C with 10 % Na2S203(aq) (0.63 ml). H2O (5 ml) was then added, the mixture washed 
with CH2CI2 (3 X 30 ml), and the organic washings combined, dried over MgS04 and the 
solvent removed under reduced pressure to afford a crude product 123 (0.108 g, '^P NMR 
analysis indicated > 60 % purity). Purification of 123 over silica gel (IPA / CH2CI2, 1:8, 
Rf = 0.30 for 123, KMn04 stain as visualiser) afforded 123 as a clear colourless oil, > 99 
% pure by '^P NMR analysis. Isolation of 122 was achieved by freeze drying the aqueous 
residue from the extracfion, followed by purification of the residue over silica gel (IPA / 
CH2CI2, 1:4, Rf = 0.27 for 122, KMn04 stain as visualiser) to'afford 122 (62.2 mg, 
0.23 mmol, 18.1 %) as a clear colourless oil. '^ 'P NMR analysis indicated > 99 % purity. 
' H NMR (400.0 MHz) 5 1.06 (3H, s, CH3), 1.33 (6H, t, VH-H = 7.0 Hz, POCH2CH3), 
1.55-2.09 (4H, m, PCH2CH2), 3.40 ( IH, d, VH-H =11.4 Hz, C H A H B O H ) , 3.64 ( IH, d, VH-
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H = 10.8 Hz, C H ( O H ) ) , 3.80 ( IH, d, VH-H = 11-4 Hz, C H A H B O H ) , 3.99-4.10 (4H, m, 
POCH2CH3). 
'^C NMR (100.6 MHz) 6 16.4 (2C, d, VC-P = 6.1 Hz, POCH2CH3), 19.1 (IC, s, CH3), 
22.5 (IC, d, Vc-P = 141.1 Hz, PCH2), 24.1 (IC, d, VC-P = 4.6 Hz, PCH2CH2), 61.9, 62.1 
(2C, d, Vc-P = 6.8, 6.4 Hz, POCH2), 67.8 (IC, s, CH2OH), 74.0 (IC, s, C(0H)(CH3)), 
75.4 (IC, d, Vc-P = 9.9 Hz, CH(OH)). 
^'P NMR (161.9 MHz) 5 35.0 (IP, s, (EtO)2P(0)CH2CH2CH(OH)C(OH)(CH3)CH20H). 
IR: 3379, 3073, 2982, 2935, 2911, 2871, 1731, 1651, 1444, 1393, 1370, 1230, 1163, 
1097, 1059, 1029, 965, 899, 792, 732. 
m/z (EI): 271 ([M+H]'' 22.9 % ) , 239 ([M-CH2OH]* 25.1 %) , 195 ([M-
C(OH)(CH3)CH20H]* 100 % ) , 152 ([(EtO)2P(0)CH3]^ 37.0 % ) , 139 ([(EtO)2P(0)H2]^ 
14.4 % ) , 125 ([(HO)(EtO)P(0)CH3+H]+ 17.5 %) , 121 ([(EtO)2P]^ 28.6 %) . 
HRMS: (CI) Calcd. for (M+1) C10H24O6P; 271.1311, found: 271.1314. 
Data for diethyl 4,5-dihydroxy-4-methyl-3-oxopentylphosphonate 123 
' H NMR (400.0 MHz) § 1,210, 1.214 (3H, s, CH3), 1.26 (6H, t, VH-H = 7.0 Hz, 
POCH2CH3), 1.96-2.06 (2H, m, PCH2), 2.83-2.93 (2H, m, CH2CO), 3.47 ( IH, d, VH-H = 
11.6 Hz, C H A H B O H ) , 3.79 ( IH, d, VH-H =11-6 Hz, C H A H B O H ) , 3.97-4.08 (4H, m, 
POCH2CH3). 
'^C NMR (100.6 MHz) § 16.2 (2C, d, VC-P = 6.1 Hz, POCH2CH3), 19.1 (IC, d, VC-P = 
143.8 Hz, PCH2), 21.1 (IC, s, CH3), 30.5 (IC, d, VC-P = 3.4 Hz, PCH2CH2), 62.0, 61.9 
(2C, d, Vc-P = 6.4 Hz, POCH2), 68.4 (IC, s, CH2OH), 80.2 (IC, s, C(0H)(CH3)), 212.4 
(IC, d, Vc-P = 12.3 Hz, CH2CO). 
^'P NMR (161.9 MHz) 6 33.3 (IP, s, (EtO)2P(0)CH2CH2COC(OH)(CH3)CH20H). 
IR: 3373, 2983, 2932, 2912, 2873, 1716, 1655, 1477, 1445, 1409, 1394, 1369, 1221, 
1163, 1097, 1054, 1027, 970, 849, 794, 731. 
m/z (EI): 269 ([M+H]^ 4.1 %) , 238 ([M-CH20]^ 36.1 %) , 195 
([(EtO)2P(0)CH2CH2CHOH]+ 26.9 % ) , 193 ([(EtO)2P(0)CH2CH2CO]* 44.4 % ) , 166 
([(EtO)2P(0)Et]* 100 % ) , 165 ([(EtO)2P(0)CH2CH2]^ 29.6 %) , 152 ([(EtO)2P(0)CH3]^ 
28.1 % ) , 139 ([(EtO)2POH2]^ 45.9 % ) , 138 ([(EtO)2POH]^ 80.9 %) , 137 ([(EtO)2PO]^ 
75.7 % ) , 125 ([(HO)(EtO)P(0)CH3+H]^ 24.7 % ) , 122 ([(EtO)2PH]^ 24.4 %) , 121 
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([(EtO)2P]^ 29.9 % ) , 111 ([(EtO)(HO)POH2]^ 53.9 %) , 110 ([(EtO)(HO)POH]^ 21.5 %) , 
109 ([(EtO)(HO)PO]+ 29.9 % ) , 82 ([(H0)2P0H]^ 38.5 %) . 
HRMS: (CI) Calcd. for (M+1) C10H22O6P: 269.1154, found: 269.1152. 
4.2.1.39 Disodium 3,4,5-trihydroxy-4-methylpentyIphosphonate 128 and 
sodium, ethyl 3,4,5-trihydroxy-4-methylpentylphosphonate 127 
O \ OH 
-F 
Nad 
NaO'/ 
OH 
Diethyl 3,4,5-trihydroxy-4-methylpentylphosphonate 122 (33.3 mg, 0.123 mmol) in 
0.1 M NaOH(aq) (6.16 ml, 0.616 mmol of NaOH) was heated under reflux for 1 h. After 
cooling, 0.1 M HCl(aq) was added until the solution became neutral. Freeze drying 
afforded a sample of NaCl and the monosodium salt 127, > 99 % pure by -^ 'P NMR. After 
addition of 127 to 2 M NaOH(aq) (7.5 ml, 15 mmol of NaOH) followed by heating under 
reflux for 5 h, the solufion was neutralised with 1 M HCl(aq) followed by freeze drying to 
afford NaCl and the disodium salt 128, > 99 % by ^ 'P NMR analysis. 
' H NMR (400.0 MHz) (D2O) 5 1.30 (3H, s, CH3), 1.67-1.80 (2H, m, PCH2), 1.91-2.10 
(2H, m, PCH2CH2), 3.67-3.82 (3H, m, CH(OH), CH2OH). 
'^P NMR (161.9 MHz) (D2O) 6 27.7 (NaO)2P(0)CH2CH2CH(OH)C(OH)(CH3)CH20H. 
Data for sodium, ethyl 3,4,5-trihydroxy-4-methylpentylphosphonate 127 
' H NMR (250.1 MHz) (D2O) 5 0.99 ( 3 H , s, CH3), 1.11 ( 3 H , t, VH-H = 7.0 Hz, 
POCH2CH3), 1.30-1.54 ( 2 H , m, PCH2), 1.60-1.80 ( 2 H , m, PCH2CH2), 3.35-3.49 ( 3 H , m, 
CH(OH), CH2OH), 3.71-3.63 ( 2 H , m, POCH2CH3). 
'^C NMR (62.9 MHz) 6 18.4 (2C, d, VC-P = 5.7 Hz, POCH2CH3), 20.2 ( I C , s, CH3), 25.9 
( I C , d, Vc-p = 135.9 Hz, PCH2), 26.7 ( I C , d, VC-P = 4.0 Hz, PCH2CH2), 63.0 ( I C , d, VC-P 
= 5.7 Hz, POCH2), 68.9 ( I C , s, CH2OH), 77.3 (IC, d, VC-P = 1.5 Hz, C(0H)(CH3)), 77.6 
( I C , d, Vc-p = 1 5 . 7 Hz, CH(OH)). 
'^P NMR (81.0 MHz) (D2O) 5 29.4 (NaO)2P(0)CH2CH2CH(OH)C(OH)(CH3)CH20H. 
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4.2.1.40 Diethyl (£)-5-hydroxyhex-3-enylphosphonate 130 and 
diethyl 5-hydroxyhexylphosphonate 131 
OH / OH 
NaBH4 (10 mg, 0.26 mmol) was added to a solufion of diethyl r/?A-eo-3,4-dihydroxy-5-
oxohexylphosphonate 82 (50 mg, 0.19 mmol) in MeOH (2 ml) at 0 °C. After 1 h tic 
indicated that 82 had been consumed (CH2CI2 / EtOAc / IPA, 3:1:1, Rf = 0.53 for 130 and 
131, KMn04 stain as visualiser). H2O (2 ml) was added, MeOH removed under reduced 
pressure then the mixture was washed with EtOAc (3 x 25 ml). The organic washings 
were combined, dried over MgS04 and the solvent was removed under reduced pressure, 
affording a crude mixture of 130 and 131 (60.5 mg). '^P NMR analysis indicated > 95 % 
purity of a mixture of 130 and 131 in the ratio of 3:1. 
' H NMR (200.0 MHz) 6 1.26 (3H, d, VH-H = 6.6 Hz, CH(0H)CH3), 1.28 (6H, t, VH-H = 
7.1 Hz, POCH2CH3), 1.60-1.85 (2H, m, PCH2CH2), 2.19-2.50 (2H, m, PCH2CH2), 3.95-
4.12 (4H, m, POCH2), 4.13-4.29 ( IH, m, CH(0H)CH3), 5.45-5.70 ( IH, m, CHCH). 
'^C NMR (50.3 MHz) S 16.4 (2C, d, VC-P = 5.9 Hz, POCH2CH3), 23.3 (IC, s, 
CH(0H)CH3), 25.0 (IC, d, VC-P = 4.4 Hz, PCH2CH2), 25.3 (IC, d, VC-P = 140.6 Hz, 
PCH2), 61.5 (2C, d, Vc-p = 6.2 Hz, POCH2), 68.2 (IC, s, CH(OH)), 128.6 (IC, d, VC-P = 
16.4 Hz, CH2CH), 135.2 (IC, s, CHCH(OH)). 
'^P NMR (81.0 MHz) 6 32.4 (IP, s, (EtO)2P(0)CH2CH2CHCHCH(OH)CH3). 
Data for diethyl 5-hydroxyhexylphosphonate 131 
' H NMR (200.0 MHz) 6 1.14 (3H, d, VH-H = 6.6 Hz, CH(0H)CH3), 1.28 (6H, t, VH-H = 
7.1 Hz, POCH2CH3), 1.60-1.85 (2H, m, PCH2), 2.19-2.50 (6H, m, 
CH2CH2CH2CH(OH)), 3.60-3.80 ( IH, m, CH(0H)CH3), 3.95-4.12 (4H, m, POCH2). 
'^C NMR (50.3 MHz) § 16.4 (2C, d, VC-P = 5.9 Hz, POCH2CH3), 22.4 (IC, d, VC-P = 5.1 
Hz, PCH2CH2), 23.5 (IC, s, CH(0H)CH3), 25.6 (IC, d, 'JC-P = 140.6 Hz, PCH2), 26.6 
(IC, d, Vc-p = 14.3 Hz, CH2CH), 38.6 (IC, s, CHCH(OH)), 61.4 (2C, d, VC-P = 5.5 Hz, 
POCH2), 67.4 (IC, s, CH(OH)). 
^'P NMR (81.0 MHz) 5 33.5 (IP, s, (EtO)2P(0)CH2CH2CH2CH2CH(OH)CH3). 
158 
4.2.1.41 r/i/'eo-5-Acetyl-4-(2-diethoxyphosphonylethyl)-2,2-dimethyl-l,3-
dioxolane 132 
Diethyl 3,4-dihydroxy-5-oxohexylphosphonate 76 (182 mg, 68 mmol) was added to a 
solution of PTSA.H2O (50 mg, 0.26 mmol) in 2,2-dimethoxypropane (15 ml, 0.12 mol). 
After 14 h, tic indicated that 76 had been consumed (CH2CI2 / EtOAc / IPA, 3:1:0.5, 
Rf = 0.65 for 132 and 0.2 for 76, KMn04 stain as visualiser). The solvent was removed 
under reduced pressure then H2O (15 ml) added and the mixture washed with CH2CI2 
(3 X 65 ml). The organic washings were combined, dried over MgS04 and solvent again 
removed under reduced pressure. Purification of the residue over silica gel (Et20 / IPA, 
25:1, Rf = 0.35 for 132, KMn04 stain as visualiser) afforded 132 (166 mg, 54 mmol, 
79.4 %) as a clear colourless oil. '^P NMR analysis indicated > 99 % purity and the 
' H NMR displayed two rotational isomers in an approximate ratio of 3 : 4. 
' H NMR (400.0 M H Z ) 5 1.28maj, 1.29niin (6H, t, VH-H = 7.0 Hz, POCH2CH3), 1.37maj, 
1.38niin, 1.40„aj, 1.41n,in (6H, S, C(CH3)2), 1.73-2.09 (4H, m, PCH2CH2), 2.23™j, 2.24n,in 
(3H, s, COCH3), 3.9Uaj, 3.92n,in ( IH, d, VH-H = 7.6 Hz, CH(OC(CH3)2)COCH3), 3.94-
4.00 ( IH , m, CH2CH(OC(CH3)2)), 4.00-4.11 (4H, m, POCH2). 
'^C NMR (100.6 MHz) 5 16.4 (2C, d, VC-P = 5.7 Hz, POCH2CH3), 21.7 (IC, d, VC-P = 
143.1 Hz, PCH2), 26.1, 26.4 (2C, s, C(CH3)2), 26.7 (IC, d, VC-P = 4.2 Hz, PCH2CH2), 
27.0 (IC, s, COCH3), 61.59, 61.53 (2C, d, VC-P = 5.9 Hz, POCH2), 77.3 (IC, d, VC-P = 
17.6 Hz, CH2CH(OC(CH3)2)), 84.9 (IC, s, CH(OC(CH3)2)COCH3), 110.4 (IC, s, 
C(CH3)2), 208.4 (IC, s, COCH3). 
'^P NMR (161.9 MHz) 6 32.3 (IP, s, (EtO)2P(0)CH2CH2CH(OC(CH3)20)CHCOCH3). 
IR: 2985, 2934, 2909, 2874, 1717 (C=0), 1457, 1442, 1418, 1382, 1372, 1358, 1241, 
1165, 1081, 1056, 1027, 963, 907, 863, 836, 787. 
m/z (EI): 309 ([M+H]^ 0.4 % ) , 293 ([M-CH3]^ 12.5 %) , 265 ([M-COCHs]^ 10.3 %) , 250 
([M-(CH3)2CO]* 20.4 % ) , 247 ([M-O-EtO]^ 27.4 %) , 235 ([M-(CH3)2CO-CH3]* 7.2 %) , 
207 ([M-(CH3)2CO-COCH3]^ 100 % ) , 195 ([(EtO)2P(0)CH2CH2CHO]^ 11.9 %) , 179 
([M-(CH3)2CO-COCH3-C2H4]* 32.9 % ) , 151 ([M-(CH3)2CO-COCH3-2(C2H4)]^ 83.4 %) . 
HRMS: (CI) Calcd. for (M+1) C13H26O6P: 309.1467, found: 309.1470. 
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4.2.1.42 rA/-eo-4-(2-Diethoxyphosphonylethyl)-5-(l(/f,5)-hydroxyethyl)-2,2-
dimethyl-l,3-dioxolane 133 
NaBH4 (16.5 mg, 0.44 mmol) was added to a solution of ^/77-eo-5-acetyl-4-(2-
diethoxyphosphonylethyl)-2,2-dimethyl-l,3-dioxolane 132 (134 mg, 0.43 mmol) in 
MeOH (5 ml) at -20 °C. After 15 min tic indicated that 132 had been consumed (CH2CI2 
/ EtOAc / IPA, 3:1:0.5, Rf = 0.4 for 133 and 0.65 for 132, KMn04 stain as visualiser). 
H2O (15 ml) was added, then the mixture was washed with CH2CI2 (3 x 80 ml). The 
organic washings were combined, dried over MgS04 and the solvent was removed under 
reduced pressure, affording 133 (123 mg, 0.40 mmol, 91.2 %) as a clear colourless oil. 
'^P NMR analysis indicated > 99 % purity of a diastereomeric mixture in the rafio of 3:7. 
' H NMR (400.0 MHz) 6 1.16-1.20 (3H, m, CH(0H)CH3), 1.27 (6H, t, VH-H = 7.0 Hz, 
POCH2CH3), 1.32-1.36 (6H, m, C(CH3)2), 1.69-2.03 (4H, m, PCH2CH2), 3,45-3.51 ( IH, 
m, CH(OC(CH3)2)CH(OH)), 3.64-3.74 ( IH, m, CH(0H)CH3), 3.76-3.90 ( IH, m, 
CH2CH(OC(CH3)2)), 3.96-4.11 (4H, m, POCH2). 
'^C NMR (100.6 MHz) 5 16.3 (2C, d, VC-P = 6.1 Hz, POCH2CH3), 19.3n,in, 19.7niaj (IC, s, 
C(0H)CH3), 21.9m,n, 22.0„aj (IC, d, VC-P = 142.3 Hz, PCH2), 26.5^], 27.4„in (IC, d, VC-P 
= 4.5 Hz, PCH2CH2), 27.0maj+min, 27.2n,in, 27.3niaj (2C, S, C(CH3)2), 61.5-61.6 (2C, m, 
POCH2), 67.1n,aj, 67.8„in (IC, S, CH(OH)), 76.9^aj, 77.7„in (IC, d, Vc-P = 16.4n,aj, 14.6„in 
Hz, CH2CH(OC(CH3)2)), 84.0n,in, 84.5maj (IC, s, CH(OC(CH3)2)CH(OH)), 108.5,in, 
108.9„aj( lC, S, C(CH3)2). 
•^P NMR (161.9 MHz) 8 32.8maj, 33.4min (IP, s, 
(EtO)2P(0)CH2CH2CH(OC(CH3)20)CHCH(OH)CH3). 
IR: 3390, 2984, 2934, 2908, 2875, 1654, 1443, 1379, 1370, 1236, 1178, 1163, 1096, 
1058, 1029, 964, 906, 871, 827, 806, 789. 
m/z (CI CH4): 351 ([M+C3H5]" 10.4 % ) , 339 ([M+Et]^ 25.5 % ) , 312 ([M+2H]^ 32.8 %) , 
311 ([M+H]"" 100 % ) , 295 ([M-CH3]^ 18.1 % ) , 281 ([M-Et]"" 8.9 %) , 265 ([M-
CH(0H)CH3]'" 9.2 % ) , 253 ([M-(CH3)2CO+H]'^ 74.0 %) , 235 ([M-(CH3)2CO-OH]^ 54.3 
% ) , 209 ([M-(CH3)2CO-COCH3]^ 21.1 % ) , 207 ([M-(CH3)2CO-CH(OH)CH3]^ 19.7 %) , 
160 
195 ([(EtO)2P(0)CH2CH2CHO]'" 17.8 % ) , 179 ([M-(CH3)2CO-CH(OH)CH3-C2H4]^ 5.9 
% ) , 139 ([(EtO)2POH2)]* 16.1 % ) . 
HRMS: (CI) Calcd. for (M+1) C,3H2706P: 311.1624, found: 311.1625. 
4.2.1.43 Disodium /^/•eo-5(/fyS)-3,4,5-trihydroxyhexylphosphonate 134 
O QH 
N a O ' P - ^ ^ ^ ^ ^ ^ 
NaO i T 
OH OH 
TMSBr (0.3 ml, 2.32 mmol) was added to /^A-eo-4-(2-diethoxyphosphonylethyl)-5-
(l(i?,5)-hydroxyethyl)-2,2-dimethyl-l,3-dioxolane 133 (56 mg, 0.18 mmol) and after 4 h, 
H2O (10 ml) was added. After 14 h I M NaOH(aq) was added until the solution was 
neutral. Freeze drying afforded (59 mg) of 134 and NaBr as a white amorphous solid 
(mp dec. ~ 250 ° C ) . '^P NMR analysis indicated ~ 85 % purity, with the main impurity 
being sodium, ethyl ^/zreo-5(i?,5)-3,4,5-trihydroxyhexylphosphonate 135, ~ 12 %. 
' H and '^C NMR analysis of 134 indicated a diastereomeric mixture in the ratio of 3:7. 
' H NMR (400.0 MHz) (D2O) 5 1.04maj, 1.06mi„ ( 3 H , d, VH -H - 6.4niaj, 7,6min Hz, 
CH(0H)CH3), 1.33-1.66 ( 4 H , m, PCH2CH2), 3.45-3.51 ( IH, m, CH(0H)CH3), 3.15maj, 
3.19min ( I H , dd, VH-H = 5.6maj, 6.8min Hz, VH-H = 3.6maj, 3.2min Hz, 
CH(OH)CH(OH)CH(OH)), 3.52-3.58niaj, 3.58-3.63n,in ( IH, m, CH2CH(0H)) , 3.67-3.79 
( l H , m , CH(0H)CH3). 
'^C NMR (100.6 MHz) (D2O) 5 18.1min, 18.5nnaj ( I C , s, C(0H)CH3), 24.6 ( I C , d, VC-P = 
133.9 Hz, PCH2), 27.6„,in, 27.5^aj ( I C , d, VC-P = 3.7 Hz, PCH2CH2), 67.4niin, 68.5n,aj ( I C , 
S, CH(0H)CH3), 71.2n,in, 72.3n,aj ( I C , d, Vc-P = 16.8 Hz, CH2CH(0H)) , 76.6n,in, 77.0n,aj 
(IC, s, CH(OH)CH(OH)CH(OH)). 
'^P NMR (161.9MHz) (D2O) 6 26. 
29.2(NaO)(EtO)P(0)CH2CH2CH(OH)CH(OH)CH(OH)CH3). 
z) 3 (NaO)2P(0)CH2CH2CH(OH)CH(OH)CH(OH)CH3), 
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4.2.2 Experimental section for Chapter 2 
Work carried out by Hannah F. Sore (4"^  year MSci student). 
4.2.2.1 2-(Diethoxyphosphonyl)propanamide'^^ 137 
O 
f 0 
Acrylamide (3.55 g, 0.05 mol) was added to triethyl phosphite (10.72 ml, 0.06 mmol) and 
phenol (12.5 g, 0.13 mol) and the mixture heated at 100 °C for 1 d. After cooling, the 
residue was purified over silica gel (EtOAc / IPA, 3:1, KMn04 stain as visualiser) 
affording 137 (6.03 g, 0.03 mol, 57.8 %) as a pale yellow solid (mp 76.0-76.5 °C, 
Lit."*^ 74-76 °C). '^P NMR analysis indicated > 99 % purity. 
' H NMR (400.0 MHz) 5 1.33 (6H, t, VH-H = 7.0 Hz, CH3), 2.04-2.13 (2H, m, PCH2), 
2.49-2.58 (2H, m, PCH2CH2), 4.04-4.15 (4H, m, OCH2), 5.83 (2H, s, NH2). 
'^C NMR (100.6 MHz) 5 16.4 (2C, d, VC-P = 5.7 Hz, CH3) , 20.9 (IC, d, 'Jc-p = 143.8 Hz, 
PCH2), 28.5 (IC, d, Vc-p = 4.2 Hz, PCH2CH2), 61.9 (2C, d, VC-P = 6.5 Hz, OCH2), 173.2 
(IC, d, Vc-p = 14.9 Hz, CONH2). 
'^P NMR (161.9 MHz) S 36.2 (IP, s, (EtO)2P(0)CH2CH2CONH2). 
IR: 3375, 3200, 2983, 2931, 1672, 1629, 1437, 1418, 1397, 1313, 1282, 1231, 1159, 
1024, 979, 885, 830, 803, 760, 669. 
m/z (EI): 209 ([M]^ 4.5 % ) , 166 ([M-CONH]^ 100 %) , 165 ([M-C0NH2]^ 37.8 %) , 164 
([M-HC0NH2]^ 22.9 % ) , 139 ([(EtO)2POH2]'" 21.9 %) , 138 ([(EtO)2POH]* 62.1 %) , 137 
([(EtO)2PO]"' 31.1 % ) , 136 ([M-Et,C0NH2]* 47.9 %) , 122 ([M-Et,-CH2CONH2]^ 12.4 
% ) , 111 ([(EtO)P(OH)(OH2)]^ 48.3 % ) , 110 ([(EtO)P(OH)2]'' 20.5 %) , 109 
([(EtO)PO(OH)]^ 34.0 % ) , 83 ([(H0)3PH]^ 14.0 %) , 82 ([(H0)3P]^ 35.8 %) , 81 
([(H0)2P0]^ 21.9 % ) , 73 ([CH2CH2CONH2]^ 17.5 %) , 72 ([M-P0(0Et)2)]^ 16.1 %) , 65 
([(H0)2P]^ 20.3 % ) , 55 ([(CHzCHCO]^ 25.9 % ) , 44 ([(C0NH2]^ 22.0 %) . 
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4.2.2.2 7V-(3-Diethoxyphosphonyl)propionyl-acetamide 54 
9 H 
/ 0 0 
2-(Diethoxyphosphonyl)propanamide (0.50 g, 2.39 mmol) 137 was added to acetic 
anhydride (1.13 ml, 12.0 mmol) and cone. H2SO4 (1 drop) and heated at 84 °C for 2 h. 
The mixture was then added to H2O (10 ml) at 0 °C and was washed with CH2CI2 
(3 X 20 ml). The organic washings were combined, washed with 5 % NaHC03(aq) until 
neutral, and then washed with brine (10 ml). The organic washings were then dried over 
MgS04 and solvent was removed under reduced pressure. Purification of the residue by 
kugelrohr bulb to bulb distillation (~ 30 °C / 0.1 mbar) afforded 54 (0.29 g, 1.12 mmol, 
46.9 %) as a viscous colourless oil which solidified on standing to afford white crystals 
(mp 48-52 °C). '^P NMR analysis indicated > 93 % purity. 
' H NMR (400.0 MHz) 5 1.32 (6H, t, VH-H = 7.0 Hz, CH3), 2.04-2.14 (2H, m, PCH2), 2.33 
(3H, s, COCH3), 2.78-2.87 (2H, m, PCH2CH2), 4.05-4.17 (4H, m, OCH2), 9.25 ( IH, s, 
NH). 
'^C NMR (100.6 MHz) S 16.4 (2C, d, %.? = 6.1 Hz, CH3), 20.1 (IC, d, 'Jc-p = 144.5 Hz, 
PCH2), 25.1 (IC, s, COCH3), 30.3 (IC, d, Vc-P = 3.0 Hz, PCH2CH2), 62.0 (2C, d, VC-P = 
6.5 Hz, OCH2), 171.6 (IC, s , N H C 0 C H 3 ) 171.8 (IC, d, VC.P= 16.8 Hz, PCH2CH2CO). 
'^P NMR (161.9 MHz) 6 31.8 (IP, s, (EtO)2P(0)CH2CH2CONHCOCH3). 
IR: 3161, 2985, 2934, 1755, 1705, 1514, 1443, 1393, 1375, 1229, 1098, 1026, 975, 797, 
708,610. 
m/z (EI): 252 ([M+H]"^ 2.2 %) , 236 ([M-CH3]^ 12.6 %) , 166 ([M-C0NC0CH3]^ 70.7 %) , 
165 ([M-CONHCOCHs]^ 55.5 %) , 164 ([M-HCONHCOCHa]"" 38.4 %) , 138 
([(EtO)2POH]^ 57.5 % ) , 137 ([(EtO)2PO]^ 93.4 % ) , 136 ([M-Et,C0NHC0CH3]^ 54.6 %) , 
111 ([(EtO)P(OH)(OH2)]'' 35.9 % ) , 109 ([(EtO)PO(OH)]^ 38.5 %) , 86 ([C0NHC0CH3]'' 
36.6 % ) , 84 ([(H0)3PH]^ 57.7 %) , 65 ([(H0)2P]^ 19.7 %) , 55 ([(CHiCHCO]^ 34.5 %) . 
Elemental Analysis: Calcd. for C9H18NO5P: C: 43.0, H: 7.2, N: 5.6 %, found: C: 42.3, H: 
7.2, N : 5.5 %. 
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4,2.2.3 7V-(3-DisodiumphosphonyI)propionyl-acetamide 138 
? H 
NaO T T 
0 0 
TMSBr (3 equivalents) was added to 7V-(3-Disodiumphosphonyl)propionyl-acetamide 54 
(1 equivalent) and 2 h later volatiles were removed under reduced presseure. H2O (4 ml) 
was then added and the reaction immediately neutralised with NaOH(aq). Freeze drying 
afforded impure 138 as a white solid. '^P NMR analysis indicated ~ 80 % purity. 
' H NMR (400.0 MHz) S 1.62-1.73 (2H, m, PCH2), 2.09 (3H, s, COCH3), 2.48-2.56 (2H, 
m, PCH2CH2). 
'^ C NMR (100.6 MHz) 5 23.3 (IC, d, 'Jc-p = 133.5 Hz, PCH2), 24.4 (IC, s, COCH3), 
32.3 (IC, d, Vc-p = 2.0 Hz, PCH2CH2), 174.5 (IC, s, NHCOCH3) 175.9 (IC, d, VC-P = 
17.5Hz,PCH2CH2CO). 
'^P NMR (161.9 MHz) S 23.0 (IP, s, (NaO)2P(0)CH2CH2CONHCOCH3). 
IR: 3451, 1755, 1639, 1618, 1547,1505,1410,1377,1279, 1235, 1155, 1135, 1061, 977, 
918. 
m/z : Positive or negative FAB did not afford any molecular ion information. 
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4.2.3 Experimental section for Chapter 3 
4.2.3.1 2-(Fluoromethyl)pyridine^^^ 141 
N 
K2CO3 (2.51 g, 18.2 mmol) was added to a solution of 2-(chloromethyl)pyridine 
hydrochloride (5.03 g, 30.7 mmol) in EhO (50 ml) and H2O (20 ml). After 10 min the 
mixture was extracted into Et20 (3 x 50 ml), the extracts combined, dried over MgS04 
and solvent removed under reduced pressure. The organic residue was added to a solution 
of 18-crown-6 (0.52 g, 2.0 mmol) and KF (4.84 g, 83.3 mmol) in CH3CN (40 ml) then 
heated under reflux for 8 d (reaction progress monitored by ' H NMR). After cooling, the 
reaction was quenched with sat. NaHC03(aq) (70 ml), the aqueous layer separated, and 
then extracted into Et20 (3 x 80 ml). The organic extracts were combined, washed with 
H2O (3 x 100 ml), then dried over MgS04. The solvent was removed under reduced 
pressure and distillation (64-66 °C / 15 mmHg, Lit.'^^ 80 °C / 12 mmHg) afforded 141 
(0.47 g, 4.2 mmol, 13.8 % ) , as a clear colourless oil. GCMS analysis indicated > 99 % 
purity. 
' H NMR (400.0 MHz) 5 5.44 (2H, d, VH-F = 47.1 Hz, CH2F), 7.19 ( IH, dd, VH4-H5 = 7.4 
Hz, VH5-H6 - 5.1 Hz, H5), 7.40 ( IH, d, VH3-H4 = 7.9 Hz, H3), 7.69 ( IH, dt, VH3-H4 = 7.9 
Hz, VH4-H5 = 7.4 Hz, VH4-H6 = 1.5 Hz, H4), 8.53 ( IH, d, VH5-H6 = 5.1 Hz, H6). 
'^C NMR (100.6 MHz) 6 84.3 (IC, d, 'JC-F = 169.7 Hz, Ca), 120.4 (IC, d, VC-F = 5.7 Hz, 
C3), 122.9 (IC, d, Vc-F = 1.1 Hz, C5), 136.7 (IC, s, C4), 149.1 (IC, s, C6), 156.2 (IC, d, 
Vc.F = 21.4 Hz, C2). 
'^F NMR (376.3 MHz) 5 -220.8 (IF, t, VH-F = 47.1 Hz, CH2F, Lit.'^^ 5 -203.4, VH-F = 
47.1 Hz). 
IR: (GG) 296l(m), 2360(m), 2340(m), 1259(s), 1072(s), 1014(s), 796(s). 
m/z (EI): 111 ( [ M f 100%). 
165 
4.2.3.2 Bis-2,6-(fluoromethyl)pyridine 143 
N 
Bis-2,6-(chloromethyl)pyridine (3.88 g, 22.1 mmol) in CH3CN (20 ml) was added to a 
solution of 18-crown-6 (0.30 g, 1.1 mmol) and KF (5.60 g, 96.4 mmol) in CH3CN (40 ml) 
and heated under reflux for 10 d (reaction progress monitored by ' H NMR). After 
cooling, the reaction was quenched with sat. NaHC03(aq) (100 ml), the aqueous layer 
separated, and then extracted into Et20 (3 x 100 ml). The organic extracts were 
combined, washed with H2O (3 x 150 ml), then dried over MgS04. The solvent was 
removed under reduced pressure and distillation (54-57 °C / 15 mmHg) afforded 143 
(1.58 g, 11.0 mmol, 50.0 % ) , as clear colourless crystals (mp 34.5-35.5 °C). GCMS 
analysis indicated > 99 % purity. Recrystallisation from acetone / petrol at -20 °C 
afforded crystals suitable for X-ray analysis. 
' H NMR (400.0 MHz) 5 5.46 (2H, d, VH-F = 46.7 Hz, CH2F), 7.41 (2H, d, VH-H = 7.7 Hz, 
H3), 7.81 ( IH , t, VH-H = 7.7 Hz, H4). 
'^C NMR (100.6 MHz) 5 84.1 (2C, d, 'JC-F = 169.7 Hz, Ca), 119.8 (2C, d, VC-F = 5.7 Hz, 
C3), 137.8 (IC, s, C4), 156.0 (2C, d, VC.F = 20.3 HZ, C2). 
'^ F NMR (376.3 MHz) 5 -221.4 (IF, t, VH-F = 46.7 Hz, CH2F). 
IR: (GG) 2953(w), 1597(s), 1582(s), 1460(s), 1449(s), 1368(s), 1026(s), 994(s), 898(s), 
786(s),610(s). 
m/z (EI): 142.75 ( [M]" 100%). 
HRMS: (EI) Calcd. for C7H7F2N: 143.0546, found: 143.0546. 
4.2.3.3 2-(Fluoromethyl)quinoline^^^ 144 
K2CO3 (1.69 g, 12.2 mmol) was added to a solution of 2-(chloromethyl)quinoIine 
hydrochloride (5.08 g, 23.7 mmol) in EtsO (50 ml) and H2O (10 ml). After 10 min the 
mixture was extracted into Et20 (3 x 50 ml), the extracts combined, dried over MgS04 
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and solvent removed under reduced pressure. The organic residue (3.84 g) was added to a 
solution of 18-crown-6 (0.31 g, 1.2 mmol) and KF (2.58 g, 44.4 mmol) in CH3CN (45 ml) 
then heated under reflux for 14 d (reaction progress monitored by ' H NMR). After 
cooling the reaction was quenched with sat. NaHC03(aq) (70 ml), the aqueous layer 
separated and extracted into Et20 (3 x 80 ml). The organic extracts were combined, 
washed with H2O (3 x 90 ml), then dried over MgS04. The solvent was removed under 
reduced pressure followed by fractional distillation using a Vigreux column. The first 
fraction (118-120 °C / 15 mmHg, Lit.'^^ 126 °C / 14 mmHg) afforded 144 (1.65 g, 
47.3 % ) , GCMS analysis indicated > 97 % purity, main impurity 
2-(chloromethyl)quinoline. The second fraction (45-50 °C / 0.01 mbar) afforded 143 
(0.93 g, 26.7 % ) , GCMS analysis indicated approximately a 1 : 4 ratio of 
2-(chloromethyl)quinoline : 144, to afford 144 in total yield of about 70 %. On standing 
both fractions slowly decomposed to give dark red oils. Crystallisation from MeOH / 
H2O in a sealed system at -10 °C afforded clear colourless needle shaped crystals 
(mp 39-40 °C) of monohydrated 147 suitable for X-ray analysis. 
' H NMR (400.0 MHz) 5 5.63 (2H, d, VH-F = 47.0 Hz, CH2F), 7.50 ( IH, t, VH8-H9 = 8.2 
Hz, VH7-H8 = 7.0 Hz, H8), 7.54 ( IH, d, ^J^.m = 8.6 Hz, H3), 7.67 ( IH, t, VHS-H? = 8.2 Hz, 
'JH7-H8 = 7.0 Hz, H7), 7.77 ( IH, d, VH8-H9 = 8.2 Hz, H9), 8.03 ( IH, d, VH6.H7 = 8.2 Hz, 
H6), 8.15 ( IH, d, VH3-H4 = 8.6 Hz, H4). 
'^C NMR (100.6 MHz) 6 84.8 (IC, d, 'JC-F =170.1 Hz, Ca), 118.0 (IC, d, VC-F = 4.9 Hz, 
C3), 127.5 (IC, s, C5), 126.6 (IC, s, C7), 127.6 (IC, s, C8), 128.9 (IC, s, C6), 129.8 (IC, 
s, C9), 136.9 (IC, s, C4), 147.2 (IC, s, CIO), 156.6 (IC, d, VC-F = 21.7 Hz, C2). 
'^ F NMR (376.3 MHz) 5 -221.3 (IF, t, VH-F = 47.0 Hz, CH2F). 
IR: (GG) 1600(m), 1506(s), 1428(m), 1375(m), 1032(s), 986(s), 821(s), 782(s), 750(s), 
726(s),616(s). 
m/z (EI): 161 ([M]+ 100%). 
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4.2.3.4 2-(Fluoromethyl)pyridine-Af-oxide 145 
I 
o-
2-(Fluoromethyl)pyridine (153 mg, 1.38 mmol) was added to a mixture of glacial acetic 
acid (1 ml) and H2O2 (27.5 % w/w in water, 0.5 ml) and the mixture then heated for 2 h at 
70 °C. After cooling, H2O (15 ml) was added and the volume reduced to half under 
reduced pressure. More H2O (15 ml) was added and the volume reduced to half again 
under reduced pressure. The residue was taken up in CHCI3 (5 ml), and then shaken with 
sat. K2C03(aq) Until effervescence ceased. The organic layer was then separated, dried 
over MgS04 and the solvent was removed under reduced pressure followed by kugelrohr 
bulb to bulb distillation (~ 100 °C / 0.01 mbar) to afford 145 (81 mg, 0.64 mmol, 46.3 %) 
as a clear yellow oil. GCMS analysis indicated > 99 % purity. 
' H NMR (400.0 MHz) 5 5.65 (2H, d, VH-F = 47.0 Hz, CH2F), 7.28 ( IH, t, VH4-H5 = 7.3 
Hz, VH5-H6 = 6.6 Hz, H5), 7.37 ( IH, t, VH3.H4 = 8.0 Hz, VH4-H5 = 7.3 Hz, H4), 7.49 ( IH, d, 
VH3-H4 = 8.0 Hz, H3), 8.22 ( IH, d, VH5-H6 = 6.6 Hz, H6). 
^^ C NMR (100.6 MHz) 5 78.8 (IC, d, 'JC-F = 170.9 Hz, Ca), 122.4 (IC, d, VC-F = 8.3 Hz, 
C3), 124.6 (IC, s, C5), 126.0 (IC, s, C4), 139.0 (IC, s, C6), 147.9 (IC, d, VC-F = 26.7 
Hz, C2). 
'^ F NMR (376.3 MHz) 5 -234.3 (IF, t, VH-F = 47.1 Hz, CH2F). 
IR: (GG) 3088(m), 1494(s), 1434(s), 1368(s), 1222(s), 1028(s), 846(s), 767(s). 
m/z (EI): 110 ([M-OH]* 100 % ) , 127 ([M]+ 49.6 %) . 
HRMS: (EI) Calcd. for CeHeFNO: 127.0433, found: 127.0433. 
Elemental Analysis: Calcd. for CeHgFNO: C: 56.7, H: 4.8, N: 11.0 %, found: C: 56.6, 
H: 4.7, N : 10.9%. 
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4.2.3.5 Bis-2,6-(fluoromethyl)pyridine-7V-oxide 146 
N+ 
I 
o-
Bis-2,6-(fluoromethyl)pyridine (230 mg, 1.61 mmol) was added to a mixture of glacial 
acetic acid (2 ml) and H2O2 (27.5 % w/w in water, 1 ml) and the mixture then heated for 
3 h at 70 °C. After cooling, H2O (30 ml) was added and the volume reduced to half under 
reduced pressure. More H2O (30 ml) was added and the volume reduced to half again 
under reduced pressure. The residue was taken up in CH2CI2 (20ml), then shaken with 
sat. K2C03(aq) Until effervescence ceased. The organic layer was then separated, dried 
over MgS04 and the solvent was removed under reduced pressure to yield 146 (156 mg, 
61.0 %)) as a white amorphous solid (pure by GCMS). Recrystallisation from Et20 
afforded clear colourless crystals (mp 80.5-81.5 °C) suitable for X-ray analysis. 
' H NMR (400.0 MHz) 6 5.66 (2H, d, VH-F = 46.4 Hz, CH2F), 7.41-7.50 (3H, m, H3, 4, 5). 
'^C NMR (100.6 MHz) S 78.6 (2C, d, 'JC-F = 171.4 Hz, Ca), 121.1 (2C, d, VC-F = 8.0 Hz, 
C3), 125.9 (IC, s, C4), 147.0 (2C, d, VC-F = 26.4 Hz, C2). 
'^ F NMR (376.3 MHz) 5 -234.3 (2F, t, VH-F = 46.8 Hz, CH2F). 
IR: (KBr) 3092, 3049, 2972, 2938, 2455, 1993, 1504, 1456, 1420, 1367, 1266, 1257, 
1233, 1221, 1056, 1018, 903, 848, 801, 631, 550. 
m/z (EI): 142 ([M-OH]^ 100 % ) , 159 ([M]^ 40.7 %) . 
HRMS: (EI) Calcd. for C7H7F2NO: 159.0495, found: 159.0495. 
4.2.3.6 Benzyl fluoride'^' 148 
Tetrabutylammonium bromide (5.42 g, 16.8 mmol) and CsF (25.54g, 168 mmol) were 
mixed intimately with a pestal and morter then added to benzyl bromide 
(10 ml, 84.1 mmol) and heated for 3 h and 15 min at 85 °C. After cooling, the mixture 
was filtered and washed with Et20 (3 x 100 ml). The filtrate and washings were then 
combined, and the solvent was removed under reduced pressure. Distillation (25-30 °C / 
15 mmHg, Lit.'*^ 41 °C / 17 mmHg) afforded 148 (5.94 g, 53.9 mmol, 64.2 %) as a clear 
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colourless oil. Redistillation (collecting the middle fraction (34 °C / 15 mmHg), gave a 
sample of 148 which was > 99.9 % pure by GCMS analysis) provided a sample suitable 
for low temperature X-ray analysis. 
' H NMR (400.0 MHz) 5 5.40 (2H, d, VH-F - 47.8 Hz, CH2F), 7.34-7.46 (5H, m, Ph). 
'^C NMR (100.6 MHz) 5 84.6 (IC, d, 'JC-F = 165.9 Hz, CH2F), 127.5 (2C, d, J^C-F = 5.7 
Hz, C2), 128.6 (2C, d, VC-F = 1.1 Hz, €3), 128.7 (IC, d, VC-F = 3.1 Hz, C4), 136.2 (IC, 
d, VC.F= 16.8Hz ,Cl). 
'^ F NMR (376.3 MHz) 6 -203.8 (IF, t, VH-F 47.8 Hz, PhCHzF). 
IR: 3090, 3067, 3035, 2959, 2897, 1955, 1879, 1813, 1589, 1498, 1455, 1379, 1313, 
1216, 1080, 983, 913, 820, 745, 697. 
m/z (EI): 111 ([M+H]* 3.1 % ) , 110 ([M]' ' 48.6 %) , 109 ([M-H]^ 100 %) , 91 ( [M-Ff 3.9 
% ) , 83 (8.9 % ) , 63 (5.9 % ) , 51 (5.3 %) . 
4.2.3.7 4-Bromobenzyl fluoride'*^ 149 
Diethylaminosulphur trifluoride (1.20 g, 7.44 mmol) was added dropwise to a solution of 
4-bromobenzyl alcohol 151 (1.00 g, 5.35 mmol) in CH2CI2 (15 ml) at -78 °C. After 
30 min H2O (30 ml) was added, the organic phase separated then washed with CH2CI2 
(2 X 30 ml). The organic phase was then dried over MgS04 and the solvent removed 
under reduced pressure. Purification of the residue over silica gel (petrol / EtOAc, 10 :1 , 
Rf = 0.1 for 151, and 0.6 for 149, UV lamp or KMn04 stain as visualiser) afforded 149 
(0.30 g, 1.60 mmol, 30 % yield) as a white waxy solid (mp 33 °C, Lit.'^^ 33 °C). Slow 
cooling of a neat liquid sample afforded crystals suitable for X-ray analysis. 
' H NMR (299.9 MHz) 6 5.33 (2H, d, VH-F = 47.6 Hz, CH2F), 7.23-7.27 (2H, m, Ph), 
7.51-7.54 (2H, m, Ph). 
'^C NMR (75.4 MHz) § 83.7 (IC, d, VC-F = 167.4 Hz, CH2F), 122.7 (IC, d, VC-F = 3.7 
Hz, C4), 129.0 (2C, d, VC-F = 6.2 Hz, C2), 131.7 (2C, d, VC-F = 1.1 Hz, C3), 135.1 (IC, 
d, VC-F = 17.3 Hz, C I ) . 
'^F NMR (188.2 MHz) 5 -208.0 (IF, t, VH-F = 47.6 Hz, CH2F). 
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IR: 3047, 3032, 2960, 2897, 1901, 1785, 1595, 1489, 1467, 1408, 1374, 1305, 1213, 
1106, 1071, 1011,987, 944, 837, 799, 630. 
4.2.3.8 r/'fl«5-4-fluoromethylstilbene 150 
Diethylaminosulphur trifluoride (142 mg, 0.88 mmol) was added dropwise to a solution 
of rra/75-4-hydroxymethylstilbene 152 (169 mg, 0.80 mmol) in THE (5 ml) at -78 °C. 
After 30 min H2O (10 ml) was added, the mixture washed with CH2CI2 (3 x 30 ml), the 
organic washings combined, dried over MgS04 and then solvent removed under reduced 
pressure. Purification over silica gel (neat CH2CI2, Rf = 0.2 for 152, and 0.85 for 150, UV 
lamp or KMn04 stain as visualiser) gave 150 (41 mg, 24 % yield for 150). 
Recrystallisation from CHCi3 afforded a sample > 99 %> pure by NMR. Mp 131-132 °C 
from CH3CN / H2O. 
' H NMR (400.0 MHz) § 5.31 (2H, d, VH-F = 47.6 Hz, CH2F), 7.06 (2H, d, VH-H = 2.0 Hz, 
PhCHCHPhCH2F), 7.18-7.50 (9H, m, Ph). 
'^C NMR (100.6 MHz) 5 84.4 (IC, d, 'JC-F = 165.9 Hz, Ca), 126.6 (2C, s, C8), 126.7 
(2C, d, Vc-F = 1.5 Hz, C2), 127.8 (IC, s, CIO), 128.0 (IC, s, C5), 128.1 (IC, s, C6), 
128.7 (2C, s, C9), 129.4 (2C, d, VC-F = 1.5 Hz, C3), 135.3 (IC, d, VC-F = 16.8 Hz, CI ) , 
137.1 (IC, s, C7), 137.9 (IC, d, VC-F = 3.4 Hz, C4). 
'^F NMR (376.3 MHz) § -206.3 (IF, t, ^H-F = 47.6 Hz, PhCHCHPhCH2F). 
IR: 3027, 2957, 2895, 1607, 1510, 1492, 1450, 1419, 1372, 1215, 1179, 973, 948, 839, 
824, 785, 759, 694, 625, 567, 522. 
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4.2.3.9 /V-(2-FIuoroethyl)-3,5-dinitrobenzamide 155 
O 
0,N 
K2CO3 (282 mg, 2.04 mmol) in H2O (1 ml) was added to 2-fluoroethylamine 
hydrochloride (101 mg, 1.01 mmol) and 3,5-dinitrobenzoyl chloride (219 mg, 1.01 mmol) 
in benzene (3 ml) and CH2CI2 (3 ml). The reaction was followed by tic (EtOAc / petrol, 
1:1, Rf = 0.44 for 155, KMn04 stain as visualiser). After 90 min CH2CI2 (10 ml), 10 % 
K2C03(aq) (5 ml) and MeOH (1 ml) were added, the organic layer separated, CH2CI2 
(10 ml) and 10 % K2C03(aq) (15 ml) added. The organic layer was separated again, then 
washed with H2O (10 ml), dried over MgS04 and the solvent removed under reduced 
pressure to afford crude 155 as a white solid (43 mg). Recrystallisation twice from 
CH2CI2 / CHCI3 afforded 155 as clear colourless needle shaped crystals (10 mg, 
0.04 mmol, 3.8 %) suitable for X-ray analysis (mp 139-149 °C, from CH2CI2 / CHCI3). 
' H NMR (400.0 MHz) 5 3.76 (2H, dq, VH-F = 27.9 Hz, VH-H = 5.1 Hz, NCH2), 4.60 (2H, 
dt, VH-F - 47.3 Hz, VH-H = 4.7 Hz, CH2F), 8.37 (IH, s, NH), 9.05 (2H, d, VH-H = 2.0 Hz, 
H2), 9.12 ( I H , t, VH-H = 2.0 Hz, H4). 
'^C NMR (100.6 MHz) 6 40.9 (IC, d, VC-F = 19.8 Hz, NCH2), 82.1 (IC, d, VC-F = 167.9 
Hz, CH2F), 121.0 (IC, s, C4), 127.6 (2C, s, C2), 137.5 (IC, s, CI ) , 148.5 (2C, s, C3), 
163.3 (IC, s, CO). 
'^F NMR (376.3 MHz) 5 -224.0 (IF, tt, VH-F = 47.2 Hz, VH-F = 27.8 Hz, CH2CH2F). 
IR: (KBr) 3312, 3086, 3010, 2982, 2950, 2920, 2880, 1864, 1646, 1627, 1539, 1474, 
1452, 1432, 1347, 1325, 1297, 1191, 1083, 1039, 936, 923, 863, 732, 724. 
m/z (EI): 257 ([M]^ 18.5 % ) , 237 ([M-HF]^ 11.8 %) , 224 ([M-CH2F]* 30.7 %) , 220 ([M-
HF-OH]^ 10.7 % ) , 207 ([M-NO-HF]^ 29.8 % ) , 195 ([M-HNCH2CH2F]^ 100 %) , 149 ([M-
HNCH2CH2F-N02]^ 39.0 % ) , 103 ([M-HNCH2CH2F-2(N02)]'' 11.3 % ) , 75 ([C6H3)]^ 
44.7 % ) . 
Elemental Analysis: Calcd. for C9H8FN3O5: C: 42.0, H: 3.1, N : 16.3 %, found: C: 42.0, 
H: 3.1, N : 16.0%. 
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4.2.3.10 A^-(2-Fluoroethyl)-4-nitrobenzamide 156 
O 
0,N 
K2CO3 (290 mg, 2.10 mmol) in H2O (2.5 ml) was added to 2-fluoroethylamine 
hydrochloride (10 mg, 1.00 mmol) and 4-nitrobenzoyl chloride (200 mg, 1.08 mmol) in 
benzene (3 ml) and CH2CI2 (0.5 ml). After 2 h the mixture was filtered, washed with H2O 
(30 ml), 10 % K2C03(aq) (15 ml), then additional H2O (20 ml), to afford crude 156 
(43 mg). Crystallisation from CH2CI2 afforded 156 as clear colourless needle shaped 
crystals (13.6 mg, 0.06 mmol, 6.4 %) . Recrystallisation from THE afforded crystals 
suitable for X-ray analysis (mp 123-124 °C, from THE). 
' H NMR (400.0 MHz) 5 3.82 (2H, dq, VH-F = 28.4 Hz, VH-H = 5.1 Hz, NCH2), 4.63 (2H, 
dt, VH-F = 47.3 Hz, VH-H = 4.7 Hz, CH2F), 6.59 ( IH, s, NH), 7.94-7.98 (2H, m, H2), 8.28-
8.33 (2H, m, H3). 
'^ C NMR (100.6 MHz) 5 40.7 (IC, d, VC-F = 19.4 Hz, NCH2), 82.5 (IC, d, 'JC-F = 167.1 
Hz, CH2F), 123.9 (2C, s, C3), 128.2 (2C, s, C2), 139.6 (IC, s, CI ) , 149.7 (IC, s, C4), 
165.6 (IC, s, CO). 
'^F NMR (376.3 MHz) 5 -224.7 (IF, tt, VH-F = 47.2 Hz, VH-F = 28.2 Hz, CH2CH2F). 
IR: (KBr) 3334, 3109, 3085, 2960, 2934, 1941, 1807, 1643, 1601, 1551, 1523, 1490, 
1420, 1345, 1297, 1119, 1055, 1044, 1027, 1014, 871,855,812,717, 684, 639, 624. 
m/z (EI): 212 ([M]* 12.7 % ) , 193 ([M-F]^ 5.8 %) , 192 ([M-HF]^ 42.3 % ) , 179 ([M-
CH2F]^ 9.2 % ) , 163 ([M-NO-F]"" 8.6 %) , 162 ([M-NO-HF]^ 60.4 %) , 151 ([M-
NCH2CH2F]'" 6.6 % ) , 150 ([M-HNCH2CH2F]'' 60.9 %) , 120 ([M-HNCH2CH2F-NO]^ 5.5 
% ) , 104 ([M-HNCH2CH2F-N02]^ 23.9 %) , 76 ([C6H4]^ 32.2 %) , 46 ([NO2T 43.9 %) , 30 
([NO]"" 100%). 
Elemental Analysis: Calcd. for C9H9FN2O3: C: 51.0, H: 4.3, N : 13.2 %, found: C: 50.7, 
H: 4.3, N: 12.8%. 
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4.2.3.11 A^-(2-Fluoroethyl)acetamide 157 
O 
Acetyl chloride (0.29 ml, 4.08 mmol) was added to an ice cold solution of 
2-fluoroethylamine hydrochloride (0.3 g, 3.01 mmol) in CH2CI2 (10 ml), followed by 
pyridine (0.49 ml, 6.06 mmol). After 20 min, H2O (5 ml) was added and the mixture was 
washed with CH2CI2 (4 x 20 ml). The organic extracts were combined, dried over 
MgS04 and then solvent was removed under reduced pressure. Purification of the residue 
over silica gel (CH2CI2 / IPA, 7:1, Rf = 0.35 for 157, Iodine as visualiser), followed by 
lyophilisation to remove acetic acid afforded 157 (59.6 mg, 0.57 mmol, 18.8 %>) as a clear 
pale yellow oil. '^ F NMR analysis indicated > 92 %> purity. 
' H NMR (400.0 MHz) 5 1.97 (3H, s, CH3), 3.49 (2H, dq, VH-F = 28.4 Hz, VH-H = 5.2 Hz, 
NCH2), 4.43 (2H, dt, VH-F = 47.2 Hz, VH-H = 4.8 Hz, CH2F), 6.52 ( IH, s, NH). 
'^C NMR (100.6 MHz) 5 22.9 ( I C , s, CH3), 39.9 (IC, d, VC-F = 19.4 Hz, NCH2), 82.6 
(IC, d, 'Jc-F = 166.3 Hz, CH2F), 170.8 ( I C , s, CO). 
'^ F NMR (376.3 MHz) 5 -224.4 ( I F , tt, VH-F = 47.8 Hz, VH-F = 27.7 Hz, CH2CH2F). 
IR: 3439, 3296, 3095, 2967, 2934, 2852, 1713, 1659, 1650, 1643, 1633, 1564, 1555, 
1468, 1428, 1377, 1298, 1241, 1126, 1107, 1046, 951, 884, 823. 
m/z (EI): 106 ([M+l]"" 53.1 %) , 105 ([M]"" 100 %) , 90 ([M-CH3]* 10.1 %) , 86 ([M-F]^ 2.7 
% ) , 85 ([M-HF]^ 27.3 % ) , 72 ([M-CH2F]'" 72.9 %) , 62 ([M-CH3CO]'" 8.6 %) , 60 
([CH3CONH3]^ 16.4 %) , 48 ([CH3CH2F]* 27.5 %) , 47 ([CH2CH2F]^ 28.2 %) , 44 
([CH3CHO]* 72.9 % ) , 43 ( [ C H 3 C 0 ] ^ 82.3 %) . 
HRMS: (EI) Calcd. for C4H8FNO: 105.0590, found: 105.0591. 
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Bis-2,6-(fluoromethyl)pyridine 143 
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Table 1 Crystal data and structure refinement for bis-2,6-(fluoromethyl)pyridine 143. 
Identification code 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
Volume 
Z 
Density (calculated) 
Absorption coefficient 
F(OOO) 
Crystal size 
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflections 
Absorption correction 
Refinement method 
Data / restraints / parameters 
Goodness-of-fit on F2 
Final R indices [I>2sigma(I)] 
R indices (all data) 
Largest d i f f peak and hole 
a= 114.651(3)°. 
P= 107.054(2)°. 
Y = 97.189(3)°. 
76 
C7 H7 F2 N 
143.14 
150 K 
0.71073 A 
Triclinic 
P-1 
a = 6.3493(4) A 
b = 7.6080(4) A 
c = 8.1979(5) A 
329.84(3) A3 
2 
1.441 Mg/m3 
0.126 mm-1 
148 
0.6 X 0.14 X 0.12 mm3 
2.96 to 30.30°. 
-8<=h<=9, -10<=k<=10, -11<=1<=9 
2605 
1736 [R(int) = 0.0647] 
None 
Full-matrix least-squares on F2 
1725/0/91 
1.106 
Rl =0.0629, wR2 = 0.1317 
Rl =0.1139, wR2 = 0.1788 
0.321 and -0.249 e.A-3 
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Table 2 Atomic coordinates ( x IO4) and equivalent isotropic displacement parameters 
(A2x IO3) for bis-2,6-(fluoromethyl)pyridine 143. U(eq) is defined as one third of the 
trace of the orthogonalized Uij tensor. 
X y z U(eq) 
N( l ) 15825(3) 25000(3) 17660(3) 23(1) 
C(7) 17046(5) 27990(4) 20703(4) 30(1) 
C(5) 19856(4) 26758(4) 19126(4) 25(1) 
C(6) 17639(4) 26537(4) 19110(4) 23(1) 
C(3) 18347(4) 23720(4) 16066(4) 26(1) 
C(4) 20189(4) 25317(4) 17572(4) 29(1) 
C(2) 16176(4) 23626(4) 16164(3) 22(1) 
F(2) 18985(3) 29440(3) 22250(3) 51(1) 
F(l) 14496(3) 20690(2) 13043(2) 39(1) 
C(l) 14039(4) 21995(4) 14622(4) 27(1) 
Table 3 Bond lengths [A] for bis-2,6-(fluoromethyl)pyridine 143. 
N(l)-C(2) 1.340(3) 
N(l)-C(6) 1.345(3) 
C(7)-F(2) 1.385(3) 
C(7)-C(6) 1.503(4) 
C(7)-H(7B) 0.97 
C(7)-H(7A) 0.97 
C(5)-C(4) 1.386(4) 
C(5)-C(6) 1.392(3) 
C(5)-H(5) 0.93 
C(3)-C(4) 1.384(4) 
C(3)-C(2) 1.399(3) 
C(3)-H(3) 0.93 
C(4)-H(4) 0.93 
C(2)-C(l) 1.497(3) 
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F(l)-C(l) 1.401(3) 
C(1)-H(1A) 0.97 
C(1)-H(1B) 0.97 
C(2)-N(l)-C(6) 118.2(2) 
F(2)-C(7)-C(6) 111.9(2) 
F(2)-C(7)-H(7B) 109.23(15) 
C(6)-C(7)-H(7B) 109.23(14) 
F(2)-C(7)-H(7A) 109.23(15) 
C(6)-C(7)-H(7A) 109.23(14) 
H(7B)-C(7)-H(7A) 107.9 
C(4)-C(5)-C(6) 118.0(2) 
C(4)-C(5)-H(5) 120.99(15) 
C(6)-C(5)-H(5) 120.99(15) 
N(l)-C(6)-C(5) 123.0(2) 
N(l)-C(6)-C(7) 113.7(2) 
C(5)-C(6)-C(7) 123.3(2) 
C(4)-C(3)-C(2) 118.1(2) 
C(4)-C(3)-H(3) 120.9(2) 
C(2)-C(3)-H(3) 120.93(14) 
C(3)-C(4)-C(5) 120.0(2) 
C(3)-C(4)-H(4) 120.0(2) 
C(5)-C(4)-H(4) 120.01(14) 
N(l)-C(2)-C(3) 122.7(2) 
N(l)-C(2)-C(l) 113.9(2) 
C(3)-C(2)-C(l) 123.5(2) 
F(l)-C(l)-C(2) 111.0(2) 
F(1)-C(1)-H(1A) 109.45(13) 
C(2)-C(1)-H(1A) 109.45(14) 
F(1)-C(1)-H(1B) 109.45(13) 
C(2)-C(1)-H(1B) 109.45(13) 
H(1A)-C(1)-H(1B) 108.0 
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Table 4 Anisotropic displacement parameters (A2x 103) for bis-2,6-
(fluoromethyl)pyridine 143. The anisotropic displacement factor exponent takes the 
form: -27i2[ hi a*2Uii + ... + 2 h k a* b* Ui2 ] . 
U l l U22 U33 U23 U13 U12 
N( l ) 20(1) 24(1) 27(1) 14(1) 10(1) 7(1) 
C(7) 26(1) 28(1) 29(1) 9(1) 9(1) 4(1) 
C(5) 17(1) 30(1) 28(1) 16(1) 5(1) 3(1) 
C(6) 22(1) 23(1) 25(1) 13(1) 9(1) 8(1) 
C(3) 23(1) 30(1) 32(1) 16(1) 14(1) 13(1) 
C(4) 18(1) 40(2) 35(2) 22(1) 11(1) 10(1) 
C(2) 21(1) 24(1) 23(1) 15(1) 5(1) 6(1) 
F(2) 33(1) 42(1) 41(1) -4(1) 9(1) -1(1) 
F(l) 33(1) 35(1) 33(1) 6(1) 10(1) 9(1) 
C(l) 22(1) 27(1) 26(1) 11(1) 6(1) 6(1) 
Table 5 Hydrogen coordinates ( x 104) and isotropic displacement parameters (A2x lOs) 
for bis-2,6-(fluoromethyl)pyridine 143. 
X y z U(eq) 
H(7B) 16031(5) 28648(4) 20189(4) 36 
H(7A) 16231(5) 27251(4) 21160(4) 36 
H(5) 21076(4) 27840(4) 20149(4) 30 
H(3) 18547(4) 22737(4) 15018(4) 31 
H(4) 21651(4) 25424(4) 17541(4) 34 
H(1A) 13426(4) 21234(4) 15161(4) 32 
H(1B) 12890(4) 22597(4) 14179(4) 32 
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C(3A) 
Bis-2,6-(fluoromethyl)pyridine-A^-oxide 146 
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Table 1 Crystal data and structure refinement for bis-2,6-(fluoromethyl)pyridine-A/^-oxide 
146. 
Identification code 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
Volume 
Z 
Density (calculated) 
Absorption coefficient 
F(OOO) 
Crystal size 
Theta range for data collection 
Index ranges 
Reflecfions collected 
Independent reflections 
Absorption correcfion 
Refinement method 
Data / restraints / parameters 
Goodness-of-fit on F2 
Final R indices [I>2sigma(I)] 
R indices (all data) 
Largest d i f f peak and hole 
a= 90°. 
p= 121.2660(10)°. 
Y = 90°. 
fluom 
C7 H7 F2 N O 
159.14 
150(2)K 
0.71073 A 
Monoclinic 
C2/C 
a = 14.2949(14) A 
b = 7.2427(6) A 
c = 8.1325(8) A 
719.70(12) A3 
4 
1.469 Mg/m3 
0.133 mm-1 
328 
.08mm X .38mm x .4mm mm3 
3.27 to 27.50°. 
-16<=h<=18, -9<=k<=9, -10<=I<=10 
2552 
829 [R(int) = 0.0734] 
None 
Full-matrix least-squares on F2 
822 / 0/66 
1.105 
Rl =0.0431, wR2 = 0.1217 
Rl =0.0558, wR2 = 0.1490 
0.251 and -0.292 e.A-3 
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Table 2 Atomic coordinates ( x 104) and equivalent isotropic displacement parameters 
(A2x 103) for bis-2,6-(fluoromethyl)pyridine-A^-oxide 146. U(eq) is defined as one third 
of the trace of the orthogonalized Uij tensor. 
x y z U(eq) 
C(2) 782(1) 7176(2) 9083(2) 28(1) 
O(l') 0 9917(2) 7500 35(1) 
N ( l ) 0 8087(2) 7500 27(1) 
F(2') 2367(1) 7308(2) 12201(2) 49(1) 
C(4) 0 4292(3) 7500 34(1) 
C(3) 795(1) 5258(2) 9091(2) 31(1) 
C(2') 1556(1) 8406(2) 10704(2) 36(1) 
Table 3 Bond lengths [A] for bis-2,6-(fluoromethyl)pyridine-/V-oxide 146. 
C(2)-N(l) 
C(2)-C(3) 
C(2)-C(2') 
0(1')-N(1) 
N(l)-C(2)#l 
F(2')-C(2') 
C(4)-C(3)#l 
C(4)-C(3) 
C(4)-H(4) 
C(3)-H(3) 
C(2')-H(2A) 
C(2')-H(2B) 
1.359(2) 
1.389(2) 
1.497(2) 
1.326(2) 
1.359(2) 
1.412(2) 
1.389(2) 
1.389(2) 
0.98(3) 
0.95(2) 
0.98(2) 
0.96(2) 
N(l)-C(2)-C(3) 
N(l)-C(2)-C(2') 
C(3)-C(2)-C(2') 
119.5(2) 
114.46(13) 
126.1(2) 
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0(r)-N(l)-C(2)#l 119.02(9) 
0(r)-N(l)-C(2) 119.02(9) 
C(2)#l-N(l)-C(2) 122.0(2) 
C(3)#l-C(4)-C(3) 119.5(2) 
C(3)#l-C(4)-H(4) 120.25(10) 
C(3)-C(4)-H(4) 120.25(10) 
C(2)-C(3)-C(4) 119.8(2) 
C(2)-C(3)-H(3) 118.2(14) 
C(4)-C(3)-H(3) 122.0(13) 
F(2')-C(2')-C(2) 108.99(13) 
F(2')-C(2')-H(2A) 109.4(11) 
C(2)-C(2')-H(2A) 107.8(11) 
F(2')-C(2')-H(2B) 109.6(12) 
C(2)-C(2')-H(2B) 107.1(12) 
H(2A)-C(2')-H(2B) 113.9(17) 
Symmetry transformations used to generate equivalent atoms: #1 -x,y,-z+3/2 
Table 4 Anisotropic displacement parameters (A2x lOs) for bis-2,6-
(fluoromethyl)pyridine-A^-oxide 146. The anisotropic displacement factor exponent takes 
the form: -27r2[ h2 a*2Uii + ... + 2 h k a * b* U 1 2 ] . 
U l l U22 U33 U23 U13 U12 
C(2) 36(1) 20(1) 36(1) 1(1) 24(1) 1(1) 
O(l') 50(1) 10(1) 51(1) 0 31(1) 0 
N ( l ) 39(1) 13(1) 39(1) 0 27(1) 0 
F(2') 46(1) 44(1) 41(1) 1(1) 12(1) 2(1) 
C(4) 53(1) 16(1) 47(1) 0 36(1) 0 
C(3) 43(1) 20(1) 40(1) 6(1) 28(1) 5(1) 
C(2') 41(1) 28(1) 41(1) -2(1) 22(1) -1(1) 
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Table 5 Hydrogen coordinates ( x 104) and isotropic displacement parameters (A2x IO3) 
for bis-2,6-(fluoromethyl)pyridine-7V^-oxide 146. 
U(eq) 
H(3) 1357(18) 4647(31) 10202(32) 44(6) 
H(2A) 1137(15) 9054(26) 11168(26) 32(4) 
H(2B) 1891(17) 9211(29) 10212(29) 39(5) 
H(4) 0 2943(46) 7500 51(8) 
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2-(Fluoromethyl)quinoline monohydrate 147 
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Table 1 Crystal data and structure refinement for 2-(fluoromethyl)quinoline monohydrate 
147. 
Identification code 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
Volume 
Z 
Density (calculated) 
Absorption coefficient 
F(OOO) 
Crystal size 
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflections 
Completeness to theta = 27.49° 
Refinement method 
Data / restraints / parameters 
Goodness-of-fit on F2 
Final R indices [I>2sigma(I)] 
R indices (all data) 
Largest d i f f peak and hole 
a= 90°. 
P= 95.302(4)°. 
y = 90°. 
152 
C l O H l O F N O 
179.19 
150 K 
0.71073 A 
monoclinic 
P2(l)/c 
a = 4.4905(5) A 
b = 11.6238(12) A 
c= 17.1041(19) A 
888.96(17) A3 
4 
1.339 Mg/m3 
0.101 mm-1 
376 
0.4 x 0.2 X 0.05 mm3 
2.12 to 27.49°. 
-5<=h<=5, -1 l<=k<=13, -9<=1<=22 
2700 
1877 [R(int) = 0.0659] 
92.4 % 
Full-matrix least-squares on F2 
1877/0/ 162 
1.163 
Rl =0.0656, wR2 = 0.1317 
Rl =0.0885, wR2 = 0.1474 
0.218 and -0.261 e.A-3 
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Table 2 Atomic coordinates ( x 104) and equivalent isotropic displacement parameters 
(A2x 103) for 2-(fluoromethyl)quinoline monohydrate 147. U(eq) is defined as one third 
of the trace of the orthogonalized Uij tensor. 
X y z U(eq) 
N( l ) 1101(4) 2420(2) 4051(1) 24(1) 
C(2) -692(5) 1748(2) 4416(1) 25(1) 
F(l) -3711(4) 1541(2) 5493(1) 44(1) 
C(5) 949(5) 995(2) 2995(1) 27(1) 
C(4) -960(6) 314(2) 3414(2) 31(1) 
C(9) 3887(6) 2770(2) 2943(2) 30(1) 
C(10) 1947(5) 2059(2) 3339(1) 24(1) 
C(7) 3763(6) 1387(3) 1880(2) 39(1) 
C(3) -1785(6) 674(2) 4124(2) 29(1) 
C(l) -1517(7) 2214(3) 5195(2) 35(1) 
C(6) 1878(6) 690(3) 2250(2) 35(1) 
C(8) 4774(6) 2438(3) 2230(2) 36(1) 
0(1) 2354(6) 4732(2) 4582(2) 49(1) 
Table 3 Bond lengths [A] for 2-(fluoromethyl)quinoline monohydrate 147. 
N(l)-C(2) 1.320(3) 
N(l)-C(10) 1.375(3) 
C(2)-C(3) 1.415(4) 
C(2)-C(l) 1.516(3) 
F(l)-C(l) 1.392(3) 
C(5)-C(4) 1.410(4) 
C(5)-C(6) 1.423(4) 
C(5)-C(10) 1.424(4) 
C(4)-C(3) 1.368(4) 
C(4)-H(4) 0.98(3) 
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C(9)-C(8) 1.373(4) 
C(9)-C(10) 1.417(3) 
C(9)-H(9) 1.01(3) 
C(7)-C(6) 1.369(4) 
C(7)-C(8) 1.416(4) 
C(7)-H(7) 0.95(3) 
C(3)-H(3) 0.99(3) 
C(1)-H(1B) 1.02(3) 
C(1)-H(1A) 1.07(4) 
C(6)-H(6) 0.97(4) 
C(8)-H(8) 0.99(3) 
0(1)-HB 0.86(5) 
0(1)-HAA 0.95(8) 
0(1)-HAB 0.87(7) 
C(2)-N(l)-C(10) 118.0(2) 
N(l)-C(2)-C(3) 124.2(2) 
N(l)-C(2)-C(l) 114.4(2) 
C(3)-C(2)-C(l) 121.4(2) 
C(4)-C(5)-C(6) 123.9(3) 
C(4)-C(5)-C(10) 117.5(2) 
C(6)-C(5)-C(10) 118.6(2) 
C(3)-C(4)-C(5) 120.4(2) 
C(3)-C(4)-H(4) 121.0(15) 
C(5)-C(4)-H(4) 118.6(15) 
C(8)-C(9)-C(10) 120.2(3) 
C(8)-C(9)-H(9) 121.3(17) 
C(10)-C(9)-H(9) 118.5(17) 
N(l)-C(10)-C(9) 118.6(2) 
N(l)-C(10)-C(5) 121.9(2) 
C(9)-C(10)-C(5) 119.5(2) 
C(6)-C(7)-C(8) 120.2(3) 
C(6)-C(7)-H(7) 116(2) 
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C(8)-C(7)-H(7) 123(2) 
C(4)-C(3)-C(2) 118.1(2) 
C(4)-C(3)-H(3) 122.0(18) 
C(2)-C(3)-H(3) 119.8(18) 
F(l)-C(l)-C(2) 111.1(2) 
F(1)-C(1)-H(1B) 107.8(19) 
C(2)-C(1)-H(1B) 109.7(18) 
F(1)-C(1)-H(1A) 103.7(18) 
C(2)-C(1)-H(1A) 110.4(19) 
H(1B)-C(1)-H(1A) 114(3) 
C(7)-C(6)-C(5) 120.8(3) 
C(7)-C(6)-H(6) 123(2) 
C(5)-C(6)-H(6) 116(2) 
C(9)-C(8)-C(7) 120.6(3) 
C(9)-C(8)-H(8) 121.4(18) 
C(7)-C(8)-H(8) 117.9(18) 
HB-0(1)-HAA 100(5) 
HB-0(1)-HAB 103(6) 
HAA-0(1)-HAB 109(7) 
Table 4 Anisotropic displacement parameters (A2x 103) for 2-(fluoromethyl)quinoline 
monohydrate 147. The anisotropic displacement factor exponent takes the form: -27t2[ 
h2 a*2Ul 1 + ... + 2 h k a* b* U12 ] . 
U l l U22 U33 U23 U13 U12 
N ( l ) 28(1) 18(1) 28(1) -3(1) 4(1) 0(1) 
C(2) 26(1) 20(1) 30(1) 0(1) 4(1) 0(1) 
F(l) 47(1) 46(1) 43(1) 0(1) 22(1) -10(1) 
C(5) 26(1) 24(1) 29(1) -4(1) -1(1) 6(1) 
C(4) 31(1) 18(1) 42(2) -6(1) -4(1) -1(1) 
C(9) 30(1) 27(2) 32(1) 4(1) 5(1) 2(1) 
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C(10) 25(1) 20(1) 26(1) 0(1) 2(1) 5(1) 
C(7) 38(2) 51(2) 27(1) -4(1) 4(1) 15(1) 
C(3) 28(1) 22(1) 37(1) -1(1) 3(1) -4(1) 
C(l) 42(2) 30(2) 37(2) -4(1) 17(1) -7(1) 
C(6) 37(1) 34(2) 33(1) -10(1) -3(1) 9(1) 
C(8) 38(2) 41(2) 32(1) 8(1) 11(1) 8(1) 
0(1) 62(2) 27(1) 59(2) -12(1) 15(1) -6(1) 
Table 5 Hydrogen coordinates ( x IO4) and isotropic displacement parameters (A2x I O 3 ) 
for 2-(fluoromethyl)quinoline monohydrate 147. 
U(eq) 
H(4) -1640(60) -430(20) 3190(15) 24(7) 
H(9) 4640(60) 3500(30) 3205(18) 39(8) 
H(8) 6210(70) 2900(30) 1956(18) 40(8) 
H(3) -3220(60) 240(30) 4413(17) 38(8) 
H(1B) 310(70) 2210(30) 5593(19) 51(10) 
HB 2160(80) 4040(40) 4420(20) 66(12) 
H(6) 1140(70) -30(30) 2030(20) 53(10) 
H(1A) -2560(80) 3040(30) 5120(20) 59(10) 
H(7) 4320(70) 1130(30) 1390(20) 56(10) 
HAA 4130(170) 4660(70) 4920(50) 60(30) 
HAB 830(170) 4820(70) 4860(50) 60(30) 
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4-Bromobenzyl fluoride 149 
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Table 1 Crystal data and structure refinement for 4-bromobenzyl fluoride 149. 
Identification code 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
Volume 
Z 
Density (calculated) 
Absorption coefficient 
F(OOO) 
Crystal size 
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflections 
Absorption correcfion 
Refinement method 
Data / restraints / parameters 
Goodness-of-fit on F2 
Final R indices [I>2sigma(I)] 
R indices (all data) 
Absolute structure parameter 
Largest diff. peak and hole 
asb 
C7 H6 Br F 
189.03 
150K 
0.71073 A 
Monoclinic 
F2(l) 
a = 5.9266(2) A a= 90°. 
b = 7.3604(3) A p= 90.753(2)°. 
c = 7.9376(3) A y = 90°. 
346.23(2) A3 
2 
1.813 Mg/m3 
5.855 mm-1 
184 
0.6 X 0.16 X 0.10 mm3 
2.57 to 27.43°. 
-7<=h<=7, -9<=k<=9, -10<=1<=10 
3129 
1432 [R(int) = 0.0919] 
None 
Full-matrix least-squares on F2 
1427/ 1 /86 
1.725 
Rl = 0.0940, wR2 = 0.2266 
Rl =0.1100, wR2 = 0.2464 
0.27(5) 
2.573 and-1.351 e.A-3 
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Table 2 Atomic coordinates ( x IO4) and equivalent isotropic displacement parameters 
(A2x 103) for 4-bromobenzyl fluoride 149. U(eq) is defined as one third of the trace of 
the orthogonalized Uij tensor. 
X y z U(eq) 
Br 5351(2) 2502(2) 8418(1) 39(1) 
C(l) 3656(15) 2798(14) 6403(12) 18(3) 
C(2) 1578(16) 3601(14) 6459(15) 23(2) 
C(3) 374(16) 3939(13) 4945(16) 24(2) 
C(4) 1276(18) 3392(16) 3428(15) 26(2) 
C(5) 3401(14) 2519(29) 3379(10) 24(2) 
C(6) 4627(16) 2256(23) 4896(13) 23(3) 
C(7) -229(17) 3676(14) 1685(12) 15(2) 
F(1A) -1330(29) 2307(40) 1346(39) 52(5) 
F(1B) -452(33) 2007(38) 1109(44) 52(5) 
Table 3 Bond lengths [A] for 4-bromobenzyl fluoride 149. 
Br-C(l) 1.890(9) 
C(l)-C(2) 1.367(13) 
C(l)-C(6) 1.393(14) 
C(2)-C(3) 1.41(2) 
C(2)-H(2) 0.93 
C(3)-C(4) 1.38(2) 
C(3)-H(3) 0.93 
C(4)-C(5) 1.42(2) 
C(4)-C(7) 1.649(15) 
C(5)-C(6) 1.411(14) 
C(5)-H(5) 0.93 
C(6)-H(6) 0.93 
C(7)-F(1A) 1.23(3) 
203 
C(7)-F(1B) 1.32(3) 
C(2)-C(l)-C(6) 122.3(10) 
C(2)-C(l)-Br 119.4(8) 
C(6)-C(l)-Br 118.2(7) 
C(l)-C(2)-C(3) 119.6(10) 
C(l)-C(2)-H(2) 120.2(7) 
C(3)-C(2)-H(2) 120.2(6) 
C(4)-C(3)-C(2) 119.5(9) 
C(4)-C(3)-H(3) 119.9(6) 
C(2)-C(3)-H(3) 120.6(6) 
C(3)-C(4)-C(5) 120.7(10) 
C(3)-C(4)-C(7) 118.9(9) 
C(5)-C(4)-C(7) 120.4(9) 
C(6)-C(5)-C(4) 119.2(11) 
C(6)-C(5)-H(5) 120.0(8) 
C(4)-C(5)-H(5) 120.7(6) 
C(l)-C(6)-C(5) 118.7(10) 
C(l)-C(6)-H(6) 120.5(6) 
C(5)-C(6)-H(6) 120.7(7) 
F(1A)-C(7)-C(4) 111.1(16) 
F(1B)-C(7)-C(4) 102.9(16) 
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Table 4 Anisotropic displacement parameters (A2x IO3) for 4-bromobenzyl fluoride 149. 
The anisotropic displacement factor exponent takes the form: -27i2[ h2 a*2Ul 1 + ... + 2 h 
ka* b*U12] . 
U l l U22 U33 U23 U13 U12 
Br 32(1) 43(1) 43(1) 2(1) -9(1) 0(1) 
C(l) 11(4) 16(8) 27(4) -4(4) 0(3) 1(3) 
C(2) 8(4) 14(5) 49(7) -5(5) 5(4) 1(4) 
C(3) 7(4) 12(5) 54(7) 0(5) -2(4) 2(4) 
C(4) 19(5) 23(6) 37(6) -11(5) -3(4) 2(4) 
C(5) 24(4) 26(4) 21(4) 4(8) -2(3) -7(9) 
C(6) 17(4) 25(9) 27(4) -2(5) 4(3) 0(5) 
C(7) 28(5) 7(4) 9(4) 3(3) 6(4) -2(4) 
F(1A) 37(12) 38(12) 80(11) -23(7) -36(12) 10(11) 
F(1B) 37(12) 38(12) 80(11) -23(7) -36(12) 10(11) 
Table 5 Hydrogen coordinates ( x IO4) and isotropic displacement parameters (A2x I O 3 ) 
for 4-bromobenzyl fluoride 149. 
X y z U(eq) 
H(2) 962(16) 3925(14) 7488(15) 28 
H(3) -1024(16) 4511(13) 4962(16) 29 
H(5) 3960(14) 2073(29) 2371(10) 28 
H(6) 6087(16) 1794(23) 4885(13) 28 
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Table 1 Crystal data and structure refinement for benzyl fluoride 148. 
Identification code 99srvl54 
Empirical formula C7 H7F 
Formula weight 110.13 
Temperature 120 K 
Wavelength 0.71073 A 
Crystal system Orthorhombic 
Space group Pbcn 
Unit cell dimensions a = 7.3453(15) A a = = 90° 
b = 12.048(2) A P = = 90° 
c = 13.586(3) A Y = = 90°. 
Volume 1202.3(4) A3 
Z 9 
Density (calculated) 1.369 Mg/m3 
Absorpfion coefficient 
F(OOO) 
Crystal size 
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflecfions 
Completeness to theta = 30.45° 
Absorption correction 
Refinement method 
Data / restraints / parameters 
Goodness-of-fit on F2 
Final R indices [I>2sigma(I)] 
R indices (all data) 
Largest diff. peak and hole 
0.102 mm-1 
522 
diameter 0.3mm, length 0.7mm 
3.00 to 30.45°. 
-9<=h<=10, -16<=k<=15, -18<=1<=18 
13119 
1710 [R(int) = 0.0367] 
93.4 % 
None 
Full-matrix least-squares on F2 
1710/0/101 
1.054 
Rl =0.0421, wR2 = 0.1077 
Rl =0.0561, wR2 = 0.1180 
0.345 and -0.183 e.A-3 
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Table 2 Atomic coordinates ( x IO4) and equivalent isotropic displacement parameters 
(A2x IO3) for benzyl fluoride 148. U(eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
X y z U(eq) 
F(l) 2423(1) 8857(1) 3132(1) 44(1) 
C(2) 3439(1) 8929(1) 4796(1) 23(1) 
C(3) 2241(2) 9626(1) 5312(1) 26(1) 
C(5) 2492(2) 8451(1) 6750(1) 31(1) 
C(7) 4172(2) 7995(1) 5272(1) 27(1) 
C(6) 3704(2) 7760(1) 6247(1) 30(1) 
C(4) 1753(2) 9384(1) 6282(1) 30(1) 
C(l) 3904(2) 9178(1) 3739(1) 31(1) 
Table 3 Bond lengths [A] for benzyl fluoride 148. 
F(l)-C(l) 1.4194(13) 
C(2)-C(3) 1.4040(15) 
C(2)-C(7) 1.4054(15) 
C(2)-C(l) 1.5057(15) 
C(3)-C(4) 1.3959(16) 
C(3)-H(3) 0.998(15) 
C(5)-C(6) 1.3967(17) 
C(5)-C(4) 1.4003(17) 
C(5)-H(5) 0.952(17) 
C(7)-C(6) 1.3980(16) 
C(7)-H(7) 0.983(15) 
C(6)-H(6) 0.950(16) 
C(4)-H(4) 0.961(16) 
C(1)-H(1B) 0.989(17) 
C(1)-H(1A) 0.994(17) 
C(3)-C(2)-C(7) 119.30(10) 
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C(3)-C(2)-C(l) 119.96(10) 
C(7)-C(2)-C(l) 120.74(10) 
C(4)-C(3)-C(2) 120.46(10) 
C(4)-C(3)-H(3) 118.4(9) 
C(2)-C(3)-H(3) 121.2(9) 
C(6)-C(5)-C(4) 120.21(10) 
C(6)-C(5)-H(5) 120.9(10) 
C(4)-C(5)-H(5) 118.9(10) 
C(6)-C(7)-C(2) 120.25(10) 
C(6)-C(7)-H(7) 119.8(8) 
C(2)-C(7)-H(7) 119.9(8) 
C(5)-C(6)-C(7) 119.96(10) 
C(5)-C(6)-H(6) 121.6(9) 
C(7)-C(6)-H(6) 118.4(9) 
C(3)-C(4)-C(5) 119.80(10) 
C(3)-C(4)-H(4) 118.5(9) 
C(5)-C(4)-H(4) 121.7(9) 
F(l)-C(l)-C(2) 109.06(9) 
F(1)-C(1)-H(1B) 106.5(9) 
C(2)-C(1)-H(1B) 111.8(9) 
F(1)-C(1)-H(1A) 107.4(10) 
C(2)-C(1)-H(1A) 112.5(10) 
H(1B)-C(1)-H(1A) 109.4(14) 
209 
Table 4 Anisotropic displacement parameters (A2x IO3) for benzyl fluoride 148. The 
anisotropic displacement factor exponent takes the form: -2n2[ h2 a*2Uii + ... + 2 h k a* 
b* U12]. 
U l l U22 U33 U23 U13 U12 
F(l) 45(1) 60(1) 27(1) 0(1) -9(1) -19(1) 
C(2) 20(1) 27(1) 23(1) -1(1) -2(1) -4(1) 
C(3) 23(1) 26(1) 30(1) 0(1) -3(1) 1(1) 
C(5) 31(1) 37(1) 24(1) 0(1) 0(1) -7(1) 
C(7) 23(1) 27(1) 31(1) -2(1) 0(1) 2(1) 
C(6) 30(1) 29(1) 32(1) 6(1) -5(1) 0(1) 
C(4) 26(1) 33(1) 30(1) -7(1) 3(1) 0(1) 
C(l) 29(1) 39(1) 24(1) 0(1) -1(1) -7(1) 
Table 5 Hydrogen coordinates ( x 104) and isotropic displacement parameters (A2x 10 3) 
for benzyl fluoride 148. 
X y z U(eq) 
H(7) 5000(20) 7498(12) 4915(10) 38(4) 
H(3) 1750(20) 10316(12) 5006(11) 35(4) 
H(4) 940(20) 9882(13) 6618(11) 38(4) 
H(6) 4220(20) 7125(13) 6551(11) 39(4) 
H(5) 2150(20) 8298(13) 7412(12) 40(4) 
H(1B) 4090(20) 9981(14) 3629(11) 41(4) 
H(1A) 4990(20) 8764(14) 3509(12) 48(4) 
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Table 6 Torsion angles [°] for benzyl fluoride 148. 
C(7)-C(2)-C(3)-C(4) -1.27(16) 
C(l)-C(2)-C(3)-C(4) 177.85(10) 
C(3)-C(2)-C(7)-C(6) 0.33(16) 
C(l)-C(2)-C(7)-C(6) -178.79(10) 
C(4)-C(5)-C(6)-C(7) -0.45(18) 
C(2)-C(7)-C(6)-C(5) 0.53(17) 
C(2)-C(3)-C(4)-C(5) 1.35(17) 
C(6)-C(5)-C(4)-C(3) -0.49(18) 
C(3)-C(2)-C(l)-F(l) -76.61(13) 
C(7)-C(2)-C(l)-F(l) 102.50(12) 
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Table 1 Crystal data and structure refinement for 7V-(2-fluoroethyl)-3,5-dinitrobenzamide 
154. 
Identification code 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
Volume 
Z 
Density (calculated) 
Absorption coefficient 
F(OOO) 
Crystal size 
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflections 
Completeness to theta = 23.25° 
Absorption correction 
Refinement method 
Data / restraints / parameters 
Goodness-of-fit on F2 
Final R indices [I>2sigma(I)] 
R indices (all data) 
Largest d i f f peak and hole 
99srv092 
C9 H8 F N3 05 
257.18 
150K 
0.71073 A 
Monoclinic 
P2(l)/n 
a = 10.1176(6) A a=90°. 
b = 4.8253(3) A |3= 93.610(4)°. 
c = 21.0006(14) A 7 = 90°. 
1023.22(11) A3 
3 
1.252 Mg/m3 
0.112mm-l 
396 
0.6 X 0.15 X 0.12 mm3 
1.94 to 23.25°. 
- l l < = h < = l l , -5<=k<=5, -23<=1<=19 
4851 
1475 [R(int) = 0.0572] 
100.0% 
None 
Full-matrix least-squares on F2 
1475/0/ 195 
1.056 
Rl =0.0310, wR2 = 0.0764 
Rl =0.0373, wR2 = 0.0803 
0.132 and -0.216e.A-3 
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Table 2 Atomic coordinates ( x IO4) and equivalent isotropic displacement parameters 
(A2x 103) for #-(2-fluoroethyl)-3,5-dinitrobenzamide 154. U(eq) is defined as one third 
of the trace of the orthogonalized Uij tensor. 
X y z U(eq) 
F(l) 8660(1) 1239(2) 5067(1) 30(1) 
0(1) 16687(1) 3667(3) 7806(1) 29(1) 
0(2) 15449(1) 7359(3) 7805(1) 29(1) 
0(5) 11287(1) 7781(3) 6440(1) 23(1) 
N(3) 10588(1) 3766(3) 5963(1) 19(1) 
C(6) 12842(2) 4055(4) 6419(1) 17(1) 
0(3) 16188(1) -2296(3) 5939(1) 30(1) 
N( l ) 15733(2) 5066(3) 7600(1) 22(1) 
C(4) 14578(2) 883(4) 6194(1) 17(1) 
N(2) 15077(2) -1367(3) 5795(1) 21(1) 
0(4) 14353(1) -2205(3) 5346(1) 30(1) 
C(5) 13325(2) 1945(4) 6040(1) 18(1) 
C(2) 14882(2) 3926(4) 7068(1) 19(1) 
C(l) 13635(2) 5076(4) 6934(1) 20(1) 
C(3) 15386(2) 1802(4) 6709(1) 19(1) 
C(8) 9245(2) 4827(4) 5813(1) 20(1) 
C(9) 8298(2) 2535(4) 5635(1) 22(1) 
C(7) 11498(2) 5359(4) 6277(1) 18(1) 
Table 3 Bond lengths [A] for A^-(2-fluoroethyl)-3,5-dinitrobenzamide 154. 
F(l)-C(9) 
0(1)-N(1) 
0(2)-N(l) 
0(5)-C(7) 
N(3)-C(7) 
N(3)-C(8) 
1.415(2) 
1.234(2) 
1.228(2) 
1.240(2) 
1.341(2) 
1.467(2) 
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N(3)-H(8) 0.86(2) 
C(6)-C(l) 1.394(3) 
C(6)-C(5) 1.399(3) 
C(6)-C(7) 1.512(2) 
0(3)-N(2) 1.2291(19) 
N(l)-C(2) 1.473(2) 
C(4)-C(5) 1.387(3) 
C(4)-C(3) 1.386(3) 
C(4)-N(2) 1.480(2) 
N(2)-0(4) 1.2268(19) 
C(5)-H(5) 0.94(2) 
C(2)-C(3) 1.388(3) 
C(2)-C(l) 1.391(3) 
C(l)-H(l) 0.93(2) 
C(3)-H(3) 0.93(2) 
C(8)-C(9) 1.496(3) 
C(8)-H(8B) 0.99(2) 
C(8)-H(8A) 0.97(2) 
C(9)-H(9B) 0.99(2) 
C(9)-H(9A) 1.01(2) 
C(7)-N(3)-C(8) 120.21(16) 
C(7)-N(3)-H(8) 117.7(14) 
C(8)-N(3)-H(8) 120.1(14) 
C(l)-C(6)-C(5) 119.57(16) 
C(l)-C(6)-C(7) 118.25(16) 
C(5)-C(6)-C(7) 122.15(15) 
0(2)-N(l)-0(l) 124.38(15) 
0(2)-N(l)-C(2) 117.70(15) 
0(1)-N(1)-C(2) 117.92(16) 
C(5)-C(4)-C(3) 123.32(17) 
C(5)-C(4)-N(2) 118.62(15) 
C(3)-C(4)-N(2) 118.06(16) 
0(4)-N(2)-0(3) 124.14(15) 
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0(4)-N(2)-C(4) 117.94(14) 
0(3)-N(2)-C(4) 117.92(15) 
C(4)-C(5)-C(6) 118.87(16) 
C(4)-C(5)-H(5) 119.0(12) 
C(6)-C(5)-H(5) 122.2(12) 
C(3)-C(2)-C(l) 122.95(17) 
C(3)-C(2):N(1) 118.06(16) 
C(l)-C(2)-N(l) 118.95(17) 
C(2)-C(l)-C(6) 119.12(18) 
C(2)-C(l)-H(l) 119.9(12) 
C(6)-C(l)-H(l) 121.0(12) 
C(4)-C(3)-C(2) 116.16(17) 
C(4)-C(3)-H(3) 123.6(12) 
C(2)-C(3)-H(3) 120.2(12) 
N(3)-C(8)-C(9) 111.45(16) 
N(3)-C(8)-H(8B) 109.3(11) 
C(9)-C(8)-H(8B) 109.2(11) 
N(3)-C(8)-H(8A) 108.1(11) 
C(9)-C(8)-H(8A) 111.6(11) 
H(8B)-C(8)-H(8A) 107.0(16) 
F(l)-C(9)-C(8) 110.01(15) 
F(1)-C(9)-H(9B) 105.6(11) 
C(8)-C(9)-H(9B) 112.1(11) 
F(1)-C(9)-H(9A) 106.7(11) 
C(8)-C(9)-H(9A) 111.5(11) 
H(9B)-C(9)-H(9A) 110.6(15) 
0(5)-C(7)-N(3) 123.46(17) 
0(5)-C(7)-C(6) 120.39(16) 
N(3)-C(7)-C(6) 116.14(16) 
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Table 4 Anisotropic displacement parameters (A2x lOs) for #-(2-fluoroethyl)-3,5-
dinitrobenzamide 154. The anisotropic displacement factor exponent takes the form: 
-27c2[ h2 a*2Ui i + ... + 2 h k a* b* Ui2 ] . 
U l l U22 U33 U23 U13 U12 
F(l) 27(1) 34(1) 29(1) -12(1) 1(1) 1(1) 
0(1) 22(1) 36(1) 27(1) 1(1) -6(1) 0(1) 
0(2) 34(1) 28(1) 25(1) -7(1) 0(1) -3(1) 
0(5) 23(1) 18(1) 29(1) -4(1) 2(1) 1(1) 
N(3) 17(1) 15(1) 23(1) -2(1) 0(1) 2(1) 
C(6) 17(1) 17(1) 18(1) 2(1) 1(1) -3(1) 
0(3) 20(1) 30(1) 41(1) -7(1) -1(1) 8(1) 
N(-l) 22(1) 26(1) 18(1) 1(1) 2(1) -5(1) 
C(4) 18(1) 16(1) 18(1) 0(1) 3(1) -1(1) 
N(2) 19(1) 20(1) 24(1) 0(1) 3(1) 0(1) 
0(4) 27(1) 34(1) 30(1) -13(1) -2(1) 1(1) 
C(5) 19(1) 18(1) 16(1) 1(1) 1(1) -3(1) 
C(2) 19(1) 21(1) 15(1) 1(1) 0(1) -5(1) 
C(l) 22(1) 17(1) 20(1) 1(1) 6(1) -2(1) 
C(3) 17(1) 20(1) 22(1) 6(1) 1(1) -2(1) 
C(8) 18(1) 21(1) 20(1) -1(1) 0(1) 4(1) 
C(9) 19(1) 27(1) 20(1) -3(1) 2(1) 2(1) 
C(7) 19(1) 19(1) 15(1) 1(1) 4(1) -1(1) 
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Table 5 Hydrogen coordinates ( x 104) and isotropic displacement parameters (A2x 103) 
for 7V-(2-fluoroethyl)-3,5-dinitrobenzamide 154. 
X y z U(eq) 
H(3) 16220(20) 1090(40) 6814(9) 24(5) 
H(9B) 8318(18) 1060(40) 5960(9) 23(5) 
H(5) 12835(19) 1260(40) 5676(10) 24(5) 
H(8B) 8938(18) 5820(40) 6188(9) 23(5) 
H(8A) 9286(18) 6180(40) 5472(10) 23(5) 
H( l ) 13335(19) 6490(50) 7190(10) 28(6) 
H(9A) 7370(20) 3250(40) 5548(9) 23(5) 
H(8) 10740(20) 2020(50) 5941(10) 31(6) 
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Table 1 Crystal data and structure refinement for //-(2-fluoroethyl)-4-nitrobenzamide 
155. 
Identification code 
Empirical formula 
Formula weight 
Temperature 
Wavelength 
Crystal system 
Space group 
Unit cell dimensions 
Volume 
Z 
Density (calculated) 
Absorption coefficient 
F(OOO) 
Crystal size 
Theta range for data collection 
Index ranges 
Reflections collected 
Independent reflections 
Completeness to theta = 30.13° 
Refinement method 
Data / restraints / parameters 
Goodness-of-fit on F2 
Final R indices [I>2sigma(I)] 
R indices (all data) 
Absolute structure parameter 
Largest diff. peak and hole 
pna21 
C9 H9 F N2 03 
212.18 
150K 
0.71073 A 
Orthorhombic 
Pna2(l) 
a = 9.955(2) A a = 90°. 
b = 20.411(4) A P = 90°. 
c = 4.6400(9) A Y = 90°. 
942.8(3) A3 
4 
1.495 Mg/m3 
0.126 mm-1 
440 
0.5 x 0.2 X 0.05 mm3 
2.00 to 30.13°. 
-13<=h<=13, -27<=k<=28, -6<=1<=6 
11454 
2644 [R(int) = 0.0455] 
96.3 % 
Full-matrix least-squares on F2 
2644/ 1 / 177 
1.039 
Rl =0.0473, wR2 = 0.1034 
Rl =0.0795, wR2 = 0.1146 
-0.6(12) 
0.221 and -0.244 e.A-3 
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Table 2 Atomic coordinates ( x IO4) and equivalent isotropic displacement parameters 
(A2x IO3) for A/^-(2-fluoroethyl)-4-nitrobenzamide 155. U(eq) is defined as one third of 
the trace of the orthogonalized Uij tensor. 
X y z U(eq) 
N(2) 7122(2) 7427(1) 1551(4) 33(1) 
C(3) 7313(2) 9314(1) 8624(4) 30(1) 
0(3) 4955(1) 7675(1) 2497(4) 42(1) 
C(6) 6621(2) 8322(1) 4864(4) 27(1) 
C(8) 6789(2) 6880(1) -330(5) 38(1) 
C(2) 8321(2) 8997(1) 7110(5) 35(1) 
N( l ) 7687(2) 9830(1) 10666(4) 37(1) 
C(7) 6175(2) 7780(1) 2874(4) 30(1) 
C(l) 7974(2) 8496(1) 5242(5) 34(1) 
C(4) 5967(2) 9156(1) 8287(5) 35(1) 
C(5) 5635(2) 8657(1) 6386(5) 35(1) 
0(2) 8867(2) 9944(1) 11066(4) 54(1) 
0(1) 6792(2) 10113(1) 11973(6) 80(1) 
C(9) 6755(3) 6237(1) 1248(6) 51(1) 
F(2) 6043(3) 6248(1) 3519(7) 50(1) 
F(l) 7832(2) 6052(1) 2630(8) 52(1) 
Table 3 Bond lengths [A] for A^-(2-fluoroethyl)-4-nitrobenzamide 155. 
N(2)-C(7) 
N(2)-C(8) 
C(3)-C(2) 
C(3)-C(4) 
C(3)-N(l) 
0(3)-C(7) 
C(6)-C(5) 
1.337(3) 
1.455(3) 
1.386(3) 
1.387(3) 
1.465(3) 
1.245(2) 
1.390(3) 
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C(6)-C(l) 1.403(2) 
C(6)-C(7) 1.508(3) 
C(8)-C(9) 1.503(3) 
C(2)-C(l) 1.384(3) 
N(l)-0(2) 1.211(2) 
N(l)-0(1) 1.222(3) 
C(4)-C(5) 1.387(3) 
C(9)-F(2) 1.270(4) 
C(9)-F(l) 1.305(3) 
C(7)-N(2)-C(8) 121.90(17) 
C(2)-C(3)-C(4) 122.21(19) 
C(2)-C(3)-N(l) 118.73(17) 
C(4)-C(3)-N(l) 119.06(17) 
C(5)-C(6)-C(l) 119.29(19) 
C(5)-C(6)-C(7) 117.65(16) 
C(l)-C(6)-C(7) 123.05(17) 
N(2)-C(8)-C(9) 112.48(18) 
C(l)-C(2)-C(3) 118.80(18) 
0(2)-N(l)-0(l) 122.7(2) 
0(2)-N(l)-C(3) 118.84(17) 
0(1)-N(1)-C(3) 118.38(18) 
0(3)-C(7)-N(2) 122.1(2) 
0(3)-C(7)-C(6) 119.99(18) 
N(2)-C(7)-C(6) 117.95(15) 
C(2)-C(l)-C(6) 120.35(19) 
C(5)-C(4)-C(3) 118.23(18) 
C(4)-C(5)-C(6) 121.09(18) 
F(2)-C(9)-F(l) 93.2(3) 
F(2)-C(9)-C(8) 113.7(2) 
F(l)-C(9)-C(8) 118.3(2) 
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Table 4 Anisotropic displacement parameters (A2x 103) for 7V-(2-fluoroethyl)-4-
nitrobenzamide 155. The anisotropic displacement factor exponent takes the form- -2n2f 
h2a*2Uii + ... + 2 h k a * b* Ui2 ] . 
U l l U22 U33 U23 U13 U12 
N(2) 19(1) 43(1) 36(1) -1(1) -4(1) -4(1) 
C(3) 24(1) 31(1) 34(1) 5(1) 0(1) 2(1) 
0(3) 17(1) 54(1) 54(1) -3(1) -5(1) -6(1) 
C(6) 19(1) 34(1) 30(1) 6(1) -3(1) -2(1) 
C(8) 25(1) 54(1) 34(1) -8(1) -2(1) -1(1) 
C(2) 20(1) 39(1) 45(1) -2(1) 0(1) -2(1) 
N( l ) 34(1) 35(1) 42(1) 0(1) -1(1) 4(1) 
C(7) 20(1) 37(1) 34(1) 7(1) -2(1) -3(1) 
C(l) 17(1) 41(1) 46(1) 0(1) 3(1) 0(1) 
C(4) 22(1) 44(1) 39(1) 0(1) 1(1) 7(1) 
C(5) 18(1) 44(1) 43(1) 6(1) -2(1) 2(1) 
0(2) 31(1) 63(1) 68(1) -21(1) -2(1) -7(1) 
0(1) 40(1) 84(1) 114(2) -58(2) 1(1) 12(1) 
C(9) 60(2) 45(1) 48(1) -16(1) -13(1) 10(1) 
F(2) 47(2) 44(1) 58(2) 0(1) 12(1) -1(1) 
F(l) 34(1) 46(1) 76(2) -1(1) -24(1) 3(1) 
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Table 5 Hydrogen coordinates ( x 104) and isotropic displacement parameters (A2x IO3) 
for A^-(2-fluoroethyl)-4-nitrobenzamide 155. 
X y z U(eq) 
H( l ) 8670(20) 8282(12) 4070(60) 44(7) 
H(8B) 7470(20) 6864(10) -1890(50) 34(6) 
H(4) 5300(20) 9354(12) 9410(60) 44(6) 
H(9) 6540(20) 5903(11) -110(60) 38(6) 
H(5) 4720(20) 8521(10) 6120(60) 45(6) 
H(8A) 5890(20) 6940(10) -1330(50) 35(6) 
H(2) 9270(20) 9103(11) 7320(70) 47(7) 
H(6) 7930(30) 7488(13) 2000(60) 48(7) 
224 
Conferences 
RSC 30^ Stereochemistry at Sheffield, Dec 17'^ 1996. 
RSC Perkin Division - BioOrganic Group, Cardiff, University of Wales, Dec 17'\ 1997. 
RSC National Congress & Young Researchers' Meeting, University of Durham, April 
6-9'\ 1998. 
12"" European Symposium on Fluorine Chemistry, Freie Universitat Berlin, July 8-12'^ 
1998. Presented poster, 'Conformational preferences of 2-(fluoromethyl)pyridines and 
related compounds'. 
RSC 32^ ^ Stereochemistry at Sheffield, Dec 7'^ 1998. 
RSC Perkin Division - BioOrganic Group, University of Leicester, Dec 17"^ , 1999. 
Presented poster, 'Synthesis of l-deoxy-D-xyulose-5-phosphates analogues as putative 
antibiofics'. 
Heterocycles as Synthetic Reagents: a Review Symposium, University of Sunderland, 
May5"' 1999. 
RSC National Congress & Young Researchers' Meefing, Heriot-Watt University, 
September 6-10"", 1999. Presented poster 'Synthesis of l-deoxy-D-xyulose-5-phosphates 
analogues as putafive antibiotics'. 
225 
